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Summary 
 
The thymus provides the microenvironment for the maturation and selection of the majority of 
peripheral T cells. Endodermal cells of the ventral aspect of the third pharyngeal pouch (3rdpp) at 
10.5 days of mouse gestation (E10.5) adopt a thymic epithelial cell fate while cells of the dorsal 
part of the 3rdpp give rise to the parathyroid glands. To identify novel genes potentially involved 
in the commitment of endodermal cells to the thymic epithelial cell fate, the transcriptome of the 
3rdpp was compared to that of the 2ndpp and to that of the 4thpp with the help of laser 
microdissection and gene expression profiling (microarrays). Similarly, the transcriptome of the 
ventral circumference of the 3rdpp was in addition compared to its dorsal counterpart. Taken 
together, fifty genes were identified by microarray and confirmed by quantitative RT-PCR as 
being differentially expressed between the ventral and the dorsal aspects of the 3rdpp while 12 
genes were revealed as being upregulated if not exclusively expressed in the entire 3rdpp when 
compared to the 2ndpp. Among the genes revealed to be differentially expressed within the 3rdpp, 
two expressed sequence targets (ESTs) were found as being expressed in the ventral aspect of the 
3rdpp but not in the dorsal side of the pharyngeal pouch while 5 genes (Tbx1, FoxA1, FoxA2, 
Sfrp2 and CXCL12) demonstrated an upregulation in the dorsal aspect of the 3rdpp. Analysis of 
fetal thymic tissue at different stages of development (E10.5, E12.5 , E16.5, E18. 5) demonstrated 
that 8 of the candidate genes (Nrxn1, WIF1, Bmp4, Fst, c-Myc, Phlda2 and Flrt3) further 
examined were expressed throughout development. Analysis of embryos at E10.5 by 
immunohistochemistry for the protein expression of CCL21, Meox2, CD44, WIF1, Fst, Phlda2 
confirmed an upregulation if not an exclusive expression in the 3rdpp. Moreover, an analysis of 
the thymic expression revealed that two of the candidate genes examined (WIF1 and Flrt3) are 
expressed in adult primary thymic epithelial cells but not in thymocytes in contrast to other 
candidate genes analysed (e.g. Nrxn1, Bmp4, Fst, c-Myc and Phlda2). Other candidate genes like 
Sp8 and Phlda2, for which deficient embryos were available to us, respectively, were analysed 
for their thymic architecture by immunohistochemistry for several markers (e.g. K5, K8 and 
CD45). However,  any significative difference in comparison to wild type littermates could be 
noticed for these two genes. A functional analysis by Fetal thymic organ cultures (FTOCs) of 
E13.5s in the presence of human WIF1 recombinant proteins revealed that WIF1 can positively 
influence the overall cellularity of thymocytes if not expressed at too high levels. However, in 
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contrast to FTOCs in presence of Bmp4 proteins, the in vitro overexpression expression of WIF1 
did not inhibit the normal development of thymocytes in these FTOCs.  
 
In conclusion, this project allowed to identify several candidate genes using microdissected 
tissues to not only provide global information on gene expression during early development of 
the thymus but it also provides novel targets to study the inductive signalling pathways that direct 
the patterning and the differentiation of endodermal cells to the thymic epithelial cell fate. In that 
regard, several of the candidate genes are known to be involved in Wnt, Tgfβ2 signaling 
pathways or other singaling pathways, predicting that several pathways seem to play a role in 
early thymus organogenesis. 
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1.Introduction 
 
Little is known concerning the molecular mechanisms of early thymus development. Therefore 
the aim of this project will be to characterize further the genetic programs which determine 
thymic epithelial cell fate and differentiation by identifying new genes critically involved in this 
process. Since the thesis work will mainly focus on aspects of thymus development, a detailed 
description of the known cellular and molecular events related to the organogenesis of the thymic 
microenvironment will first be given. 
 
1.1 An overview on thymic function and development 
 
The thymus is located in the mediastinum. The completion of its development has two major 
functions for the immune system. First, the thymus provides the correct microenvironment for 
haematopoietic progenitors to differentiate into functional T cells. Developing T cells in the 
cortex of the thymic microenvironment are designated thymocytes. Immediate extrathymic 
precursors to the T cell lineage are generated during embryogenesis in the fetal liver and usually 
in the bone marrow after birth. The CD4 and CD8 co-receptors are exclusively expressed by T 
cells (with some notable exceptions such as dendritic cells) and therefore serve as specific T cell 
markers. 
 
The second and related function of the thymus concerns its role in central T cell self-tolerance. 
This event prevents the recognition of self-antigens and thus precludes the changes of T cells 
eliciting an autoimmune disease. The establishment of a functional T cell repertoire  is achieved 
by a complex series of events referred to as positive and negative thymic selection. Positive 
selection occurs if the T cell receptor (TCR) of the thymocytes engages a peptide self MHC 
(major histocompatibility complex) ligand with low affinity, resulting in the transduction of a 
survival and differentiation signal. The thymocytes that fail to engage a peptide-MHC ligand and 
therefore do not undergo positive selection, die by neglect in a passive manner because they do 
not receive a survival signal. Negative selection occurs when the TCR of a thymocyte engages a 
peptide-MHC ligand with high affinity, leading to the apoptotic death of the cell. Negative 
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selection deletes potentially self-reactive thymocytes, thereby generating a repertoire of 
peripheral T cells that is largely self-tolerant. For these reasons fewer than 5% of the developing 
thymocytes survive and leave the thymus as mature T cells. For autoreactive T cells that escape 
regular negative selection there are additional regulatory mechanisms in place that function in the 
periphery and that control there functionality. 
 
The maturation and selection processes during thymocyte development are effected by the thymic 
stroma which provides a unique microenvironment for T-cell development. The epithelial 
compartment of the thymic stroma center is subdivided based on phenotype and function into 
cortex and medulla. The cortical thymic stroma consists of epithelial cells that are closely 
associated with the early maturational stages of intrathymic development, and scattered 
macrophages, which are involved in clearing apoptotic thymocytes. The medullary thymic stroma 
consists of epithelial cells, together with haematopoietic macrophages and dendritic cells, that 
interact with mature thymocytes. The thymic stroma also comprises surrounding mesenchyme 
that consists of mesenchymal cells of ectodermal origin. 
 
Thymus organogenesis commences in the mouse embryo at day 10.5 of gestation (E10.5) 
although an overt thymus primordium is only formed at around E11.5. At this time point during 
mouse development, the mouse thymus primordium emerges as an epithelial anlage budding 
from the ventral endodermal lining of the 3rd pharyngeal pouch (pp) while dorsal aspects of this 
invagination develop into the parathyroid glands (Rowen et al., 2002). Each organ is surrounded 
by a condensing mesenchymal capsule that still contacts both the surface ectoderm and the 
pharyngeal endoderm. Seeding of  lymphoid precursor cells into the epithelial primordium occurs 
at around E12.5. This immigration of haematopoietic precursors cells is paralleled by rapid 
epithelial cell proliferation and differentiation giving eventually rise to distinct stromal 
compartments. By E13.5, the parathyroid and thymus are separated into physically distinct organs 
and soon afterwards they reach their respective adult positions within the embryo. The thymus 
anlage separates from the pharynx and with the accompanying neural crest-derived mesenchyme 
descend to the mediastinum where it sits on top of the heart with the lobes touching each other at 
the midline while the parathyroid glands are positioned at the lateral margins of the thyroid gland. 
The different events that occur in early thymus organogenesis have been schematized in Fig.1.1. 
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Figure 1.1. Diagram of the early steps in the formation of the thymus anlage. Neural crest (NC) cells migrate 
from rhombomere 6 to the region of the third pharyngeal pouch (3pp). Mesenchymal cells of ectodermal origin (M) 
surround the expanding epithelial mass (E). The developing epithelial primordium attracts lymphoid precursor cells 
(LP) from neighbouring blood vessels. The haematopoietic cells migrate into the epithelial anlage. The figure has 
been adopted from ( Bockman, 1997). 
 
 
1.2 Thymus organogenesis 
 
The 3rd pharyngeal pouch is lined by the endoderm. Adjacent to this tissue, the mesenchymal core 
with the contributions of neural crest cells that have migrated to the 3rd pharyngeal arches where 
they adopt a mesenchymal phenotype (Le Lievre and Le Douarin, 1975)(Gordon et al., 2004). 
These ectomesenchymal cells surround the emerging thymus primordium and provide molecular 
cues necessary for the expansion of thymic epithelial cells (Suniara et al., 2000)(Jenkinson et al., 
2003; Revest et al., 2001b). Whether the proximity of cleft ectoderm is important for and may 
thus contribute (directly or indirectly) to the thymus development is still controversial (Manley 
and Blackburn, 2003). However most recent studies would argue against such a contention 
(Gordon et al., 2004).  
 
 
Epithelium 
Mesenchyme 
Neural crest 
E 
3pp E 
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Recent studies have further more shown that most of the mesenchymal cells surrounding the 
pharyngeal pouch is originating from neural crest cells and does not derive from the surrounding 
mesoderm (Jiang et al., 2000). Moreover endothelial cells derived from the pharyngeal arches 
may also play a role in the patterning of the thymus primordium, albeit such a contribution to 
thymic epithelial cell differentiation has still to be unequivocally proven (Lammert et al., 2001; 
Matsumoto et al., 2001). Nevertheless, a recent study of the thymic vasculature provided cues 
that discrete segments of thymic vessels may act in concert with thymocyte-derived stimuli to 
effect normal development of the thymic environment (Anderson et al., 2000). However, a study 
from Müller and colleagues who demonstrated that the inactivation of the vascular endothelial 
growth factor A (VEGF-A), a key vascular factor in thymic epithelial cells, results in a 
hypovascularization and disruption of the thymic typical network of vascular arcades but support 
normal thymopoiesis (Muller et al., 2005). Thus, vascular growth factor production by thymic 
epithelial cells is rather required for normal thymus vascular architecture than conversely. 
Interfering with the mesenchymal derivatives from neural crest cells during the functional 
development of the epithelial primordium inhibits thymic development in a manner similar to that 
observed in congenital conditions such as the DiGeorge syndrome or the fetal alcohol syndrome 
(Ammann et al., 1982; Bockman, 1997; Suniara et al., 2000). 
 
1.2.1 Development of pharyngeal endoderm 
 
In contrast to many other organs including the bone marrow and all secondary lymphoid organs, 
where the cellular framework is made of connective tissue, it is the epithelial cells in the thymus 
that form the scaffold for T cell development. The thymic epithelium is derived from the 
endodermal germ layer through a series of consecutive steps, each of which have to be completed 
in order to achieve the capacity to form the correct environment able to provide the primary 
function of the thymus i.e. the development and selection of T cells (Gill et al., 2003). Early in 
development, the embryo assumes a roughly cylindrical form with the endoderm forming the 
inner lining. The epithelium of the roof of the endodermal yolk sac is folded into the expanding 
embryo and forms the lining of the primitive gut. A blind-ending sac of this epithelial lining 
extends forward in the embryo as the foregut. The foregut extends as the embryo expands, 
eventually forming both the anterior parts of the digestive tract and the respiratory tract. The 
development of the pharyngeal region occurs as part of foregut differentiation and is required for 
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the formation of the thymus anlage. The embryonic pharynx serves also as the anatomical origin 
for the thyroid, the parathyroid glands, the ultimobranchial body, the palatine tonsil, the auditory 
tube, the mastoid antrum as well as the tympanic cavity. In more detail, the first pharyngeal 
pouch (1stpp) elongates to form the tubotympanic recess, which will give rise to the lining of the 
tympanic cavity, auditory tube and mastoid antrum. The second pharyngeal pouch (2ndpp) forms 
the surface epithelium and lining of the crypts of the palatine tonsil. The third pharyngeal pouch 
(3rdpp) (as already mentioned above) differentiates into the thymus and the parathyroid glands 
while the fourth pharyngeal pouch (4thpp) gives rise to the ultimobranchial body that contributes 
to the development of the thyroid gland. This close proximity of these different tissues during 
early development does explain why some of the complex anatomical defects regularly observed 
can also be associated with a defective thymic development despite the fact that some of these 
organs in the adult mouse are not adjacent anymore (Cordier and Haumont, 1980). 
 
 
1.2.1.1 Expansion of pharyngeal pouches 
 
The walls of the developing pharyngeal region consist in mammals of a series of individual pairs 
of branchial (a.k.a. pharyngeal) arches, designated ba1 to ba6. As ba5 is not found in mammals 
but does exist in fish the annotation jumps in the former species from ba4 to ba6. Hence only 5 
branchial arches are present in mammals. Primitive blood vessels, called aortic arches, run 
through the branchial arches. The  vessels are surrounded by mesenchyme. The boundaries of 
each arch are demarcated on the embryo's surface by intervening grooves. The anterior region of 
the foregut, which forms the primitive pharynx, expands toward the surface within this 
framework and is directed along the intervals between the branchial arches. Consequently, blind-
ending sacs extend from the foregut laterally in the direction of the embryo's body surface, 
producing a bilateral series of four different pharyngeal pouches (pp) that are lined by 
endodermal epithelium. These pouches designated 1st, 2nd, 3rd and 4thpp are located between the 
ba1 and ba2, ba2 and ba3, ba3 and ba4 and finally ba4 and ba6 respectively (Fig.1.2A). Since the 
thymus emerges from the 3rd pharyngeal pouch (3rdpp), its formation is juxtaposed to the third and 
fourth branchial arches (ba3 and ba4) (Fig.1.2B).  
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Figure 1.2. Scanning electron microscopy of the mouse pharyngeal area at E10.5. A. Pharyngeal area, pink 
arrows are pointing to the four distinct pharyngeal pouches (pp) each located between two branchial arches (ba). B. 
Close up view of the third pharyngeal pouch area located between the third branchial arch  (ba III) and fourth 
branchial arch (ba IV). The pictures have been adopted from a public database. 
 
The developing endodermal lining is in contact with the ectoderm, which covers the surface of 
the embryo, thereby temporarily producing thin, narrow diaphragms called pharyngeal 
membranes. These structures fill the interval between the arches. Evidence had previously been 
presented suggesting that ectodermal cells with endodermal cells in the area of the pharyngeal 
membranes results in ectoderm being incorporated into the thymus epithelial primordium 
(Cordier and Heremans, 1975). Although this understanding had been broadly accepted, recent 
studies in mice could not demonstrate any evidence supporting the fact that ectodermal cells play 
a direct role in the development of the thymic anlage (Cordier and Haumont, 1980)(Gordon et al., 
2004). Specifically, these studies show by ectopic transplantations of pharyngeal endoderm that a 
fully functional thymus could develop from endodermal epithelium alone. Importantly, this 
capacity was not enhanced by pharyngeal ectodermal cells. 
 
Overtime, the proliferating epithelial cells from the third pharyngeal pouch form on each bilateral 
side of the embryo a cellular accumulation that extends into the surrounding mesenchyme. The 
continued cell proliferation and development of the thymic primordium lead to a separation of the 
cell mass that has formed in this area and eventually the attachment to the pharyngeal cavity is 
1pp  
   2pp 
      3pp 
       4pp 
ba III 
ba II 
ba IV 
3pp 
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lost. Thus a solid body of cells is formed that expands as it migrates ventrally and caudally. The 
mass of epithelial cells now constitutes the primordial thymus and is finally in the position to 
attract lymphoid precursor cells that colonizes the ba3 and ba4. These latter cells will then have 
to migrate to the perithymic mesenchyme before they can enter the epithelial compartment as 
long as the vascularization of the thymic rudiment is not established (Itoi et al., 2001). This latter 
aspect of thymus development occurs at E14.5-E15-5. 
 
1.2.2 Interaction of the thymic epithelium with the perithymic mesenchyme 
 
1.2.2.1 Neural crest cells as a source of mesenchyme 
 
Much of the mesenchyme that fills the pharyngeal arches is derived from descending neural crest 
cells. Neural crest cells are of ectodermal origin and originate at the dorsal most aspect of the 
neural tube. These cell‘s importance lies in their ability to migrate extensively and generate 
various differentiated cells types. Neural crest cells from the 2nd and 4th rhombomeres migrate to 
the 1st and 2nd pharyngeal arches respectively, while cells from the 6th rhombomere travel into the 
3rd and 4th pharyngeal arch. Neural crest cells from the 3rd and 5th rhombomeres do not migrate 
through the mesoderm but instead enter the migrating streams of an adjacent rhombomere. 
During their ventrolateral migration, neural crest cells proliferate and some aggregate to produce 
neural components, such as the dorsal root ganglia and sympathetic ganglia, while others become 
ectomesenchymal cells (mesenchymal cells of ectodermal origin). Once migrated into their 
respective pharyngeal region and transformed to ectomesenchymal cells, these cells interact with 
the epithelial cells of the pharyngeal endoderm, inducing the proliferation, migration, and 
differentiation of these latter cells (Bockman, 1997). 
 
1.2.2.2 Interference with epithelial-mesenchymal interactions 
 
The interaction required to occur between epithelium and the mesenchyme for a regular thymus 
development to take place was experimentally verified by (Auerbach, 1960) in mice. 
Explantation of the thymus (fetal thymic organ culture) at E12.5 produces robust epithelial 
proliferation. This does, however, not occur if the mesenchymal component of the developing 
thymus is removed at the beginning of the culture. Importantly, recombining the epithelial 
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component with mesenchyme from various sources reveals that both the origin of the 
mesenchyme and the timing appear to be significant factors in the development of the thymus. 
For example, delayed growth occurred when mesenchyme from lung or submandibular gland 
were used as an mesenchymal source to be allowed to interact with thymic epithelium and 
practically no induction of growth was observed when the mesenchyme was taken from fetal 
limb bud or from newborn mice. That is, the presence of mesenchyme from an appropriate source 
and at a proper stage of development permits the proliferation of previously committed epithelial 
cells along the regular course of thymic development. 
 
Extending these observations to an in vivo experiment in chicks, the extirpation of the neural 
crest resulted in a severely compromised development of the thymus. This effect was explained 
by the lack of the ecto-mesenchymal contribution to the developing thymus anlage (Bockman and 
Kirby, 1984; Bockman and Kirby, 1989). Specifically the ablation of neural crest over the 
somites 1–5, reduced the ectomesenchyme and results in either a thymus that was completely 
missing or a thymus that was greatly reduced in size. In the latter instance, the lobes were 
irregularly shaped, remained of primitive pharyngeal lumen and inhibited lymphocyte 
proliferation occurred in these lobes. 
 
A more direct assessment of the capacity of ectomesenchymal cells to participate in the 
development of thymic epithelium was carried out in more recent experiments where neural crest 
cells from selected axial levels were transplanted. Unilaterally grafted from quail donors to the 
corresponding region in chick hosts these neural crest cells migrate normally and interact with the 
primordial thymus (Kuratani and Bockman, 1991). Thus, these experiments revealed that neural 
crest from isotopic locations contributed most significantly to the developing thymus while this 
capacity obviously decreased when neural crest transplants were derived from more anterior or 
posterior anatomical locations. These observations were later confirmed and extended to the 
understanding, that the mesenchymal production of soluble growth factors, such as epidermal 
growth factor, might be needed for normal thymic epithelial development to occur (Shinohara 
and Honjo, 1996; Shinohara and Honjo, 1997). In addition, reaggregate thymus organ culture 
studies with individual or combinations of different precursor subsets of stromal cells showed 
that mesenchymal cells were required for the maturation of early thymocytes (Anderson et al., 
1997; Anderson et al., 1993; Kawakami et al., 1999). In these studies, treatment of mesenchymal 
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cells with hyaluronidase was found to abrogate the ability to support thymocyte development, 
indicating a direct role for mesenchymal-associated extracellular matrix in early T-cell 
development. Although the precise mechanism by which the mesenchymal cells contribute to the 
thymic development is still incompletely understood. 
 
In the fetal thymus, neural crest derived mesenchymal cells contribute to the thymic capsule and 
septae, and can also be located within the thymic cortex where they interact with immature 
thymocytes as shown by immunohistochemistry analysis (Anderson et al., 1997; Owen et al., 
2000; Suniara et al., 2000). However, one cannot exclude the possibility that ectomesenchymal 
cells indirectly influence thymopoiesis by providing inductive signals to generate and maintain a 
correctly organized epithelial microenvironment. As thymus development proceeds, the 
mesenchyme of neural crest origin surrounding the pharyngeal organs is replaced by mesodermal 
mesenchyme (Yamazaki et al., 2005). Thus, ecto-mesenchyme provides only a modest to 
marginal contribution to the thymus in late fetal and postnatal life (Jiang et al., 2000). Indeed, the 
recent study of Yamazaki and colleagues demonstrated that large numbers of neural crest-derived 
cells are detected as part of the thymus between E11.5 to E16.5 but were rarely present at later 
stages and almost absent after birth (Yamazaki et al., 2005). These data suggest that neural crest-
derived cells may only play a role in thymic organogenesis at an early embryonic stage. 
 
A two-stage mechanism for the involvement of the mesenchyme in thymopoiesis has been 
proposed on the basis of current experimental data (Anderson and Jenkinson, 2001). One 
requirement for mesenchyme in thymus development might be in the initial stages of thymic 
formation, when neural crest-derived mesenchymal cells surround the thymus anlage and 
eventually migrate into the thymic epithelial rudiment. Distinct epithelial–mesenchymal 
interactions, possibly involving the production of fibroblast growth factors (Fgfs) by 
mesenchyme (Xu et al., 1999), might then directly regulate the differentiation and/or proliferation 
of the thymic epithelial cells. These kind of interactions have been shown to have an important 
role in the formation of many organs shaped by epithelial–mesenchymal interactions. A typical 
example is the limb bud, where the mesenchymal production of fibroblast growth factors 
stimulates the growth and differentiation of Fgf-receptor-bearing epithelial cells (Xu et al., 1999). 
Indeed, mice lacking either Fgf10 (Ohuchi et al., 2000) or its receptor FgfR2-IIIb (Revest et al., 
2001a) display a thymus that is largely reduced in size (Revest et al., 2001b). This result indicates 
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a role for specific Fgfs for epithelial–mesenchymal interactions during thymus development. 
However, signals of Fgf10 via its receptor, FgfR2-IIIb, seem not to be essential for the 
commitment to a thymic epithelial cell fate and the ability to support thymocyte development, as 
mice deficient for Fgf10 or its receptor display a phenotypically regular maturation of the few 
thymocytes that are present in their thymus. FgfR2-IIIb deficient mice die at birth because those 
mutant mice fail to develop lungs. Consequently, any conclusion as to the competence of the 
thymus in these mutant mice to generate a regular repertoire of T cells is not known. A time-
constrained role of the mesenchyme for thymic epithelial cell development was described by 
Jenkinson and colleagues who provided evidence that after E12, the differentiation of immature 
thymic epithelial cells into cortical and medullary phenotypes is independent of sustained 
interactions with mesenchyme (Jenkinson et al., 2003). However, the continued presence of Fgf7 
and Fgf10 is necessary to support the proliferation of thymic epithelial cells leading to thymus 
growth. These experiments have therefore defined a key role for Fgfs in the regulation of thymic 
organogenesis. 
 
A role for mesenchymal cells in thymus development has also been shown in experiments 
involving the generation of reaggregate thymus organ cultures (RTOC) (Anderson et al., 1997; 
Anderson et al., 1993). In addition to mature thymic epithelial cells from 2-deoxyguanosine-
treated thymus lobes, mesenchymal fibroblasts were found to be necessary for the maturation of 
thymocyte precursors beyond the most immature, intrathymic stage ( i.e. DN1 stage, see 
below)(Anderson et al., 1993). However it remains uncertain just how mesenchymal cells 
influence thymocyte development. Possible mechanisms include the generation of specific 
components of the extracellular matrix (ECM) and soluble growth factors such as cytokines that 
effect the development of the immature T-cell precursors (Banwell et al., 2000). 
 
1.3 Defective thymic development 
 
The thymic stromal development (and there in particular that of thymic epithelial cells) and the 
maturation of thymocytes influence each other, a phenomenon referred as "crosstalk". It has been 
postulated that in the absence of crosstalk development of both T-cells and thymic epithelium are 
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impaired, thus affecting the functions of each of the participating cell types (Hollander et al., 
1995; van Ewijk et al., 2000b; van Ewijk et al., 1994; van Ewijk et al., 1999).  
 
One of the first studies to reveal the importance of the thymic stromal components for normal 
thymopoiesis were drawn from mice with a spontaneous deficiency in the transcription factor 
FoxN1, resulting in an abortive thymic development (Kingston et al., 1984). These mice are also 
known as nude mice due their inability to form a normal coat. In that study from Kingston and 
colleagues, the stromal composition of a developing thymus from a normal mouse was compared 
to that of a nude mouse (Kingston et al., 1984). This analysis revealed that class II major 
histocompatibility complex (MHC) antigens were missing on the epithelial cells of the nude mice 
in contrast to normal mice. As the class II MHC antigens enables functional cell-cell interaction 
with lymphoid cells, it was concluded that the epithelial cells of the thymus are the components 
of the thymus that are essential for a normal thymic function. 
 
The so called complete DiGeorge syndrome is an other example of a congenital condition in 
which defective development of the thymus stroma is accompanied by an impairment of the T 
cell development and thus a deficiency in the adaptive immune system. This condition also 
comprises the clinical findings of parathyroid hypoplasia or aplasia, a submucous cleft palate, 
velopharyngeal insufficiency, an aberrant function of the cardiac outflow tract, and typical facial 
features such as a short philtrum and a small mouth. The DiGeorge syndrome is caused in the 
majority of patients by a heterozygous deletion within the chromosomal band of 22q11 
(del22q11). Recent studies have shown that a mutation in Tbx1 (T-box transcription factor 1), a 
gene situated in this region of chromosomal 22 may suffice to explain most of the features of the 
DiGeorge syndrome (Brown et al., 2004; Lindsay et al., 1999; Lindsay et al., 2001; Merscher et 
al., 2001). It has been suggested that the DiGeorge syndrome is caused by a failure of neural crest 
cells to contribute appropriately to the development of great vessels, which then serve the thymus 
and other organs (Couly et al., 1983; Kirby and Bockman, 1984). In agreement with this 
suggestion is a study from Vitelli and colleagues, in which they compared the phenotype and the 
gene expression of mice homozygously deficient for Tbx1 using a Tbx1-lacZ reporter allele 
construct. Although their data do not support a direct role of neural crest cells in the pathogenesis 
of the Tbx mutant phenotype, the authors hypothesise that the misdirection of neural crest cells in 
these Tbx1 deficient mice is due to the lack of a guidance role from the pouch endoderm. 
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The fact that during development several closely associated anatomical structures appear to be 
affected is referred to as a "field defect". Offspring of women who had been exposed during 
pregnancy to the vitamin A analogue 13-cis retinoic acid (a.k.a. isotretinoin or Accutane) 
displayed a combination of structural defects clinically reminiscent of the DiGeorge syndrome 
(Lammer et al., 1985). Similarly, the fetal alcohol syndrome which results from excessive alcohol 
intake during early pregnancy provokes a similar clinical presentation (Ammann et al., 1982). 
Thus, several environmental substances can cause "field defects" that are alike to the by now 
rather well characterized DiGeorge syndrome. Moreover, it is likely that surgical ablation of 
neural crest cells, and administration of certain substances such as excess alcohol, or 13-cis 
retinoic acid causes diminished ectomesenchyme as it is a lack of regular development, which in 
turn inhibits proper development of the thymic epithelium and the capacity of the 
microenvironment to support thymocyte maturation. 
 
Other defects have been observed in the spontaneous mutant mouse strain “splotch“, which is 
deficient for the transcription factor Pax3 or in mice that have a homozygous mutation for the 
platelet-derived growth factor receptor alpha subunit, PDGFRα, which are designated Patch. In 
both of these strains the formation of neural crest is altered resulting in a loss of normal 
organogenesis for the thymus and the parathyroid glands (Franz, 1989; Morrison-Graham et al., 
1992). Mice rendered deficient for the homeobox gene hox-1.5 (a.k.a. Hoxa3) present a lack of 
both thymus and parathyroids and have also a reduced size of their thyroid in addition to other 
anatomical defects (e.g. heart and arteries) (Chisaka and Capecchi, 1991). 
 
1.4 Origin of thymic epithelial cells 
 
1.4.1 The duel-origin model for thymus organogenesis 
 
Until a couple of years ago, the most widely favoured model of thymus organogenesis suggested 
that both the third pharyngeal cleft ectoderm and the third pharyngeal pouch endoderm contribute 
physically to the thymus anlage, such that the epithelial component of the cortical compartment is 
generated from ectodermally derived cells, whereas cells of the medullary epithelium are of 
endodermal origin. Support for this model was drawn from several morphological studies. The 
26 
most convincing of these investigations used a histological sectioning and reconstruction 
approach to compare thymus organogenesis between nude mutant and wild-type embryos 
(Cordier and Haumont, 1980; Cordier and Heremans, 1975). This study reported that the 
endodermal and ectodermal germ layers made physical contact at E9.5, after which a strong 
proliferation of the third pharyngeal clefts occurred, such that ectodermal cells covered the third 
pouch endoderm between E10.5 and E11.5. The resulting compound structure would detach from 
both the ectoderm and endoderm by E12.5, giving rise to the thymus primordium. As a markedly 
diminished proliferation of the ectoderm was reported in nude embryos, it was concluded that the 
primary nude defect affects ectodermal cells (Cordier and Haumont, 1980; Cordier and 
Heremans, 1975). As the essential embryological anomaly of nude mice noticeable at E11 
consists of a failure of the ectoderm from the 3rd branchial cleft to proliferate and differentiate 
into a cervical vesicle, this analysis concluded that in consequence of an ectodermal defect the 
3rdpp endoderm degenerates and forms cysts. Based on these conclusions, the so called “dual-
origin” model of thymus development was proposed that postulates that the cortical epithelium 
derives from the ectoderm while the endoderm gives rise to medullary epithelium. Experimental-
support for this model was provided by several independent studies (Van Vliet et al., 1985) 
(Kingston et al., 1984; Owen and Jenkinson, 1984) that all concluded that a dichotomy in cellular 
origin reflects the anatomically separate compartments of cortex and medulla. 
 
1.4.2 The single-origin model for thymus organogenesis 
 
Morphological studies in mice and other mammals could have also been interpreted in an 
alternative fashion and thus concluded that the thymic epithelium is solely derived from the third 
pouch endoderm (Gordon et al., 2004; Smith, 1965). Strong functional evidence supporting the 
"single-origin" model has existed since 1975, when Le Douarin and Jotereau generated chimaeras 
by transplantation of quail pharyngeal endoderm to the somatopleura of a 3 day old chick (Le 
Douarin and Jotereau, 1975). Importantly, the graft had been taken at the 15-somite stage, a time 
when neither the development of the third pharyngeal pouch had yet occurred nor pro-thymocytes 
had homed to the anatomical area from which the tissue for transplantation was taken. Upon 
engraftment, the donor endoderm developed into a thymus anlage able to support T cells of chick 
origin. Importantly, the epithelial cells in both the cortical and medullary compartments were 
exclusively of quail origin. These experiments did thus provide evidence that purified pharyngeal 
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endoderm is sufficient to generate the epithelial component of both the cortical and medullary 
compartments. Finally these data also conveyed that, at least in birds, cells in the developing 
endoderm have adopted a fate for thymic epithelial cells well before the formation of the third 
pharyngeal pouch. Although these experiments did neither test the commitment to a single cell 
lineage directly, nor utilize a single cell approach, their data provide a stringent assessment of the 
developmental potential of the pharyngeal endoderm. Since the publication of this study the 
single-origin model has received further support from additional experimental evidence. 
 
1.4.3 Fate of the pharyngeal ectoderm 
 
The controversy whether the dual-origin or the single-origin model, respectively, is correct had 
however, persisted due to several methodological constraints. In 2004, the issue whether the 
ectoderm contributes at all to the organogenesis of the thymus epithelial stroma, was elegantly 
readdressed by Gordon and colleagues (Gordon et al., 2004). To investigate the fate of the 
pharyngeal ectoderm in the developing mouse embryo a lineage-tracing analysis was developed 
using a whole embryo culture system (Moore-Scott et al., 2003). To this end, the pharyngeal 
ectoderm of E10.5 mouse embryos was labelled specifically by dropping a cell tracker dye (5-
chloromethylfluorescein diacetate) onto each of the pharyngeal region of an E10.5 embryo. The 
embryos were then cultured for a further 30 hours. Importantly, thymus development proceeded 
normally during this time, as assessed by morphological criteria and marker analysis (Hoxa3, 
Pax1, Shh, Gcm2 and FoxN1). The fate of the labelled pharyngeal ectoderm was subsequently 
analysed by histological and fluorescence analysis of sectioned embryos. The developmental 
period covered in this experiment spanned the stages at which the ectodermal contribution to the 
thymus occurs, i.e. E10.5 to E11.5 (Moore-Scott et al., 2003). The analysis of labelled and 
cultured embryos revealed that none of the labelled cells contributed to the thymic primordium. 
Therefore, a physical contribution by pharyngeal cleft ectoderm to the developing thymus anlage 
does not occur, despite the physical contact between the 3rdpp endoderm and 3rdcleft ectoderm 
between E10.5 and E11.5. Taken together, these data fail to support the dual-origin model of 
thymus organogenesis (Cordier and Haumont, 1980). 
 
The developmental potential of mouse third pharyngeal pouch endoderm was also directly 
assessed in mice using an ectopic transplantation model (Gordon et al., 2004). In these 
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experiments, the 3rdpp and 4thpp endoderm of E8.5 to E9.0 mouse embryos was isolated from 
surrounding mesenchyme and cleft ectoderm by enzymatic and manual dissection, and 
transplanted under the kidney capsule of nude mice, which provides a permissive environment 
for thymus organogenesis (Bennett et al., 2002; Bogden et al., 1979; Zinkernagel et al., 1980). 
Under the given experimental condition, the extracted endodermal tissue was isolated before its 
contact with the pharyngeal cleft ectoderm. Again, purified endoderm was sufficient to generate a 
functional thymus regularly organized into a distinct cortical and medullary compartment, 
respectively. When compared to stage-matched endoderm, E9.0 tissue from the entire third and 
fourth pharyngeal arch grafted under the kidney capsule and analysed, for the capacity to confer 
thymus function to recipients, was less efficient. These data revealed that pharyngeal cleft 
ectoderm provides no advantage for thymus development in these grafts. As a variety of other 
tissues than thymus including skin, hair follicles, cartilage, ossified bone, muscle and adipose 
tissue developed in some of these grafts in contrast to purified pharyngeal endodermal grafts, the 
authors suggested that cleft ectoderm does even inhibit thymus formation in favour of other 
differentiated cell types. This study therefore confirmed and expanded in mice the results of the 
classic chick–quail chimera experiments, indicating that purified pharyngeal endoderm can 
generate both cortical and medullary thymic epithelial cell (TEC) compartments, while the cleft 
ectoderm fails to contribute to the formation of a normal thymus. These experiments also 
indicated that some cells in the pharyngeal endoderm are specified to enter the TEC lineage 
before overt signs of organogenesis, as previously reported in birds (Le Douarin and Jotereau, 
1975). 
 
1.4.4 A putative common thymic epithelial progenitor cell 
 
The existence of a common thymic epithelial stem cell has previously been suggested by several 
authors, based on evidence from marker studies of normal thymus and the observation that some 
thymomas can give rise to both cortical and medullary TEC types (Ropke et al., 1995; Schluep et 
al., 1988; Von Gaudecker et al., 1997). An indication of the probable phenotype of thymic 
epithelial progenitor cells (TEPCs) was provided by analyses of thymi in nude–wild-type 
aggregation and transplantation chimaeras (Blackburn et al., 1996; Klug et al., 1998). These 
studies investigated whether all or part of the nude thymic epithelium could be rescued by the 
presence of wild type cells in nude-wild type chimeric mice. Detailed immunohistochemical 
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analyses indicated for the development of all major subpopulations of mature thymic epithelium a 
cell autonomous requirement for the nude gene product, forkhead box N1 (FoxN1) (Blackburn et 
al., 1996). This study also showed that nude cells apparently committed to TEC lineages were 
phenotypically similar in nude–wild-type chimaeras and in the thymic remnants of nude mice. 
However these nude cells lacked markers associated with mature TEC subtypes, including MHC 
class II molecules, but expressed the determinants recognized by monoclonal antibodies MTS20 
and MTS24. The use of these antibodies defines in the adult mouse thymus a rare subpopulation 
of cells with thymic epithelial cell precursor potential (Bennett et al., 2002; Blackburn et al., 
1996; Gill et al., 2002; Godfrey et al., 1990). When purified and grafted ectopically into mice, 
these cells can differentiate into all known thymic epithelial cell types, attract lymphoid 
progenitors, and support normal thymopoiesis (Bennett et al., 2002; Gill et al., 2002). 
Collectively, these data indicated that in the absence of functional FoxN1, TECs are arrested at an 
immature progenitor stage that is characterized phenotypically by expression of the MTS20 and 
MTS24 determinants (Blackburn et al., 1996). 
 
The differential expression of cytokeratin 5 (K5) and 8 (K8) further distinguish several mouse 
TEC subpopulations (Klug et al., 1998). The main cortical and medullary subsets are K8+K5- and 
K8-K5+, respectively, with a minor subpopulation of K5 and K8 double positive cells found 
typically at the cortico–medullary junction. An aberrant, mainly K5+K8+ epithelial-cell phenotype 
was observed in the thymi of transgenic mice that express human CD3epsilon under the control 
of its endogenous promoter (designated CD3epsilon line 26, CD3ε26) which was found to 
correlate with a block in TEC differentiation due to an absence of cross-talk between early 
prothymocytes and thymic epithelial and an early block in thymopoiesis at the transition from 
DN1 (CD44+CD25-) to DN2 thymocytes (CD44+CD25+) (Wang et al., 1994) (Hollander et al., 
1995). This abnormality can be corrected in fetal but not adult animals by transplantation of 
either fetal or adult wild-type haematopoietic stem cells (Hollander et al., 1995). Furthermore 
transplantation of newborn CD3ε26 transgenic thymi under the kidney capsule of recombination-
activating gene 1 (Rag1) deficient mice resulted in a partial correction of the observed defect, as 
indicated by the development of a substantial K5-K8+ TEC population (Klug et al., 1998). These 
data indicate a precursor–progeny relationship, in which K5+K8+ progenitors give rise to K5-K8+ 
cortical epithelial cells (Klug et al., 1998). Moreover, these results are also consistent with 
subsequent ontological studies that show the presence of K5+K8+ TECs in the earliest thymic 
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rudiments, including stages before the appearance of cortex or medulla-specific markers (Bennett 
et al., 2002; Klug et al., 2002). A subsequent study has shown that the T-cell development 
blockade in CD3ε26 transgenic mice results from an insertion effect that affects the T/B-cell fate 
choice by reporting that an abnormal accumulation of mature B cells was found in the thymi of 
these mice (Tokoro et al., 1998). As this accumulation of B cells could not be observed in other 
human CD3epsilon transgenic mouse lines, ruling out the possibility that the aberrant mainly 
K5+K8+ TEC phenotype which predominates in any CD3epsilon transgenic mouse line results as 
a direct consequence of increased intrathymic B-cell development in CD3ε26 transgenic mice 
(Tokoro et al., 1998). Taken together these results suggest (but do not prove) that a common 
progenitor cell might exist, bearing the phenotype of MTS20+MTS24+K5+K8+. 
 
To test the contention that MTS24+ cells serve as a pool of thymic epithelial precursor cells, 
TECs with this phenotype were isolated from mouse thymic tissue at distinct developmental 
stages. Using immunohistochemistry, the population of MTS24+ cells constitute half of all thymic 
epithelial cells at E12.5 but only a very small population at developmental stages beyond E15.5 
(Bennett et al., 2002; Gill et al., 2002). Intriguingly, the MTS24 negative population could not 
reconstitute thymic function as assessed by any of the parameters mentioned earlier. Thus, all 
thymic epithelial precursor cell activity is contained in the MTS24+ fraction, which is, however, 
still rather heterogeneous when analysed for other cell surface markers. 
 
Phenotypic analysis of MTS24+ thymic epithelial cells from both E11.5 and E12.5 tissue 
displayed homogeneously the co-expression of K5 and K8 (Bennett et al., 2002). At E12.5, this 
population also stains either weakly or is completely negative for other differentiation markers 
that are indicative of mature cortical and/or medullary epithelial-cell types including 4F1, 
MTS10, MHC class II molecules (Bennett et al., 2002). At E15.5, 96% of MTS24+ cells express 
MHC class II molecules and the population can be further divided on the basis of UEA-1 
reactivity, which identifies a subpopulation of medullary TECs in the postnatal thymus (Gill et 
al., 2002). Based on these data, it has been proposed that MTS24+K5+K8+ cells comprise the 
multipotent TEC precursor, which via intermediate TEC populations gives rise to fully 
differentiated (MTS24-) cortical and medullary epithelial cells (Gill et al., 2003). The 
regenerative capacity of the thymus and turn over studies focusing on thymic epithelial cells, 
suggest that tissue-resident multipotent precursor cells could persist in the post-natal thymus. 
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However, whether this population still contains in the adult mouse true precursor stem cells with 
or without self-renewing potential is unclear. In the absence of clonal analysis for the 
demonstration of a single thymic epithelial cell progenitor, the possibility has to be entertained 
that the population of MTS20+MTS24+ cells harbours distinct cortical and medullary progenitors. 
However, new unpublished data has revealed that a single MTS24+ thymic epithelial cell is able 
to reconstitute both cortical and medullary thymic epithelial cells (S.Rossi, in press). 
 
The medullary compartment appears to arise as a series of clonal islets, each arising from a single 
progenitor rather than from an epithelial cell layer, which coalesce as the thymus matures 
(Rodewald et al., 2001). This has been revealed by non-parental balanced chimeric mice, 
whereby injection of embryonic stem (ES) cells into blastocysts using ES cells and blastocysts 
that differ in their major histocompatibility complex (MHC) type revealed that the medullary 
epithelium in these chimaeras is composed of discrete cell clusters derived from either the 
embryonic stem cell or from the blastocyst, but never of mixed origin. Notably, no correlation 
was found between the haplotype of a given medullary islet and that of the surrounding cortical 
epithelium, suggesting the existence of medullary thymic epithelial precursor cells. This finding 
is however in contradiction to more recent work mentioned above. The mechanism of the thymic 
epithelial architecture formation from such progenitor cells might not only occur during 
organogenesis, but might also be involved in tissue maintenance or self-reorganization. To test 
this, Rodewald and colleagues investigated whether the compartmentalization between the cortex 
and the medulla can occur from isolated and purified thymic epithelial cells. These thymic 
epithelial cells were taken at E16.5 (a stage at which the medulla is already partly developed) and 
were then re-assembled to form epithelial reaggregate fetal thymic organ cultures (RFTOC) in 
vitro before they were grafted under the kidney capsule of recipient mice (Rodewald et al., 2001). 
These RFTOC grafts restored a normal cortex-medulla organization and thymopoiesis, thereby 
showing that purified thymic epithelium has the capacity to self-reorganize into a structurally and 
functionally competent microenvironment. To reveal in these RFTOC grafts whether the medulla 
formation has occurred by the segregation and the clustering of pre-existing medullary epithelial 
cells, or, alternatively, from single progenitors, the reaggregates were assembled from an equal 
mixture of thymic epithelial cells isolated from two different mouse strains characterized by 
separate MHC class II molecules. To avoid any ambiguity caused by the colonization of the graft 
by bone marrow-derived MHC class II positive host cells such as the dendritic cells, the mixed-
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MHC reaggregates were implanted into MHC class II deficient mice. These experiments showed 
the persistence of a putative medullary epithelial progenitor cell until at least E16.5 (Rodewald et 
al., 2001). These results can be interpreted by one of two ways. First, a common endoderm-
derived thymic epithelial precursor cell might give rise directly to all TEC populations, or 
second, separate progenitors exist for the cortical and the medullary epithelial compartment. 
Although at the time of writing this thesis, single cell analysis have not been reported that can 
discriminate between these two distinct models, Rodewald's data on the clonal origin of 
medullary islets seem to favour a model in which intermediate progenitor cells exist for the 
cortical and medullary epithelial-cell compartments. Observations on the early patterning of the 
thymic primordium into cortical and medullary compartments would, however, be consistent with 
either model (Bennett et al., 2002; Klug et al., 2002). 
 
1.5 The genetic control of early thymus development 
 
The existing data on the development of thymic epithelial cells suggests that endodermal cells of 
the 3rdpp acquire a thymic epithelial cell fate and form a population of progenitor cells that 
subsequently differentiate phenotypically into diverse thymic epithelial cells. Some of the 
important molecular mechanisms that control the individual steps in this thymic differentiation 
have been identified from genetic studies. 
 
1.5.1 Transcription factors 
 
Analyses of gene-expression and mutant phenotype patterns have identified a network of 
transcription-factors that is required for the initial formation and early patterning of the 
thymus/parathyroid rudiment. At present, this network is composed of six factors: homeobox A3 
(Hoxa3), pre-B-cell leukaemia transcription factor 1 (Pbx1), paired box gene 1 (Pax1), Pax9, eyes 
absent 1 homologue (Eya1) and sine oculis-related homeobox 1 homologue (Six1). In mice, these 
6 transcription factors are co-expressed in the pharyngeal endoderm. In addition, Pax1 and Pax9 
are also expressed in the neural crest-derived mesenchyme. The direct importance of these factors 
for thymus organogenesis have been demonstrated in spontaneous and gene targeted mutant mice 
(Chisaka and Capecchi, 1991; Hetzer-Egger et al., 2002; Laclef et al., 2003; Manley and 
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Capecchi, 1995; Manley et al., 2004; Peters et al., 1998; Wallin et al., 1996; Xu et al., 2002). 
Interestingly, some of these factors have been identified to be important for the eye development 
in Drosophila where the Pax–Eya–Six axis operates cell-autonomously to regulate common steps 
in eye development including cell proliferation, patterning, and neuronal development (Pignoni et 
al., 1997). Taken together, these data have suggested that the Pax-Eya-Six regulatory network, if 
indeed conserved in the vertebrate organogenesis, must act specifically during the development 
of some of the endodermal derivatives, as the thymus, parathyroid glands and thyroid are all 
dependent on this network (Laclef et al., 2003).  
 
Based on the understanding that Hox genes control the axial position identity during 
embryogenesis and in view of the observation that the anterior boundary of Hoxa3 expression is 
along the third pharyngeal pouch, it has been hypothesized that the expression of Hoxa3 
determines the positioning and identity of the thymus/parathyroid rudiment (Krumlauf, 1994). 
Moreover, the Pax–Eya–Six pathway together with Hoxa3 might also control the separation of 
the thymus/parathyroid primordium from the pharynx and its subsequent migration. Indeed, 
thymic rudiments do not detach from the pharynx of Pax9 mutant mice and the normal separation 
is delayed in Hoxa3+/-Pax1-/- deficient animals (Hetzer-Egger et al., 2002; Su et al., 2001). The 
intrinsic ability of the thymus primordium to migrate caudally is also disturbed in Hoxa3+/-Pax1-/- 
mutant mice (Manley et al., 2004). 
 
Following initiation of organogenesis, two additional processes must occur for the development 
of the thymus to be eventually successful: (i) a patterning of the rudiment into thymus and 
parathyroid-specific domains needs to take place; and (ii) TEC differentiation has to be initiated. 
Insights into these processes have come from analysis of two transcription factors, forkhead box 
N1 (FoxN1) and glial cells missing homologue 2 (Gcm2). FoxN1 and Gcm2 are expressed in 
complementary domains by the developing thymus/parathyroid primordium at E11.5, indicating 
at this point in development the existence of distinct, prospective thymus and parathyroid regions 
(Gordon et al., 2001). Gcm2 was identified as a homologue of the Drosophila gene Gcm that acts 
as a binary switch between neuronal and glial cell determination (Kim et al., 1998). A loss of 
function of the mammalian homologue results in a failure to form the parathyroid glands 
(Gunther et al., 2000). Gcm2 is already expressed in a discrete domain of the third pharyngeal 
pouch as early as E9.5, while FoxN1 expression is only detectable by PCR at E10.5 (Balciunaite 
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et al., 2002) and by in situ hybridization by E11.25 (Gordon et al., 2001). Thus, establishment of 
the Gcm2-expression domain may in fact define the future thymus–parathyroid boundary. Gcm2 
expression seems to be controlled in the endoderm by the Pax–Eya–Six pathway together with 
Hoxa3 and Sonic hedgehog (Shh), as it is not initiated in either Hoxa3, Shh or Eya1 deficient 
mice and downregulated in Hoxa3+/-Pax1-/- compound mutants (Blackburn and Manley, 2004; 
Moore-Scott and Manley, 2005; Su et al., 2001; Xu et al., 2002). 
 
The FoxN1 transcription factor (Nehls et al., 1994), encoded by the gene that is mutated in nude 
mice, is crucial for the development of a mature thymus (Flanagan, 1966; Nehls et al., 1996; 
Pantelouris, 1968). Although often referred to as athymic, FoxN1-deficient mice undertake the 
initial stages of thymus organogenesis. Although a primordium is formed, this anlage fails to 
differentiate further and is not colonized by lymphocyte progenitors (Nehls et al., 1996). This 
observation fits a "two-step model", in which expression of FoxN1 divides thymus development 
into a FoxN1-independent, early phase in organogenesis culminating in thymic epithelial 
precursor cell formation, and a FoxN1-dependent late phase that includes thymic epithelial 
precursor cell differentiation. FoxN1 expression was not detected by in situ hybridization in the 
Hoxa3, Eya1 or Six1 mutants. At present, the only factors known to regulate the expression of 
FoxN1 in the thymus are specific Wnt glycoproteins and Bmp4 (Balciunaite et al., 2002; Tsai et 
al., 2003). FoxN1 expression was not detected by in situ hybridization in the Hoxa3, Eya1 or 
Six1 mutants at E11.5. Since high-level of FoxN1 expression is detected (as already mentioned) 
at E11.25, the lack of these transcription factors reveal a block in thymus organogenesis that 
occurs before FoxN1 expression (Gordon et al., 2001). 
 
It is unlikely that FoxN1 is responsible for specifying thymic identity during the initial steps of 
organogenesis because their is no specific phenotype in FoxN1-deficient mice before E11.25. 
Moreover, cells with an apparent phenotype typical for thymic epithelial precursor cells are 
generated despite the absence of FoxN1 function (Blackburn et al., 1996). The transplantation 
experiments of quail tissues to chicks provide functional evidence for these species that the 
endoderm is specified to a thymus fate well before an obvious organ formation has taken place 
(Le Douarin and Jotereau, 1975). A possible explanation for this observation is that the thymus 
fate constitutes a "default" identity for tissue of the third pharyngeal pouch that does not receive 
the normal set of molecular cues. Such a program could be either established by the Pax–Eya–Six 
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axis in conjunction with the function of Hoxa3 and Pbx1 or alternatively, the expression of Gcm2 
in the third pharyngeal pouch may suppress the acquisition of a thymus identity and replaces it 
with a parathyroid fate. In that regard a very recent study provides support for this explanation 
since Shh acts in unison with Gcm2 as a factor required for the development of the parathyroids 
but not the thymus (Moore-Scott and Manley, 2005). Moreover, an abnormal expansion of the 
thymus within the third pharyngeal pouch has been observed in Shh deficient mice as the 
expression of Gcm2 was absent. Concomitantly, the expression of FoxN1 and BMP4 was 
expanded in these animals throughout the entire primordium. Taken together, these data suggest 
that Shh expression in the thymus/parathyroid primordium is required for its dorsal-ventral 
patterning and for parathyroid specification and organogenesis by acting as a positive regulator of 
Gcm2 and a negative regulator of BMP4 in the 3rdpp. However BMP4 expression in the entire 
3rdpp alone does not explain FoxN1 expanded expression within the primordium in Shh deficient 
mice because BMP4 has been recently shown to be not immediately required for FoxN1 
expression, as transgenic mice for xenopus noggin (a direct inhibitor of BMP4) under the control 
of the FoxN1 promoter did not affected FoxN1 expression at E11.5 and E12.5 (Bleul and Boehm, 
2005). 
 
Factors other than Gcm2 may also specify parathyroid fate within the third pharyngeal pouch. A 
possible candidate for such a function is Ehox, a distant member of the paired-box family of 
homeodomain transcription factors (Jackson et al., 2002). Ehox displays a markedly restricted 
expression pattern that would be consistent with a role in early thymus organogenesis and/or 
specification of the thymic epithelial lineage. Ehox is expressed throughout the foregut endoderm 
at E8.5, but by E9.5, its expression is limited to a ventral domain in the second and third 
pharyngeal pouches (Jackson et al., 2003). At E10.5, Ehox is largely restricted to a domain 
complementary to that of Gcm2. A day later, Ehox cannot be detected anymore by in situ 
hybridization within the pharyngeal pouches but the domain previously marked by its expression 
is now strongly positive for FoxN1 transcripts (Blackburn and Manley, 2004). Therefore, the 
expression of Ehox defines a region that will eventually give rise to the thymus. 
 
The T-box transcription factor Tbx1 is normally expressed in the endodermal lining of the third 
pharyngeal pouch and the mesodermal core of the third pharyngeal arch (Garg et al., 2001). 
Tbx1, which is also detected in the thymus at later stages of development is regulated by Sonic 
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hedgehog signalling. Tbx1 has been implicated in the complex phenotype of the DiGeorge 
syndrome (Abu-Issa et al., 2002; Frank et al., 2002b; Jerome and Papaioannou, 2001; Lindsay et 
al., 2001; Merscher et al., 2001; Yagi et al., 2003). In the mouse, overexpression of Tbx1 
resulted in a small thymus that was abnormally positioned in the mediastinum (Merscher et al., 
2001). It was concluded from these experiments that the overexpression of Tbx1 may in turn 
effect the coordinated expression of several factors required for the descent of the thymus into the 
thoracic cavity. The DiGeorge syndrome is likely caused by haploinsufficiency of Tbx1, but its 
variable phenotype indicates the involvement of additional genetic modifiers. For example, 
absence of the Vegf(164) isoform causes birth defects in mice, that are reminiscent of those 
found in the DiGeorge patients (Stalmans et al., 2003). Indeed, Tbx1 expression was reduced in 
Vegf(164)-deficient mice and a knock-down of Vegf in zebrafish enhanced pharyngeal arch 
artery defects induced by Tbx1 deficiency (Stalmans et al., 2003). Moreover, five of 12 Vegf 
(120) isoform deficient mice had either a hypoplastic, an absent, or an ectopically located thymus 
and the parathyroid glands were absent in four of 12 of these mutants, whereas all of these 
animals had cardiac outflow tract anomalies, characteristically observed in DiGeorge patients 
(Stalmans et al., 2003). In keeping with this experimental evidence is the observation in 
DiGeorge patients that a specific Vegf promoter haplotype, documented to reduce Vegf 
expression, was associated with an increased risk for cardiovascular defects (Stalmans et al., 
2003). Taken together these data suggest that Vegf is involved in the DiGeorge syndrome by 
regulating Tbx1. 
 
Although marked progress has been made in identifying the transcription factors that act in the 
endoderm during early thymus organogenesis, the molecular events that occur concurrently in the 
mesenchyme are less well established. Hoxa3, Eya1 and Six1 are also expressed in the 
mesenchyme, and a role for neural crest cells during thymus organogenesis has been suggested 
by Kuratani and colleagues (Kuratani and Bockman, 1990a; Kuratani and Bockman, 1990b; 
Kuratani and Bockman, 1991). Hence the expression of Hoxa3, Eya1 and Six in neural crest cells 
might also be required for a proper development of the thymus. In fact an analysis of mutants of 
Hoxa3 and its paralogues, Hoxb3 and Hoxd3, indicate that these gene products have a redundant 
function in promoting migration of the primordium after it separates from the pharynx. The 
removal of one functional copy of Hoxa3 from the Hoxb3, Hoxd3 double mutants (Hoxa3+/- , 
Hoxb3-/-, Hoxd3-/-) results in the failure of the thymus and parathyroid glands to migrate to their 
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normal positions in the throat (Manley and Capecchi, 1998). Defining specific functional roles 
for Hoxa3, Eya1 and Six1 in neural crest cell and in endodermal cell differentiation and function, 
respectively, during thymus organogenesis will require tissue-specific genetic approaches that 
separate their role for endoderm development from that of other functions in the mesenchyme. So 
far, Pax3 is the only transcription factor known to affect thymus development and to be expressed 
by neural crest cells. Mutations in Pax3 cause the splotch phenotype in mice (Franz, 1989). 
However, the thymus hypoplasia/aplasia observed in Pax3 mutants appears to be secondary to the 
death or failure in migration of neural crest cells (Conway et al., 1997; Epstein et al., 2000). 
 
1.5.2 Signalling molecules 
 
The evidence presented so far indicates that at least some molecular mechanisms operational in 
the patterning of the thymus/parathyroid primordium may be intrinsic to the endoderm. But, 
many of the initial steps in the formation of different organs are known or thought to involve 
cell–cell interactions including those between mesenchymal and epithelial cells. In fact, signals 
from cell types, such as the surrounding neural crest-derived mesenchymal cells have been shown 
to be required for thymus organogenesis (Anderson et al., 1993; Jenkinson et al., 2003; Kuratani 
and Bockman, 1990b). Such an interaction is in keeping with additional observations detailing 
neural crest cells to contribute to the formation of the fetal thymus (Suniara et al., 2000). 
 
As discussed previously, ablation studies in chicks, and the phenotypes of mutant and transgenic 
mice with specific defects in neural crest cell formation, migration or survival, have indicated 
that the loss of these cells correlated with an absence or a variable reduction in thymic size 
(Bockman and Kirby, 1984; Bockman and Kirby, 1989; Conway et al., 1997; Ohnemus et al., 
2002; Soriano, 1997). Furthermore, thymic aplasia or hypoplasia secondary to a compromised 
function of neural crest cells did occur despite a normal expression pattern of Tbx1, Pax1, Pax9 
and Hoxa3 in the pharyngeal endoderm and were concurrent with a regular thymopoiesis 
(Ohnemus et al., 2002). The different thymic phenotypes produced by neural crest deficiencies 
may thus be the consequence of an aberrant formation of the pharyngeal pouches and the 
impaired migration of thymic primordia caused by alterations of the mesenchymal content of the 
branchial arches. 
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Similarities with the development of other endodermal organs would predict that a cascade of 
reciprocal signals between the endoderm and mesenchyme control positioning and outgrowth of 
the thymic rudiment. Although all of the main developmental signalling pathways including the 
fibroblast growth factors (Fgfs), Wnts, bone morphogenetic proteins (Bmps) and Shh have been 
implicated in thymus development, unequivocal genetic evidence for their involvement in the 
very early stages of development is however scarced and at present only available for Fgfs. 
 
Two recent genetic studies have shown that decreasing Fgf signalling between the endoderm and 
mesenchyme results in thymus hypoplasia, but does not markedly affect thymocyte 
differentiation. Fgf8 is expressed at E10.5 in the pharyngeal pouch endoderm, where it 
presumably signals to the surrounding neural crest-derived mesenchyme (Abu-Issa et al., 2002; 
Brown et al., 2004). Reduction of Fgf8-signaling using a hypomorphic Fgf8 allele resulted in two 
separate phenotypes: (i) some embryos were athymic, possibly due to a secondary effect of 
severe defects in the formation of the third and fourth pharyngeal arch and pouch, and (ii) some 
embryos displayed a hypoplastic, sometimes ectopic thymus which supported a phenotypically 
normal thymopoiesis (Frank et al., 2002b). This second phenotype is reminiscent of the one 
reported for a knockout of the isoform IIIb of Fgf receptor 2 (FgfR2IIIb); This receptor is 
expressed by TECs as early as E13, where it is thought to receive signals from its ligands Fgf7 
and Fgf10, which are apparently secreted by the surrounding mesenchyme (Jenkinson et al., 
2003; Revest et al., 2001b). In FgfR2IIIb deficient mice, thymus organogenesis proceeds 
normally until about E12.5, after which the organ fails to increase in size (Revest et al., 2001b). 
However, sufficient TEC differentiation occurs in the hypoplastic thymus of these animals to 
support a phenotypically normal T-cell differentiation. The few T cells generated in FgfR2IIIb-
deficient thymi have never been tested functionally (Revest et al., 2001b). There may be a 
genetic link between the phenotype observed in Fgf8 and FgfR2IIIb mutant mice as the 
expression of Fgf10 is reduced in mice homozygous for an hypomorphic Fgf8 allele (Frank et al., 
2002b). Thus, it is thought that reciprocal Fgf signalling may be required between the endoderm 
and the mesenchyme at an early stage of thymus formation. This interdependence is reminiscent 
of reciprocal Fgf signalling that is required both for initial placement and induction of limb-bud 
formation and for the initial lung organogenesis (Hogan and Yingling, 1998; Martin, 1998). In 
view of a role for Fgf8 in pouch formation, mice homozygous for a hypomorphic allele of Fgf8 
containing loxP sites have been converted to a null allele by being mated to cre transgenic 
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animals (Meyers et al., 1998). However, from the analysis of these mutants it could still not be 
established whether Fgf signalling is directly required for the  initial development of the thymus 
primordium. 
 
Fetal thymic organ-culture (FTOC) experiments have recently provided evidence that at least 
some of the observed effects by Fgfs may be related to Bmp4 signalling. The addition of Bmp4 to 
FTOCs affected the differentiation of double negative (DN1) thymocytes along the αβ-lineage T 
cell development as this treatment led to an abnormal accumulation of these immature cells 
(Hager-Theodorides et al., 2002). This effect of Bmp4 was suppressed by inhibition of Fgf 
signalling (Tsai et al., 2003). Moreover, stimulation via Bmp4 also upregulated the expression of 
FoxN1 and FgfR2IIIb. Taken together, this study suggested that Bmp4 upregulates FoxN1, which 
in turn upregulates FgfR2IIIb expression, rendering TECs susceptible to Fgf7 and Fgf10 signals 
provided by different cells including cells of the mesenchyme as well as double or single positive 
thymocytes (Erickson et al., 2002). 
 
Alterations in the formation of the third pharyngeal pouch and endodermal expression of Fgf8, 
Tbx1, Pax1 and Pax9 have been noted in the absence of signals mediated by retinoic acid 
(Niederreither et al., 2003; Roberts et al., 2005; Wendling et al., 2000). It has therefore been 
concluded that the retinoic acid (RA) receptor constitutes an indispensable component for the 
specification of the pharyngeal endoderm (Dupe et al., 1999; Wendling et al., 2000). To further 
investigate its role, targeted inactivation of the mouse retinaldehyde dehydrogenase 2 
(Raldh2/Aldh1a2), the enzyme responsible for early embryonic retinoic acid synthesis, has been 
investigated (Niederreither et al., 2003). Because these mutant mice die between E9.5 and E10.5 
from severe defects in early heart morphogenesis, maternal RA was supplemented 
transplacentally to Raldh2(-/-) embryos to prevent heart defects and other anomalies (e.g. the 
formation of organs from the 2ndbranchial arch, hindbrain patterning early in development) 
(Niederreither et al., 1999). However, despite the rescue of several of the aforementioned defects, 
these RA-supplemented mutant embryos still exhibit impaired development of their posterior 
(3rd-6th) branchial arch region (Mark et al., 2004; Niederreither et al., 2003; Vermot et al., 
2003). While in the RA-supplemented mutant embryos, the development of the first and second 
arches and their derivatives, as well as the formation of the first pharyngeal pouch, appear to 
proceed normally, more posterior pharyngeal pouches and the cardiac outflow tract septation fail 
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to form (i.e. 3rdpp and 4thpp). Hence, all derivatives of the posterior branchial arches are affected 
in these embryos, including the aortic arches, pouch-derived organs (thymus, parathyroid gland) 
and the postotic neural crest cells, which normally establish regular segmental migratory 
pathways (Niederreither et al., 2003). Raldh2 is responsible for producing RA which in turn is 
required for the proper development of the posterior branchial arches and its endodermal 
derivatives. During the development of the posterior branchial arches, the mesoderm-specific 
Raldh2 expression is restricted to the posterior most pharyngeal region (Niederreither et al., 
1999). Thus, Raldh2 appears to play a crucial role in producing high levels of RA required for the 
pharyngeal development of the branchial arches 3 to 6. Consequently, RA is one of the diffusible 
mesodermal signals that pattern the pharyngeal endoderm of the 3rdpp and 4thpp. The defects in 
RA-supplemented Raldh2 deficient mice are similar to those observed in mice deficient for Tbx1 
expression which are providing defect similar to the clinical presentation of the DiGeorge 
syndrome (DGS) and the velocardiofacial syndrome (VCFS). These related syndromes are 
characterized by numerous but largely overlapping defects including thymic aplasia, or 
hypoplasia, hypoparathyroidism, cardiovascular pathologies, and craniofacial anomalies. In fact, 
both syndromes are resulting from a heterozygous delection of contiguous genes and are 
therefore commonly referred to as a single disease entity, designated DGS/VCFS or, 
alternatively, the 22q11.2 deletion syndrome. Moreover, a hypomorphic Raldh2 mutation in mice 
was found to selectively lead to DGS/VCFS-like defects, albeit less severe than in the Raldh2-
null mutants (Vermot et al., 2003). Thus, decreased levels of embryonic RA (through genetic 
mutations and/or nutritional deprivation during embryogenesis) may act as a major modifier for 
the clinical presentation of human 22q11del-associated DGS/VCFS syndrome. Sufficiently 
severe, a decrease in RA may also on its own lead to some of the clinical features typical for the 
DiGeorge syndrome. As Tbx1 expression is only mildly affected in both the null and 
hypomorphic Raldh2 mutants this transcription factor cannot be considered as a critical 
determinant of the Raldh2 phenotype (Niederreither et al., 2003; Vermot et al., 2003). Although 
overexpressing RA has shown to down-regulate Tbx1 expression in avian embryos and quail 
lacking endogenous RA in early development results in a subsequent loss of Tbx1 expression in 
all tissues, it has been suggested by Robert and colleagues that RA acts downstream of Tbx1 to 
regulate expression signalling of molecules required for proper pharyngeal development (Roberts 
et al., 2005). Fgf8 could represent such a critical downstream signal, as (i) Fgf8 expression is 
altered in Tbx1-/- and Raldh2-/- mutants, and as (ii) the Fgf8 hypomorphic mutation also leads to 
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DGS/VCFS-like phenotype (Abu-Issa et al., 2002; Frank et al., 2002b; Niederreither et al., 2003; 
Vermot et al., 2003). 
 
Signalling via members of the Wnt family of glycoproteins has also been implicated in the 
promotion of TEC differentiation and thymocyte development, respectively (Balciunaite et al., 
2002; Mulroy et al., 2002; Mulroy et al., 2003; Pongracz et al., 2003; Staal et al., 2001; Staal et 
al., 2004). Wnts which are differentially expressed by both TECs and developing thymocytes as 
secreted proteins act in a cell non-autonomous fashion. Wnts bind to glycosaminglycans in the 
extracellular matrix and to two distinct families of cell-surface receptors, the frizzled (Fz) and 
low-density lipoprotein receptor-related proteins 5 and 6 (LRP5/6). With the latter two 
molecules, Wnts form a complex that promotes the activation of β-catenin, a cytoplasmically 
located second messenger. The subsequent nuclear translocation of β-catenin allows for its 
association with T cell factor 1 (Tcf-1) and Lymphoid enhancer factor 1 (Lef-1) transcription 
factors which on their own act as transcriptional repressors (Balciunaite et al., 2002; Pinson et al., 
2000; Pongracz et al., 2003). In vitro culture studies using thymic epithelial cell lines 
demonstrated that some (e.g. Wnt4, Wnt5b) but not all Wnts  induce FoxN1 expression in TECs 
(Balciunaite et al., 2002). These studies indicated that Wnts might maintain/modulate FoxN1 
expression by TECs in both an autocrine and paracrine fashion. 
 
Signalling via the bone morphogenetic proteins (BMP) has been implicated in thymus 
organogenesis (Bachiller et al., 2003; Bleul and Boehm, 2005; Ohnemus et al., 2002). This has 
been revealed from a study of mice transgenic for noggin which displayed thyroid hypoplasia, 
ectopic thymic, parathyroid hypoplasia or aplasia, and cardiac outflow tract defects (Kanzler et 
al., 2000; Ohnemus et al., 2002). Noggin as a transgene in these mice was under the control of an 
genomic fragment and enhancer of Hoxa2 to drive its expression in the second and more caudal 
branchial arches as well as in rhombomere 4 and more caudal rhombencephalic areas. When 
evaluating the role of BMP-dependent neural-crest cells in these mice, it could be observed that 
these cells failed to migrate (Ohnemus et al., 2002). Taken together, these findings demonstrated 
that BMP-dependent neural-crest cells play a role in the development of the thymus, parathyroid 
and thyroid glands, and aortic arches (i.e. carotid and subclavian arteries). Hence, interfering with 
BMP signalling in the premigratory neural crest cells produces a phenotype closely resembling 
that of the DiGeorge syndrome. The expression of Tbx1, Pax9 and Hoxa3 endodermal markers 
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was not affected in these transgenic mice but Pax1 was reduced in the 3rdpp and Hoxa3 
expression was found to be absent in the neural crest cells of these mice. Thus, suggesting that 
Pax1 expression in the 3rdpp endoderm is at least partially controlled by Hoxa3-expressing and 
BMP-dependent neural crest cells (Ohnemus et al., 2002). Moreover, mice deficient for Chordin, 
a Bmp signalling antagonist, displayed an extensive array of malformations that encompass most 
features of the DGS/VCFS syndrome. For instance, these mice lack a thymus and parathyroid 
glands, and display hypoplastic thyroid gland as a consequence of a malformation of the 
pharyngeal arches 2 to 6. In addition, these mice also have a cardiac outflow tract defect possibly 
resulting from the failure of cardiac neural crest cells to reach the heart (Bachiller et al., 2003). 
Concurrently, there is a major reduction of Tbx1, Pax9 and Fgf8 expression in the pharyngeal 
endoderm. Taken together, these data suggest that Chordin acts upstream of Tbx1 and Fgf8. In 
turn, Tbx1 relays the autocrine effect of Chordin in the pharyngeal endoderm necessary for a 
proper development of the thymus, parathyroid and thyroid glands. Given these results it is 
conceivable that an allelic variant of components of the Bmp signal transduction pathway could 
cause a DiGeorge-like phenotype. In fact, a recent study demonstrated a direct role of Bmp 
signalling in thymus development. Transgenic overexpression in thymic epithelial cells patterned 
for a thymus cell fate caused a hypoplastic and ectopically positioned but functional thymus 
(Bleul and Boehm, 2005). Bmp4 is normally strongly expressed at E10.75 in epithelial cells in 
the ventral aspect of the 3rdpp and in the neural crest-derived mesenchymal cells that surround the 
thymus anlage.  By E12.5, Bmp4 expression is restricted to thymic cells of mesenchymal 
phenotype. In contrast, Bmp2 remains undetectable at this site until at least E12.5 and the 
expression of the Bmp target gene Msx1 is identical to that of Bmp4 but transcripts are more 
abundant in the peri-thymic mesenchymal cells when compared to the thymic epithelial cells 
(Bleul and Boehm, 2005). In the noggin transgenic mice, Bmp4 expression is aberrantly 
maintained in thymic epithelial cells and absent in thymic mesenchymal cells at E12.5. Bmp2 
expression which was undetectable at any time point in wild type mice, was aberrantly up-
regulated in thymic epithelial cells and Msx1 expression could not be detected in the thymic 
capsule at E12.5 (Bleul and Boehm, 2005). The expression of FoxN1 is unchanged in these mice 
suggesting that the transcription of the FoxN1 gene does not depend directly on Bmp signalling. 
The change in Bmp4 and Msx1 expression in the noggin transgenic mice suggest, however, a role 
for Bmp signalling in shaping the thymic stroma (Bockman and Kirby, 1984; Ohnemus et al., 
2002; Suniara et al., 2000). In keeping with a role for Msx in thymic development is the 
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observation that mice deficient for Msx1 and Msx2 have an impaired patterning and survival of 
their neural crest cells, and display an abnormal location of the thymus (Ishii et al., 2005). 
Furthermore Bmp4 expression was found to be increased in the cranial neural crest and 
pharyngeal arches of these mutant embryos, suggesting that Msx genes may negatively control 
Bmp signals in these tissues (Ishii et al., 2005). In Shh deficient mice, the expression of Bmp4 in 
the ventral endoderm of the 3rdpp is expanded through the entire pharyngeal pouch. It is thus 
possible that Shh and Bmp4 have opposing roles to establish the dorsal/ventral polarity of the 
third pouch. During later stages of development, Shh is also required for normal thymopoiesis to 
occur. Thymocyte differentiation is partially blocked in the transition from the earliest 
CD44+CD25- DN1 population to the subsequent CD44+CD25- DN2 population and from double 
negative to double positive thymocytes (DN to DP) in Shh deficient mice. Consequently, 
thymocyte cellular is greatly reduced in Shh deficient embryos (Shah et al., 2004). 
 
1.5.3 Regulation of TEC differentiation 
 
1.5.3.1 Lymphocyte-dependent and independent development 
 
The establishment of distinct cortical and medullary compartments within the thymus is 
dependent on a mechanism termed cross-talk, a notion which refers to the direct interaction 
between TECs and developing thymocytes (Hollander et al., 1995; Ritter and Boyd, 1993; Shores 
et al., 1994; van Ewijk et al., 2000a; van Ewijk et al., 1994). The concept of "cross-talk" relates 
to a stepwise and interdependent development of the thymic stroma and thymocytes. Initial data 
pointing to the phenomenon of "cross-talk" was derived from the analysis of the tgε26 mice. 
These mutant mice overexpress the human CD3 epsilon component of the T-cell receptor (TCR) 
as a transgene. This alteration has been believed to cause excessive signal transduction resulting 
in an observed arrest at the DN1 stage (CD44+CD25-) and lack functional thymic epithelium 
(Hollander et al., 1995; Wang et al., 1994; Wang et al., 1995). A characteristic feature of the 
tgε26 mice is the presence of several thymic cysts, and the lack of a regular organisation of a 
cortical and medullary microenvironments. In particular, a distinct border between cortex and 
medulla is lacking and many thymic epithelial cells are organized in a typical two-dimensional 
(2-D) fashion instead of an 3-D manner (Hollander et al., 1995). These abnormalities could be 
corrected in fetal but not in adult transgenic animals by transplantation of either fetal or adult 
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wild-type haematopoietic stem cells (Hollander et al., 1995). This observation concluded that the 
interaction of fetal stromal cells with early prothymocytes is required for the induction of a 
cortical microenvironment and that such a interaction is restricted to a particular window of time. 
Compared to tgε26 mice, T-cell development in recombination-activating gene (Rag) deficient 
mice progresses to a slightly later stage of T-cell development, namely to the double negative 
DN3 stage (CD44-CD25+) (van Ewijk et al., 2000a). Rag-mutant mice have a thymus with an 
increased cellularity and a well-developed thymic cortex, but their medulla is still absent when 
compared to tgε26 mice (van Ewijk et al., 2000a). By transplanting tgε26 mice with Rag2-
deficient bone marrow, thymopoiesis in these mice progressed from the DN1 towards the DN3 T-
cell developmental stage, which stimulated the conversion of 2-D organized thymic epithelial cell 
sheets into a 3-D organized thymic epithelial network (van Ewijk et al., 2000a). Subsequent 
transplantation with wild-type bone marrow cells in these tgε26 mice enables normal 
thymopoiesis and is paralleled by a correct organization of the medullary microenvironments 
(van Ewijk et al., 2000a). Similarly, the disorganized and immature thymic medullary epithelial 
islands of mice defective for the β chain of the T cell receptor (SCID mice) could be restored by 
the introduction of wild-type bone marrow cells (Shores et al., 1991). Taken together, these data 
suggest that maturing thymocytes control the development of thymic stroma in a stepwise 
fashion, resulting first in the induction of a correct cortical structure which is then followed by 
the establishment of the medullary compartment. In that regard, thymic medullary organization 
was shown to be abnormal in mice deficient for the α chain of the TCR, which suggests that the 
development of medullary thymic epithelial cells is regulated by αβTCR+ thymocytes at the 
single positive stage of development (Palmer et al., 1993). Interestingly, the ability of αβTCR+ 
thymocytes to induce maturation of medullary TEC appeared not to be related to the antigen 
specificity of the TCR as thymi from positively selecting, negatively selecting and non-selecting 
αβTCR transgenic SCID mice all have a medullary thymic compartment, although its size varies 
considerably (Shores et al., 1994). 
 
In contrast, studies in mice deficient for FoxN1 have shown that the initial stages of thymus 
development occur independently of interaction with cells of haematopoietic origin (Nehls et al., 
1996). Further evidence that the initial stages of TEC differentiation, does occur in the absence of 
thymocytes was recently provided by a comparative analysis of the stromal development of wild-
type mice, Rag2/γc mutant mice and Ikaros deficient animals (Klug et al., 2002). The absence of 
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a functional γc chain in Rag2 deficient mice (designated Rag/γc-/-) precludes IL-7/IL-7R 
interactions and consequently reduces thymocyte cellularity drastically (Colucci et al., 1999; 
Klug et al., 2002). The Ikaros transcription factor is indispensable for the commitment of 
haematopoietic stem cells to the lymphoid lineage and mice deficient for this molecule are 
characterized by an absence of T cell precursors during the fetal period (Georgopoulos et al., 
1994). Despite an early T cell developmental block in either of these mutant mice, the thymic 
epithelial cell compartment was found to be organized into a 3-D structure (Klug et al., 2002). 
However, the development into well-organized medullary region containing K8-K5+ TECs and 
the patterning of separate medullary and cortical compartments in the neonate and adult mouse 
require the continued presence of thymocytes. In fact, a recent study of fetal tgε26 thymi 
confirmed that thymocyte-derived signals are not required for the initial maturation of TECs. 
This conclusion was corroborated in FTOC experiments where TEC proliferation leading to the 
formation of a normal thymic epithelial microenvironment, the differentiation into cortical (K5-
K8+) and medullary (K5+K8-) epithelial cells, and the acquisition of a functional competence were 
independent of developing thymocytes (Jenkinson et al., 2005). On the contrary, the proliferation 
of fetal thymic epithelial cells appears to be regulated by thymic mesenchyme (Jenkinson et al., 
2003). Collectively, these findings are arguing against an essential early role for thymocyte-
derived signals during the development of the thymic epithelium. However, these results do not 
contest or rule out a role for such signals in the maintenance of the thymic epithelial 
microenvironment once such a compartment has been established. Although these studies 
demonstrate a link between T-cell development and the formation of a normal thymic 
architecture, it still remains elusive how T-cell precursors influence the differentiation and 
function of thymic stromal cells. 
 
1.5.3.2 Molecular regulation of TEC differentiation 
 
FoxN1 is expressed by all TECs throughout life, albeit lower amounts of transcripts have been 
observed in older mice (Nehls et al., 1996) and unpublished data of the Holländer Lab. The 
phenotype of TECs present in nude mice would suggest that these cells are arrested at an early 
progenitor stage with a limited capacity to proliferate and to induce the entrance of 
haematopoietic progenitor cells into the epithelial primordium (Itoi et al., 2001; Nehls et al., 
1996). It has therefore been concluded that FoxN1 promotes both the initial differentiation as 
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well as the proliferation of TECs. Such a role is not different to the one FoxN1 has been assigned 
to in skin and hair, where FoxN1 is believed to promote the proliferation of progenitor cells of 
the hair shaft and the inner root sheath (Lee et al., 1999). 
 
The domains of FoxN1 necessary for TEC differentiation have recently been identified in mice 
expressing a hypomorphic allele for FoxN1 (Su et al., 2003). This allele (designated FoxN1-Δ)  
has the sequences deleted encoding for the FoxN1 most of amino-terminal domain deleted but 
still encodes for the DNA-binding, nuclear-localization and the C-terminal domains, respectively. 
The truncated protein causes a thymic phenotype which is milder in extent when compared to the 
FoxN1 null allele, but displays no effect on hair development. The use of this mutant molecule 
highlighted a thymus-specific role for the amino-terminal domain and uncoupled the function of 
FoxN1 in the thymus from that in the skin. A detailed analysis of TECs in mice homozygous for 
this hypomorphic allele indicated that the initial development of TECs was phenotypically 
normal albeit delayed, however, the TECs subsequent differentiation into medullary and cortical 
compartments was blocked (Su et al., 2003). As this phenotype is similar to that reported for 
human CD3ε transgenic mice, which have an early block in thymocyte development and lack a 
functional thymic cortex, it may be concluded that FoxN1-Δ fails to confer thymocyte-mediated 
signals into normal TEC differentiation (Hollander et al., 1995; Klug et al., 1998; Klug et al., 
2002). In contrast to FoxN1-deficient TECs, cells expressing the hypomorphic FoxN1-Δ mutant 
support to a limited extent thymopoiesis because the number of double positive and single 
positive thymocytes observed in these mutants was decreased by 97% when compared to wild 
type mice (Su et al., 2003). In conclusion, a partial block at both DN1 (CD44+CD25-) and DP 
(CD4+CD8+) stages of thymocyte differentiation was observed. However, SP CD4+ or SP CD8+ 
cells were generated in FoxN1-Δ homozygous mice and these cells were exported to the 
periphery, although in reduced numbers. The mechanism by which the FoxN1 amino-terminal 
domain regulates TEC differentiation remains to be determined, as does the basis for its tissue-
specific activity.  
 
For its architectural organization, the medulla is dependent on distinct signals provided by 
thymocytes that have been successfully selected in a positive fashion (Shores et al., 1991). These 
signals may likely be mediated by the transcription factor RelB (component of the NFκB 
signalling pathway), as mice deficient for RelB display a medullary thymic atrophy and aberrant 
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clonal deletion of autoreactive thymocytes (Burkly et al., 1995; Laufer et al., 1996; Naspetti et 
al., 1997; Weih et al., 1995). After E14.5, the autoimmune regulator gene, designated Aire, is 
expressed in TECs and to a much lower degree in dendritic cells. Aire transcription in TECs is 
critically dependent on the presence of RelB (Heino et al., 2000; Zuklys et al., 2000). 
Homozygous mutations of the Aire locus causes in humans the monogenic autoimmune 
syndrome APECED (autoimmune-polyendocrinopathy-candidiasis-ectodermal dystrophy). This 
disorder is characterized by the loss of self-tolerance to multiple organ-specific antigens 
secondary to the specific reduction in ectopic expression for genes encoding peripheral antigens 
(Anderson et al., 2002) (Liston et al., 2004; Liston et al., 2003).  
 
While the mechanisms that regulate the initial and late-stage differentiation of medullary and 
cortical TECs remain largely undetermined, a recent study has shown that lymphocyte-dependent 
development of medullary TECs is controlled by signalling through the lymphotoxin beta 
receptor (LTbetaR), as mice deficient for LTbetaR display an aberrant differentiation and reduced 
numbers of thymic medullary TECs (Boehm et al., 2003). Furthermore these deficient mice 
revealed an abnormal retention of mature T lymphocytes. This aberrant export of mature 
thymocytes has been suggested to result from an absence of normal medullary lympho-epithelial 
interaction, which in consequence may lead to autoimmunity. 
 
The TNF receptor-associated factor 6 (Traf6), has also been recently identified to be required for 
the differentiation of medullary TECs (Akiyama et al., 2005). The deficiency of Traf6 in mice 
results in a disorganized distribution of medullary TECs and a lack of mature TECs. 
Interestingly, Traf6 deficient mice also developed spontaneous autoimmunity underscoring the 
central importance for a regularly structured and normally differentiated thymic medulla for the 
process of a correct T cell repertoire selection. In this context, it was suggested that Traf6-
dependent and independent NFκB signalling were both involved in the initial stages of mTEC 
differentiation (Akiyama et al., 2005; Ishikawa et al., 1997). In further support of this conclusion, 
mice spontaneously deficient for the NFκB-inducing kinase (NIK) also displayed a disorganized 
thymic microarchitecture with no clear cortical-medullary distinction (Miyawaki et al., 1994; 
Shinkura et al., 1999). Taken together, these results reveal a critical role for NFκB signalling in 
mTEC differentiation and reveal the importance of the thymic medulla in the induction of self-
tolerance (Kurobe et al., 2006). 
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1.6 T-cell development in the thymus 
 
1.6.1 Commitment of T cell development in the fetus 
 
The thymus is the main site where T cells are generated. T cell commitment occurs in the thymus 
by the activation of Notch 1, a member of a highly conserved family of transmembrane receptors 
that are involved in many cell lineages in the regulation of cell-fate choices (Allman et al., 2002; 
Pui et al., 1999).(Radtke et al., 1999). In the post natal mouse thymus, Delta1, a specific ligand 
for Notch1 is expressed at the cortico-medullary junction on thymic stromal cells. At this site 
blood-borne haematopoietic precursors enter the thymus and upon Notch-signalling are instructed 
to differentiate along the T-cell/NK-cell lineage (Han et al., 2000; Jaleco et al., 2001; Lind et al., 
2001). In contrast to the seeding of the vascularised thymus, the entry of precursor to the thymus 
primordium occurs through the organ's capsule. Here, several lines of evidence suggest that 
T/NK cell commitment can occur prior to thymic immigration, as such a developmental 
restriction had been observed in the thymus, blood, and spleen of E15 embryos (Carlyle et al., 
1997; Carlyle and Zuniga-Pflucker, 1998; Rodewald et al., 1994). 
 
1.6.2 Thymocyte precursors seeding and migration to the developmental 
thymus murine fetus 
 
A major focus of research into the function of the thymus has been dedicated to delineate the 
precise pathways by which haematopoietic precursor cells develop into mature T cells of the α/β 
T cell lineage. These precursor cells originate from haematopoietic stem cells (HSCs), which at 
the time of their seeding to the thymus are still located in the aorta-gonad-mesonephros (AGM) 
region or in the placenta (Gekas et al., 2005; Godin and Cumano, 2002). The HSC pool in the 
placenta occurs prior to and during the initial expansion of HSCs in the fetal liver (Gekas et al., 
2005). 
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1.6.3 T cell differentiation in fetal thymus 
 
The events that eventually lead to the generation of a mature T cell population with a diverse T-
cell receptor (TCR) repertoire are divided into two separate but sequential phases: (i) the early 
development of thymocytes proceeds in the absence of a rearranged α/β TCR locus, and (ii) the 
subsequent differentiation depends on the successful cell surface expression of an αβ TCR from a 
productively rearranged locus. The earliest intrathymic precursors approximately of all 
thymocytes in the post-natal thymus belong to a subpopulation of cells expressing neither CD4 
nor CD8. This population of cells has been referred to as the double negative (DN) thymocyte 
cells. Using additional cell surface markers, the population of DN cells can be further subdivided 
in the mouse into four distinct populations, which reflect distinct and sequential stages in the 
maturation. The most immature population of T-cells (known as DN1) is defined by the 
concommitment cell surface expression of CD44 (phagocyte glycoprotein-1/Pgp-1), CD117 (c-
kit, tyrosine kinase receptor for stem cell factor), CD127 (IL-7Rα), and CD90 (Thy-1) but with 
the notable absence of CD25 (IL-2 receptor α chain) (Wu et al., 1991) (Godfrey et al., 1993). 
The term “DN“ is, however, a misnomer for this subpopulation as these cells express low levels 
of CD4. It appears that CD4 molecules are taken up by DN1 cells from cells that express this T-
cell coreceptor. Moreover, these CD4 molecules do not seem to be functionally important for 
DN1 cells as their loss of CD4 does not affect their capacity to contribute to early T cell 
development (Rahemtulla et al., 1991). In this context it is important to point out that a 
CD44+CD25- subpopulation of CD4-CD8- thymocytes has been identified that fails to express 
CD117 but that is positive for the expression of an αβ TCR (Godfrey et al., 1994). However, 
these cells do not contribute to early thymopoiesis. The expression of CD25 marks the 
progression from a DN1 to a DN2 (CD44+CD25+) stage in thymocyte development (Godfrey et 
al., 1994). This developmental stage is characterized by the start of the rearrangement of β, γ, and 
δ loci of the T cell receptor (TCR) (von Boehmer and Fehling, 1997). The subsequent loss of 
CD44 expression defines the DN3 (CD44-CD25+) stage of early T cell development. DN3 is also 
a population of cells, which are now also devoid of a CD117 expression and have completed their 
rearrangement of the β, γ, and δ chains locus. These cells are now in the position to either express 
a pre-TCR consisting of a productively rearranged β chain plus a surrogate and invariant TCR 
α  chain (known as pTα, as gp33) or, alternatively, to express a complete γδ TCR. Thymocytes 
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that fail to express any of these two receptors fail to receive survival signals and thus undergo 
apoptosis before they gain the ability to transit to the DN4 (CD44-CD25-) cell stage. In contrast, 
the cells that have successfully rearranged the TCR β loci and thus bear a pre-TCR on their cell 
surface begin to proliferate. Not all cells with a DN phenotype are yet committed to the α/β T cell 
lineage as (i) DN1 and DN2 thymocytes retain the capacity to differentiate to NK (Nature Killer) 
and thymic DC (Dendritic cell) and (ii) harbour the potential to develop (given specific 
conditions) into B cells and myeloid cells (Ardavin et al., 1993; Carlyle et al., 1997; Wu et al., 
1996). The "Katsura/Kawamoto model" of haematopoiesis  predicts that myeloid potential is a 
typical feature of early T and B cell development with T-cells and B-cells derived from a 
common myelo-lymphoid progenitor (CMLP) through bi-potent the intermediates of myeloid-T-
cell (MT) and myeloid-B-cell (MB) precursors, respectively (Akashi et al., 2000; Katsura, 2002; 
Kawamoto et al., 1999; Traver et al., 2001). At E12, all cells of the T cell lineage correspond to 
DN1 cells and their absolute numbers have been estimated to be 80 (Douagi et al., 2000). By E13 
DN2 cells are also present and DN3 and DN4 develop over the course of the next 2 days. At E15, 
the number of T cell precursors has increased to more than 10,000. Although most thymocytes at 
this developmental stage divide every 10 hours, the observed increase in lymphoid cellularity 
cannot be only explained by in situ expansion of the originally seeding 80 haematopoietic cells. It 
has been calculated that approximately 20 T cell precursors enter the thymus between E11.5 and 
E12.5, 300 between E12 and E13, and 3000 between E13 and E14 (Douagi et al., 2000). 
Multipotent haematopoietic cells have not been detected in the fetal thymus at any stage of 
gestation. This finding indicates that the differentiation potential of thymic immigrants is 
restricted to the lymphoid lineage and that commitment to the T cell lineage must occur prior to 
thymus colonization (Kawamoto et al., 1998; Rodewald et al., 1994). The majority of developing 
thymocytes are characterized by the concommitment expression of CD4 and CD8, a phenotype 
referred to as double positive (DP). DP thymocytes that have successfully rearranged their β 
locus for the TCR attain this developmental stage (so called β-selection). The stage of DP 
thymocytes follows that of DN cells and is attained via a transitional intermediary  phenotype 
referred to as immature single positive (ISP) cells. These ISP express either CD4 or CD8 but not 
both co-receptors at the same time, and can be distinguished from more mature single positive 
thymocytes by a lower cell surface expression of their TCR β chain (Paterson and Williams, 
1987; Yu et al., 2004). The ISP to DP transition is an actively regulated differentiation step that 
leads to the generation of a large pool of DP thymocytes (Yu et al., 2004). At the ISP stage of 
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maturation, the rearrangement of the TCRα locus is initiated which still coincides with cell’s 
active phase of proliferation. Hence no rearrangement of the α loci occurs until the proliferative 
phase has ended. This sequence of events ensures that each successful rearrangement of the TCR 
β-chain gives rise to many DP thymocytes. Each of these can independently rearrange their α-
chain genes once the cells stop dividing, so that a single functional β chain can be associated in 
the progeny of these cells with many different α chains. Following the period of α chain gene 
rearrangement, a complete α/β TCR is expressed, which now allows for the process of positive 
thymic selection by peptide/MHC complexes. 
 
1.6.4 Positive and negative selection in the thymus 
 
Following their transition to a DP cell stage, developing thymocytes undergo extensive selection 
to ensure that the mature T cells to be exported from the thymus are functional and self-tolerant. 
In this context of testing the functional usefulness of specific thymocyte antigen specification, the 
terms positive and negative thymic selection denote two separate but interconnected and essential 
processes, designated positive and negative thymic selection. Positive and negative thymic 
selection are both dependent on lymphostromal interactions within the thymus (Anderson et al., 
1999; Chidgey and Boyd, 2001; Jameson and Bevan, 1998; Klein and Kyewski, 2000; Sebzda et 
al., 1999). Positive selection occurs if the TCR of the thymocytes engages a self peptide-MHC 
ligand on cortical TECs with a sufficiently low affinity, resulting in the transduction of a survival 
and differentiation signal (Bevan, 1997; Palmer, 2003; von Boehmer, 1994). Thymocytes unable 
to recognize any peptide-MHC-ligand with a sufficiently high affinity that allows for positive 
selection will die by neglect. In other words developing T cells are destined to die by default 
unless they are rescued by life-sustaining signals from other cells or their products (Boursalian 
and Bottomly, 1999; Raff, 1992; Sprent and Kishimoto, 2001). In contrast, thymocytes bearing a 
TCR with an affinity which is high for the self peptide-MHC-ligand (i.e. higher than necessary 
for positive selection) are deleted by the process coined as negative selection, an event effected 
by apoptosis and resulting in the removal of thymocytes with a self-reactive TCR specificity 
(Nossal, 1994; Smith et al., 1989; Sprent and Kishimoto, 2002) (Palmer, 2003; Starr et al., 2003). 
The remaining thymocytes that express a low affinity TCR mature further and begin to express 
high levels of this αβ TCR on their cell surface and subsequently cease to express one or the 
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other of the two co-receptor molecules, becoming either CD4+CD8- or CD4-CD8+ single-positive 
(SP) thymocytes (Kaye et al., 1989; Merkenschlager et al., 1997). Positive selection and the 
subsequent development into CD4+ T-helper cells requires the interaction of their TCR with their 
cognate peptide-MHC class II complex presented by thymic stromal cells, while the 
corresponding selection and development into CD8+ cytotoxic T lymphocytes (CTLs) requires 
the interaction of the cells TCR with a peptide-MHC class I complex on thymic stromal cells that 
serves as the cognate ligand for this receptor (Kaye et al., 1989; Teh et al., 1988). The different 
developmental stages of T-cell differentiation in the thymus have been summarized in Fig.1.3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3. Anatomical microenvironments in the adult thymus. The thymus of mice is a bilobed organ divided 
by mesenchymal septae und surrounded by a capsule. Lobes are organized into discrete cortical and medullary areas, 
each of which is characterized by the presence of particular stromal cell types, as well as thymocyte precursors at 
defined maturational stages. Thymocyte differentiation can be followed phenotypically by the expression of cell-
surface markers, CD4, CD8, CD44, CD25 as well as the T-cell receptor (TCR). Interactions between thymocytes and 
thymic stromal cells are known to be crucial in driving a complex thymic programme of T-cell maturation, which 
results in the generation of self-tolerant CD4+ (helper) and CD8+ (cytotoxic) T cells, which emigrate from the 
thymus to establish the peripheral T-cell pool. (4, CD4; 8, CD8; 44, CD44; 25, CD25; TCRlow, expressing the TCR 
at low levels; TCR high, expressing the TCR at high levels; CMJ, Cortico-Medullary Junction; HP, Haematopoietic 
precursor; MΦ, Macrophage; Mes. fibroblast, Mesenchymal fibroblast);DN1-4, Double negative (CD4-CD8-) 1-4 
stage; DP, Double positive (CD4+CD8+); SP Single positive (CD4+ or CD8+). 
 
 
Positive thymic selection is effected by cortical thymic epithelial cells (cTECs). Using 
reaggregate thymic organ culture (RTOC), it has been well established that MHC class II positive 
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cTECs are both necessary and sufficient for positive selection of DP of the α/β TCR lineage to 
CD4+ SP cells (Anderson and Jenkinson, 1997; Anderson et al., 1996). In contrast, medullary 
epithelium and antigen-presenting cells (APCs) of haematopoietic origin have been reported to be 
either unable to positively select or display very inefficient selection of DP thymocytes (Bix and 
Raulet, 1992; Capone et al., 2001; Chidgey and Boyd, 2001; Cosgrove et al., 1992; Laufer et al., 
1996; Markowitz et al., 1993; Zerrahn et al., 1999). In contrast to positive selection, negative 
selection is believed to occur either in the cortex at the cortico-medullary-junction or in the 
medulla itself (Baldwin et al., 1999; Murphy et al., 1990; Surh and Sprent, 1994). The cells 
responsible for negative selection are mainly bone marrow-derived thymic stromal cells; although 
thymic medullary epithelial cells have also been implicated to effect negative selection for some 
self-antigens (Hoffmann et al., 1992; Hoffmann et al., 1995; Lo and Sprent, 1986; Marrack et al., 
1989; Throsby et al., 2000). In fact, recent studies have demonstrated that medullary TECs are 
sites of promiscuous gene expression under the control of the autoimmune regulator gene (Aire), 
a phenomenon that is marked by the transcription of genes normally expressed in peripheral 
tissues (outside of the thymus) (Anderson et al., 2002; Derbinski et al., 2001; Heath et al., 1998; 
Klein et al., 1998; Klein et al., 2000; Liston et al., 2004; Liston et al., 2003; Werdelin et al., 
1998). This finding suggests that medullary TECs might be able to express the entire peptide 
repertoire of a given individual, making the medulla the ideal site for negative selection (Palmer, 
2003). 
 
1.6.5 The final step: export from the thymus 
 
After positive and negative selection is completed, the correctly selected T-cells remain in the 
medulla for up to 14 days (Gabor et al., 1997). Maintenance of the peripheral T cell pool with 
naive cells requires the controlled release of the newly generated T cells from the thymus into the 
peripheral circulation. It is presently perceived that mature T cells are exported via blood and 
lymphatic vessels (Bhalla and Karnovsky, 1978; Miyasaka et al., 1990; Sainte-Marie and 
Leblond, 1965; Toro and Olah, 1967). In the mouse, approximately one million naive T cells are 
exported every day from the thymus to the periphery. In this regard, two predictions have been 
made concerning the exit of T cells from the thymus: (i) exit should only be possible for T cells 
that have achieved post selection maturity in the medulla, and (ii) in order to be able to exit the 
thymus, T cells change either the expression or activation of integrins, alter their requirements for 
adhesion and change their responsiveness to positional cues. 
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2. Materials and Methods 
2.1 Materials 
 
2.1.1 Mice 
Mice (C57BL6/J) were housed at the Animal Facility of the Kantonsspital Basel and at the 
Institute of Biomedicine of the University of Basel, according to Governmental regulations. 
 
2.1.2 Tissues 
Tissues were obtained from adult mice and embryos of distinct developmental stages following 
timed pregnancies (Detection of the vaginal plug was considered as day 0.5 of gestation 
(designated E0.5). Embryos homozygously deficient for the transcription factor Sp8 and for the 
pleckstrin homology-like domain family A2 (Phlda2, a.k.a IPL) were kindly provided by 
Dr.A.Mansouri (Göttingen, Germany) and by Dr.B.Tycko (New York, USA), respectively. 
Embryos of different gestational age were embedded in O.C.T (Tissue-Tec, Miles, Elhart, IN) for 
immunohistological analysis. Some transgenic tissue (Dr.S.Bell, Cincinnati, OH, USA) was also 
examined by β-galactosidase-based histochemistry. 
 
2.1.3 Cell lines 
The following cell lines were experimentaly used as part of this thesis work: 
Cell line Origin Reeference 
cTEC 1.2 
cTEC 1.4 
cTEC C9 
mTEC 2.3 
mTEC 3.10 
mTEC C6 
HEK 293 
Mouse thymic cortical epithelium 
Mouse thymic cortical epithelium 
Mouse thymic cortical epithelium 
Mouse thymic medullary epithelium 
Mouse thymic medullary epithelium 
Mouse thymic medullary epithelium 
Human Kidney 
(Kasai et al., 1996) 
(Kasai et al., 1996) 
(Kasai et al., 1996) 
(Kasai et al., 1996) 
(Kasai et al., 1996) 
(Kasai et al., 1996) 
 
Cells were grown at 37°C and in 5% CO2 in Iscove's Mod. dulbecco's medium (IMDM) 
containing 5% of fetal calf serum (FCS). To detach cells from vessels, cells were incubated for 2-
3 minutes in undiluted Trypsin solution (Invitrogen Corporation, Basel, CH). 
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2.1.4 Cell culture, plastic ware, and chemicals 
 
Media Iscove's Mod. Dulbecco's medium (IMDM) supplemented with NaHCO3 and L-Glutamine 
were purchased from (Invitrogen Corporation, Basel, CH). Additional supplements were 
employed according to the specific requirements (see 2.1.4.1 and 2.1.4.2). Sterile disposable 
plactic ware for tissue culture was purchased from Falcon Labware (Oxnard, CA, USA). 
Chemicals were purchased from Fluka (Buchs, Switzerland), Sigma (St. Louis, MO, USA) and 
other commercial venders as indicated. 
 
2.1.4.1 Supplements for thymic epithelial cells 
 
For 1L of media for thymic epithelial celsl, 10 ml of 1M Hepes, 1ml of Gentamycin (50mg/ml) 
and 100ml of FCS (Fetal Calf Serum) were added. 
 
2.1.4.2 Supplements for HEK 293 cells 
 
For 1L of media for HEK 293 cells, 20ml of FCS were added and 100µl of β-mercaptoethanol 
(1M) were added. 
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2.1.5 Antibodies 
Antibody Clone Source 
Used in immunohistology 
anti-CCL21, rabbit 
anti-Meox2, rabbit 
anti CD44, rat 
anti CD44v6, rabbit 
anti CD44 v10, rabbit 
anti-mWIF1, goat 
anti-hWIF1, rabbit 
anti-Fst, rabbit 
anti-Phlda2 (IPL, Tssc3), rabbit 
anti-β gal (E.coli), monoclonal 
anti-k5, rabbit 
anti-k8, goat 
anti-CD45, rat 
anti-rabbit IgG, goat Biot conjugated 
anti-rabbit IgG, goat HRP conjugated 
anti-goat IgG, rabbit Biot conjugated 
anti-goat IgG, rabbit HRP conjugated 
anti-rat IgG, goat HRP conjugated 
anti-mouse IgG, goat FITC conjugated 
anti-human IgG, goat HRP conjugated 
 
 
 
IM7 
 
 
 
 
 
 
 
 
 
30-F11 
 
 
 
 
 
 
 
 
 
Kindly provided Dr.K.Mankoo 
Pharmingen 
Kindly provided by Dr.U.Gunthert 
Kindly provided by Dr.U.Gunthert 
R & D systems 
Kindly provided by Dr.J.Hsieh 
Kindly provided by Dr.S.Werner 
Kindly provided by Dr.B.Tycko 
Promega 
 
 
Pharmingen 
Southern Biotechnology 
Southern Biotechnology 
Southern Biotechnology 
Southern Biotechnology 
Southern Biotechnology 
Southern Biotechnology 
Sigma 
Used in flow cytometry 
anti-CD3ε Biotin 
anti-CD4 (L3T4) PE 
anti-CD4 Biotin 
anti-CD8 FITC 
anti-CD8 Biotin 
anti-CD25 FITC 
anti-CD44 PE 
 
145-2C11 
RM4-5 
RM4-5 
53-6.7 
53-6.7 
PC61 
IM7 
 
Pharmingen 
Pharmingen 
Pharmingen 
Pharmingen 
Pharmingen 
Pharmingen 
Pharmingen 
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2.1.6 Standard buffers 
 
Name Composition 
FACS-buffer 1% BSA, 0.1% NaN3 in PBS 
Formaldehyde gel-running buffer (5x) 0.1 M MOPS, ph 7.0, 40mM NA Acetate, 
5mM EDTA, pH 8.0 
SSC 150mM NaCl, 15 mM Na-citrate 
TAE 40mM Tris/acetae, ph 8.0, 1mM EDTA 
TBE 89 mM Tris, 89 mM bori acid, 2mM EDTA 
pH 8.3 
PBS (1x) 0.14M NaCl, 2.7mM KCl, 6.5mM Na2HPO4, 
1.5mM KH2PO4, pH 7.3, autoclave 
TE 10mM Tris/Cl, 1mM EDTA, pH8.0 
MES (12x) 70.4g MES (free acid monohydrate), 193.3g 
MES sodium salt complete to 1L with H2O-
tridest pH 6.5-6.7 filter, do not autoclave 
MES-Hyb (2x) 8.3ml of 12x MES, 17.7ml 5M NaCl, 4ml 
0.5M EDTA, 0.1ml 10% Tween 20, 19.9ml 
H2O-tridest filter sterilize 
MES-Wash 83.3ml 12x MES, 5.2ml 5M NaCl, 1ml 10%, 
complete to 1L with H2O-tridest, filter 
sterilize 
SSPE-Tw (6x) 300ml 20x SSPE, 1ml 10% Tween 20, 
complete to 1L with H2O-tridest, pH 7.6, 
filter sterilize 
Stain buffer (2x) 41.7ml 12x MES, 92.5ml 5M NaCl, 2.5ml 
10% Tween 20, 113.3ml H2O-tridest, filter 
sterilize 
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2.2 Methods 
 
2.2.1 Microarray analysis from microdissected tissues 
 
Details to the method of preparation for total RNA extraction from laser microdissected tissue 
have been published elswhere (Klur et al., 2004). This report is based on procedures established 
part of this PhD work. 
 
2.2.1.1 Laser capture microdissection (LCM) 
 
The preparation of the tissue for Laser capture microdissection (LCM) was carried out as follows:  
 
• Embryos were immediately removed from euthanized pregnant mice of E10.5 days of 
gestationand and rapidly frozen in a drop of O.C.T (Tissue-Tec, Miles, Elhart, IN) using a 
plastic support submerged in a mixture of  dry ice (stored at -80°C until use) and a few ml of 
isopentyl (Flucka, Buchs, CH). 
• For sectioning by the cyrotome (Roche, Basel, CH) the embedded tissue was placed onto the 
support block at -20°C with some O.C.T. Once O.C.T has solidified, each edge of the block is 
cut with a razor blade so that a small rectangular shop is formed. 
• The sections were mounted on glas slides covered with a 1.35µm thin polyethylene foil 
(PALM Microlaser Technologies, Germany). 
• Sections were fixed for 10s in 75% of ethanol (Flucka, Buchs, CH), followed by a short rinse 
in DEPC-treated water (Sigma, Buchs, CH). 
• The sections were subsequently stained in 0.5% toluidine blue for 10s and rinsed twice in 
DEPC-treated water. 
• Sections were dehydrated in 50, 75, 95 and 100% of ethanol for 10s each. 
• Sections were then left at room temperature (RT) under a hood for 90min and subsequently 
used for LCM. 
 
Importantly, only DEPC-treated water was used to dilute the ethanol and the Toluidine Blue 
solutions. 
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• For preparing the support in which the laser microdissected tissue was to be catapultated, the 
cap of an 0.5ml RNase free tube (Vaudaux-Eppendorf AG, Schonenbuch, CH) was detached 
with the help of cisors. Subsequently, 5µl of Trizol (Invitrogen corportation, Basel, CH) was 
pipetted and has been droped into the inside of the separated cap before being placed on top 
of the specially designed cap-support of the LCM Robot-Microbeam microscope (PALM 
Microlaser Technologies, Germany). 
• The tissue of interest were microdissected using the laser of the microscope according to the 
manufacturer's recomendations. 
• The microdissected tissue was catapulted by slightly increasing the energy of the Laser. 
Importantly, the cap has to be as close as possible to the top of the section when catapulting 
the microdissected tissue into the 5µl of Trizol. 
• At the end of each LCM session, the cap was put back on top of the 0.5ml tube and closed 
before being spined at 14,000g for 1min and stored at -80°C until further processing. The 
different steps above were repeated until at least 1000 cells of the region of interest were 
collected. 
 
2.2.1.2 Total RNA extraction for microdissected tissue 
 
To extract total RNA from microdissected tissues, the standard protocol for the use of the Trizol 
reagent (Invitrogen Corporation, Basel, CH) has been modified. In short,  
• Individual drops from a single LCM dissection were pooled for the same tissue so that the 
combined lysate would represent approx 1000 cells. The volume was then completed to 1ml 
with Trizol reagent and the tube was subsequently mixed gently. For the RNA analysis of 
complete cross-sectioning of embryos, the tissue was removed from the foil by use of a sterile 
razor blade, The recovered tissue was solved in 1ml of Trizol. 
• After addition of 0.1ml of bromochloropropane (Flucka, Buchs, CH), the tube was vigorously 
shaken for 20 to 30s with the help and were left for 15min at room tempaterature before being 
centrifuged at 12,000 g for 15 min at 4°C. 
• The aqueous phase (~450µl) was transferred into a new 1ml tube (Vaudaux-Eppendorf AG, 
Schonenbuch, CH), mixed with 1µl of Linear polyacrylamide LPA (Sigma, 5µg/µl) and 
500µl of isopropanol to precipitate the RNA.  
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• The precipitated mix was stored for 1 hour at room temperature and centrifuged for 2 hours at 
20,000g at 4°C. 
• The RNA pellet was washed twice with 1ml of cold 75% ethanol and shortly spined in order 
to remove the remaining ethanol before being air-dried for 3min under a hood. The pellet was 
then stored at -80°C until further used. 
 
2.2.1.3 Random PCR-based amplification 
 
cDNA synthesis and amplification were performed using the Microarray Target Amplification 
Kit (Roche Diagnostics, Germany) according to the manufacturer's recomendations.  
 
First strand cDNA synthesis: 
• The total RNA pellet was resuspended in 8.5µl of double-distilled water and transferred to a 
new 0.5ml tube and the subsequent components were added to the solved pellet: 2µl of TAS-
T7 Oligo (dT)24 (25µM), 4µl of 5x reverse transcriptase buffer, 2µl of DTT (100mM), 2µl of 
dNTP Mix (10mM each) and 1.5µl of the Reverse transcriptase Enzyme mix (17U/µl ) 
• The mixture was well mixed by vortexing before being shortly spined in a microcentrifuge. 
The reaction was then incubated in a thermal cycler at 42°C for 60 min. 
 
Second strand cDNA synthesis: 
• The reverse transcribed RNA was incubated at 95°C in a thermal cycler for 5 min to achieve 
the denaturation of the RNA/DNA hybrid, placed immediately on ice and left for 5 min. The 
following components were then added to the mixture: 2.5µl of dNTP mix (10mM each), 5µl 
of TAS-(dN)10 (100µM), 5µl of 10x Klenow reaction buffer, 13.5µl of double-dist water and 
4µl of Klenow Enzyme (2U/µl). 
• The mixture has been mixed by vortexing before being briefly spined in a microcentrifuge. 
The reaction was then incubated in a thermal cycler at 37°C for 30min. 
 
Purification of the double stranded cDNA: 
The double stranded cDNA were purified using the Microarray Target Purification Kit (Roche 
Diagnostics, Germany) according to the instructions of the manufacturer. Importantly, 1.25µl of 
carrier RNA and 50µl of double-distilled water were added to each sample. 
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First PCR: 
 
A first PCR was required to determine the optimal cycle number so as to ascertain that the 
amplification of the cDNA was still exponential as "overcyling" may result in lower yields of 
cRNA which in turn could influence the subsequent quality of the microarray analysis. The 
correct cycle number for each sample is dependent on the initial amount and quality of the RNA 
recovered. In that regard, 50ng of intact total RNA from the K562 cell line (included in the 
microarray target amplification Kit) was amplified in parallel and served as positive control for 
the estimation of the RNA amount present in the microdissected tissue samples. 
 
• The purified double stranded cDNA was pipetted into a new 0.2ml microtube and the 
subsequent components were added to the reaction: 1µl of TAS Primer (50µM), 2µl dNTP 
Mix (10mM each), 73µl of double-distilled water, 10µl of 10x Expand PCR buffer and 1.5µl 
of the Expand Enzyme Mix (3.5U/µl). 
• The mixture has been mixed, briefly spined in a microcentrifuge before being placed in a 
PCR cycler. The PCR was effectuated as decribed here below (see PCR conditions). 
• In the last minute of cycle 18 at the elongation step, 10µl were removed from each tube for an 
gel electrophoresis analysis. This procedure has been repeated in cycle 21/24/27/30. 
• The aliquots of 10µl were analysed on a 1.2% agarose/ethidium bromide 0.25µg/ml gel for 
the determination of the optimal cycle number, which was considered when the observed 
smear of the PCR amplicons (ranging from 0.7 to 2.2kb) started to be clearly detected (see 
Fig.2.1 for example on next page). 
 
PCR conditions: the reactions were incubated for 2min at 95°C and subsequently for 30s at 95°C, 
30s at 55°C and for 3min at 72°C, respectively for the denaturation, the annealing and the 
elongation of the amplicons. These subsequent steps were repeated 29 times. 
 
Second PCR: 
 
The second PCR, a PCR identical to the first PCR was performed, with the previously determined 
optimal cycling number (see First PCR section). The amplicons of this PCR were then analysed 
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by electrophoresis on a 1.2% agarose/ethidium bromide 0.25µg/ml gel for a quality verification 
of the amplified cDNA. The amplicons systematically presented an expected smear between 0.7 
and 2.2kb. 
 
 
 
 
 
 
 
 
Figure 2.1. Gel electrophoris analysis of the semiquantitative PCR-based amplified cDNA (First PCR step) for 
the different samples of the dorsal and ventral aspects of the 3rdpp. Three different batches, Batch 1 (A),  Batch 2 
(B) and Batch3 (C) of the dorsal (D) and the ventral aspect (V) of the 3rdpp have been independently generated. 
Batch 1 and 2 were used for microarray and qRT-PCR analysis while Batch 3 was only used for the independent 
verification of candidate genes by qRT-PCR. Control sample for random PCR-based amplification (50ng of intact 
total RNA provided with the kit of amplification was used for the reverse transcription in parallel for the generation 
of Batch3 samples. The number above the lanes indicate at which PCR cycle 10µl have been subsequently deducted 
for the analysis. M, stands for the DNA molecular ladder and the number represented on the left or the right from it 
indicate the lengh in base pairs for two of its DNA products. From these data, the following PCR cycle for the 
second PCR step (see previous page) were decided: D_1 (21 cycles), V_1 (21 cycles), D_2 (20 cycles), V_2 (21 
cycles), D_3 (22 cycles), V_3 (22 cycles). 
A Batch 1 B Batch 2 
C Batch 3 
         D_1    V_1             D_2           V_2 
     Control           D_3              V_3 
-2000 
-2000 
-300 
-2000 
-300 
 18   21  24  27  30   M  18  21  24  27  30  M                       M  18  21 24 27  30  M 18  21 24  27 30  M 
-300 
M  18 21 24 27 30  M  18 21 24 27 30 M 18 21 24  27 30 M 
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Purification of the PCR product: 
 
The amplicons were purified using the Microarray Target Purification Kit (Roche Diagnostics, 
Germany) according to the instructions of the manufacturer. Importantly, the purified amplicons 
were eluated in 50µl of Elution Buffer B (included in the kit). For an OD (optical density) 
measurement, 5µl of the purified PCR reaction was deducted and was placed in a new 1.5ml tube 
containing 5µl of water before being cenfrifuged at 14,000rpm for 2min to spin down remaining 
purification column beads, as they can disturb OD measurement. The concentration of DNA in 
each sample was determined using the following formula: concentration (µg/ml) = 50 x OD260 x 
dilution. Importantly, DNA is considered to be pure when the ratio OD260/OD280 is more than 
1.8. 
 
2.2.1.4 In vitro transcription labelling (IVT) 
 
• Two hundred and fifty nanogramm of purified amplicons were deducted and dessicated using 
a Speedvact (BioRad, Reinach, CH). Forteen and a half microliter of a prepared biotinylated-
NTP mix sufficient for 4 reactions containing 8µl of Ambion's T7 10x ATP (75mM), 8µl 
Ambion's T7 10x GTP (75mM), 6µl of Ambion's T7 10x CTP (75mM), 6µl of Ambion's T7 
10x UTP (75mM), 15µl of Biotinylated-11-CTP (10mM) and 15µl of  Biotinylated-16-UTP 
(10mM) were added to the lyophilized sample. All ambion NTPs were ordered from Ambion 
(Huntingdon, UK). 
• The volume of the mixture was adjusted to 16µl with DEPC-treated water and 2µl of the 10x 
T7 transcription buffer (Ambion, Huntingdon, UK), as well as 2µl of the 10x T7 enzyme mix 
(Ambion, Huntingdon, UK) were added to the mixture. The reaction was then incubated for 4 
hours at 37°C for the synthesis of labeled cRNA. 
• For an quality verification of the amplified cRNA, 3µl of the reaction was deducted for an gel 
electrophoresis analysis (gel composition: 1.2% agarose formaldehyde-treated/ethidium 
bromide (0.25µg/ml). The distribution of the cRNA was systematically found to be as 
expected between 0.24 to 4.4kb. 
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Purification of the PCR product: 
 
The labeled cRNA was purified using the Microarray Target Purification Kit (Roche Diagnostics, 
Germany) according to the instructions of the manufacturer. Importantly, the purified cRNA was 
eluated in 50µl of Elution Buffer A (included in the kit). For an OD (optical density) 
measurement, 3µl of the purified IVT reaction were deducted and placed in a new 1.5ml tube 
containing 19µl of water before being cenfrifuged at 14,000rpm for 2min to spin down remaining 
purification column beads, as they can disturb OD measurement. The concentration of DNA in 
each sample was determined using the following formula: concentration (µg/ml) = 40 x OD260 x 
dilution. Importantly, RNA is considered to be pure when the ratio OD260/OD280 is more than 
1.8. 
 
2.2.1.5 Hybrization and stainings of Microarrays 
 
The protocols as well as the reagents for microarray hybridization were kindly provided by Dr. 
Ullrich Certa and Sandra Klur (Hoffman La Roche, Basel, CH). Microarrays processing, 
reading/scanning were carried out at the Roche center for medical genetics (Basel, CH). 
 
Fragmentation of the IVT products: 
 
• Twenty microgramm of the purified cRNA was deducted, placed in a new Rnase-free 1.5ml 
tube and dessicated in a Speedvac before adding 20µl of a fragmentation buffer to the 
lyophilized cRNA. 
• The reaction was then incubated at 95°C for 35min in a thermal cycler and placed on ice after 
the incubation 
 
Genechip Hybridization: 
 
• For the pre-hybridization of the microarrays of the MGU74v2 Genechip set (Affymetrix, 
Santa Clara, USA), a pre-treatment solution sufficient for 4 microarrays was prepared 
containing the following reagents: 25µl of acetylated BSA (20µg/µl), 50µl of Herring Sperm 
(HS) DNA (10µg/µl), 500µl of 2x MES-hybridization-Buffer (see section 2.1.6) and 425µl of 
DEPC-H2O). Two hundred and twenty microliter of the pre-treatment solution was loaded 
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into each microarray. Each microarray was then incubated in a hybridization chamber for 
rotation at 40°C at 60rpm for 15min. 
• For the preparation of the sample to be loaded on the microarray, 2.5µl of a control stock mix 
(100x) (Roche, Basel, CH) was added to the fragmented cRNA, as well as 2.5µl of 
Biotinylated Oligo 948, 2.5µl of HS DNA (10µlg/µl), 6.25µl of acetylated BSA 
(20µg/µl),125µl of 2x MES-hybridization-buffer, 91.25µl of DEPC-H2O. 
• The mixture was then incubated at 95°C for 5min in a thermal cycler and then in a 45°C 
waterbath until 220µl of it was loaded into the microarray. The microarray was then 
incubated in a hybridization chamber for rotation at 45°C, 60rpm O.N for microarray 
hybridization. 
 
Washing and Staining: 
 
• The remaining solution in the hybridized microarray was then removed and stored at -20°C 
until loaded on a subsequent microarray of the MGU74v2 Genechip set, as this set is 
composed of 3 different microarrays (A, B and C) that were subsequently hybridized with the 
same sample. The hybrized microarray was then rinsed with 6x SSPE-Tw solution (see 
section 2.1.6), washed on Basel Fluidics (BSFs) with 6x SSPE-Tw for 5min, before being 
rinsed with MES-wash-buffer (see section 2.1.6). 
• Two hundred and thirty microliter of fresh MES-wash-buffer was loaded into the microarray, 
which was then placed in a hybridization chamber for rotation at 45°C for 30min to wash it. 
The MES-wash-buffer was then removed from the microarray. 
• The microarray was stained with 250µl of a freshly prepared streptavidin-staining solution 
(125µl 2x Stain buffer, 91.25µl of DEPC-H2O, 31.25µl of acetylated BSA (20µg/µl) and 
2.5µl of recombinant Streptavidin (1mg/ml)). The microarray was then iucubated in a 
hybridization chamber for rotation at 40°C, 60rpm for 15min, before being rinsed with 6x 
SSPE-Tw and washed on BSFs with 6x SSPE-Tw for 5 min. 
 
Amplification of staining: 
 
• The SSPE-Tw solution was removed from the stained microarray and 230µl of a freshly made 
antibody solution (99µl DEPC-H2O, 125µl of 2x Stain Buffer (see section 2.1.6) , 25µl of 
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acetylated BSA (20µg/µl) and of 1µl biotinylated-anti-Streptavidin (500µg/µl)) was loaded 
into the microarray. The microarray was then incubated in a hybridization chamber for 
rotation at 40°C 60rpm for 30 min before being rinsed with 6x SSPE-Tw and washed on the 
BSFs for 5min with 6x SSPE-Tw. 
• For amplifying the staining of the microarray, 250µl of a freshly made SAPE solution (125µl 
2x Stain buffer, 91.25µl DEPC-H2O, 31.25µl of acetylated BSA (20µg/µl) and 2.5µl of 
Phycoerythrin (1mg/ml) was loaded into the microarray. The microarray was then incubated 
in a hybridization chamber for rotation at 40°C, 60rpm for 15min before being rinsed with 6x 
SSPE-Tw and washed on the BSFs for 5min. 
• For scanning the microarray was completely filled with 6x SSPE-Tw so that there was no 
bubles left! 
 
2.2.1.6 Microarray analysis 
 
All microarrays were analysed with the Affymetrix suite 5.0 software (Affymetrix, Santa Clara, 
USA) to determine the quality of the hybridization (see Table 2.1). All data reported in this thesis 
have been generated with a hybridization quality determined to be "good". 
 
Table 2.1.  Quality assessment for hybridization using the MGU74Av2 gene microarrays 
(adapted from Dr.C.Barlow, Salk institute for Biological Studies, Laboratory of Genetics, La 
Jolla, CA). 
 
Quality measurements Good Questionable Bad 
Outliers 0-100 400-600 >600 
Backround 50-100 100-300 >300 
Standard Deviation of Backround <7 7-10 >10 
Raw Q <3.4 3.6-8 >8 
Scaling factor <3.4 3.4-5 >5 
Percent Present calls >45%* 40-48%* <40% 
3'/5' Actin ratio <2 2.0-2.5 >2.5 
3'/5' GAPDH ratio <2 2.0-2.5 >2.5 
 
* depends on tissue! 
 
The Affymetrix suite 5.0 software was also used with its default settings for the determination of 
the normalized fluorescent intensity values as well as for the Present, Marginal and Absent calls. 
Whereas the dChip software (adapted from Dr. Cheng Li, Dana-Farber Cancer institute, Boston, 
USA) was used for analysing the representation of the Perfect Match vs the Mismatch of a given 
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probe set. The Mismatch is defined by being identical to the Perfect Match DNA sequence except 
for a single incorrect nucleotide in the middle of the oligomer.Hybridization conditions and probe 
compositions are such that the target sequence should hybridize to the Perfect Match but not to 
the Mismatch probe. Signals from the Mismatch features are subtracted from the perfect matches 
as background or non-specific binding. In cases of excessive background the gene is labeled as 
undetected and gets an absent call and vice versa. All these data can be exported to microsoft 
excel software and be analysed for differential gene expression (i.e Fold change). 
 
 
2.2.2 Linear amplification 
 
The protocol for linear amplification has been published previously by (Baugh et al., 2001) using 
the following (dT)-T7 primer sequence: 
5'GCATTAGCGGCCGCGAAATTAATACGACTCACTATAGGGAGA(T)21V 3' (V = A, C, or 
G) 
 
First stand systhesis: round 1 
• Twenty nanogramm of the (dT)-T7 primer was combined with 10ng of total RNA in a 0.5 ml 
tube. The mixture was then dessicated in a SpeedVac (BioRad, Reinach, CH) down to 1ml. 
Importantly, in case of overshooting the 1ml, milliQ 18.2 water was used to bring the volume 
back up. 
• For denaturing the RNA and the (dT)-T7-primer in the reaction, the mixture was incubated at 
70°C for 4 minutes in a thermal cycler with a heated lid and subsequently snap cooled on ice. 
Importantly, as the volume may drop after denaturation due to evaporation, the amount of 
water evaporated has to be determined and adjusted accordingly in a way that the volume of 
the mixture contains 1ml after the incubation. 
• One microliter of the following prepared RT solution (per 5ml: 2.0 ml 5x 1st Strand Buffer 
(Invitrogen corporation, Basel, CH), 1ml of 100 mM DTT, 0.5 ml 10 mM dNTP, 0.5 ml 
T4gp32 (8.0 mg/ml) (BD Biosciences, Allschwil, CH), 0.5 ml Rnase Inhibitor (~20 U) 
(Ambion, Huntingdon, UK) and 0.5 ml of SuperScript II (100U) (Invitrogen corporation, 
Basel, CH) was added to the dessicated sample and mixed by pipetting. The mixture was then 
incubated for 1 hr at 42°C in either a thermal cycler with a heated lid. Subsequently, the 
reaction was inactivated at 65°C for 15 min before being chilled on ice. 
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Second strand synthesis: round1 
 
• Thirteen microliter of a ice-cold second strand synthesis (SSS) premix (per 65ul: 15 ml of 5x 
Second-Strand Buffer (Invitrogen corporation, Basel. CH), 1.5 ml of 10 mM dNTP, 20U of 
DNA Polymerase I (Roche, Basel, CH), 1U of E. coli Rnase H (BD Biosciences, Allschwil, 
CH), 5U of E. coli DNA Ligase (Roche, Basel, CH), and completed with H2O), were added 
to the reverse transcribed RNA and mixed by pipetting. 
• The mixture was then incubated at 16°C for 2 hours. For generating blunt ends of double 
stranded DNA, 2 units of T4 DNA Polymerase (Bioconcept, Allschwil, CH) were added to 
the reaction, mixed by gentle flicking the microtube and was incubated at 16°C for an other 
15min. 
• For the inactivation of the reaction, the mixture was incubated at 70°C for 10 min. Once 
inactivated the reaction was adjusted to 75 ml by adding 60 ml TE (see section 2.1.6). 
• For purifying the double stranded DNA 75ml of a phenol:chloroform solution (1:1) was 
added to the reaction and mixed by pipetting vigorously before being loaded on a prespuned 
Phase Lcok Gel Heavy 0.5 ml tubes (Vaudaux-Eppendorf. Schonenbuch, CH) and 
centrifuged at 13K rpm for 5min. 
• The aqueous phase of the mixture was then further purified by being loaded on a BioGel P-6 
MicroSpin Column (BioRad, Reinach, CH) and spined at 1000g for 4min in a 
microcentrifuge. Importantly the column has to be spined for 2 min at 1000 g before loading 
the aqueous phase. The flow through (approx. 80ml) was transfered into a new 1.5ml tube. 
For precipitating the RNA, 5mg of Linear polyacrylamide (LPA) (Sigma, Buchs, CH) carrier 
was added to the mixture and precipitated by adding 3.5ml (approx. 1/25th volume) of 5M 
NaCl, as well as 220ml (approx. 2.5 volumes of the mixture) of 95% ethanol (Fluka, Buchs, 
CH). The mixture was then allowed to precipitate at -20°C O.N. 
• The precipitated DNA was then spined at 13K rpm for 20 min. The supernatant of the mixture 
was then carefully removed and the DNA pellet was washed with 500 ml of 70% ethanol, and 
spined for 5 min at 13K rpm. The 70% ethanol was then removed to the last drop. 
Importantly, all residual ethanol has to be removed. The DNA pellet was then dessicated by 
leaving it at 2-3 min under a hood. 
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In vitro transcription (IVT): round1 
 
• Twenty microliter of a IVT prepared premix (per 40ml: 16.5ml DEPC ddH2O, 4.0ml 10x of 
Ampliscribe Buffer (Epicentre, Madison, USA), 3.0ml 100 mM ATP, 3.0ml 100 mM CTP, 
3.0ml 100 mM GTP, 3.0ml 100 mM UTP (Epicentre, Madison, USA), 4.0ml of 100 mM 
DTT, 1.5ml Rnase Inhibitor (~60U) (Ambion, Huntingdon, UK), 2.0ml of a highly 
concentrated T7 RNA Polymerase (80U/ml) (Catalys AG, Wallisellen, CH)) was added to the 
lyophilized pellet at room temperature. 
• The reaction was then mixed by gently flicking and incubated at 42°c for 9 hours. The 
product can be stored at -20°C. 
• For the purification of cRNA, 480ml of Rnase-free TE (10 mM of Tris, 1 mM of EDTA at pH 
8.0) were added to the reaction and loaded on YM-50 Microcon columns (Millipore AG, 
Volketswil, CH). The columns were then spined for 20min at 12000g and have subsequently 
been washed with 500ml of Rnase-free TE. 
• The cRNA was then recovered from the columns by inverting those, adding 10ml of milli-Q 
18.2 water and by spining the columns for 5min at 500g according to the manufacturer's 
instruction. 
 
First strand synthesis: round 2 
• For reverse transcribing the cRNA, 5ml of random primers (0.5mg) (Invitrogen, Basel, CH) 
was added and dessicated in a Speedvac (BioRad, Reinach, CH). The mixture was then 
incubated at 70°C for 5 minutes in a thermal cycler with a heated lid before being snaped 
cooled on ice. 
• Five microliter of the RT premix (same as an round1) were added to the purified cRNA. The 
reaction was then incubated using the following temperature protocol in a thermal cycler: RT 
incubation (round 2): 20 min at 37°C, 20 min at 42°C, 10 min at 50°C, 10 min at 55°C, 15 
min at 65°C. The reaction was then maintained at 37°C in the thymal cycler until 1U of Rnase 
H was added to the mixture. 
• The reaction was then incubated at 37°C for 30min and at 95°C for 2 min. For the collection 
of the condensation, the reaction was chilled on ice, briefly spined and returned on ice. One 
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microliter of the (dT)-T7 primer (100ng) was added to the mixture. The reaction was then 
incubated at 42°C for 10min to anneal the primer. 
 
Second strand synthesis: round2 
 
• Sixty five microliter of a prepared SSS premix (same as in round1 but without the adjonction 
of the ligase). The reaction was then incubated at 16°C for 2 hours before 10U of T4 DNA 
Polymerase were added to it in order to generate blunt ends. For inactivating the reaction, the 
mixture was incubated at 70°C for 10 min. The purification and the precipitation of the 
double stranded DNA has been carried as in round1. 
 
In vitro transcription: round2:  
 
Forty microliters of a prepared IVT premix. (same as in round1) was added to the purified cRNA 
pellet. The mixture was then incubated at 42°C for 9 hours. The reaction was then washed and 
purified as in round1. 
 
2.2.3 Quantitative PCR (real time PCR) 
 
The primers for qRT-PCR were designed so that the amplicons were relatively short in size (< 
200bp) so as to ensure a maximum for quantitative PCR (qPCR) amplification.  Most primers of 
the 186 primer pairs ordered (Invitrogen, Microsynth or Sigma by Internet) were designed with 
the software Primerexpress 1.0. All primers (Table 2.2) were first verified using the conventional 
PCR as described in section of 2.2.5 using cDNA from unseparated E10.5 embryos. The 
amplification product was loaded on a 1% agarose/ethidium bromide gel for verification of the 
amplicon size. In case of a qPCR verification of the microarray differential gene expression the 
remaing purified dsDNA of the second PCR in section 2.2.1.3 was diluted 15 times (i.e 10ml + 
140ml of milli-Q 18.2 water). 
 
• Forteen microliter of a prepared master mixture of primers (per 14µl: 12.5µl of 2x SybrGreen 
Master Mix (Applied Biosystems, Rotkreuz. CH), 0.75µl of forward primer (10µM) and 
0.75µl of reverse primer (10µM)) was pipetted into a well of a 96 well plate (Applied 
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Biosystems, Rotkreuz, CH). The sequence of the respective used primers can be found in 
Table2. 
• Eleven microliter of a prepared mixture of template (per 11µl: 1µl of purified dsDNA or 
cDNA 2-10ng/µl) was then added to each well. The 96 well plate was sealed with a special 
adapted plastic foam for qPCR (Applied Biosystems, Rotkreuz, CH) according the 
manufacturer's instructions. The plate was briefly spined in a special adapted centrifuge 
(Vaudaux-Eppendorf, Schonenbuch, CH) and was placed in a Real time PCR ABI5700 
instrument (Applied Biosystems, Rotkreuz, CH). The PCR was then effectuated as described 
here below (see PCR conditions). 
 
PCR conditions: the reactions were incubated for 10min at 95°C and subsequently for 15s at 
95°C and 1min at 60°C , respectively, for the denaturation, the annealing and the elongation of 
the amplicons. These subsequent steps were repeated 39 times. The software of the instrument 
was programmed as such as at the end of the PCR, an dissociation protocol from 60°C to 93°C 
was effectuated for the verification of the specificity of the amplicons. 
 
Analysis: 
 
The baseline of the amplification plot was selected from cycle 6 to cycle 15 (default settings). In 
case the measured fluorescence started to be detected earlier than cycle 15, then the baseline was 
adjusted appropriately according the manufacturer's instructions. The threshold of the fluoresence 
for determining the Ct value was systematically selected to 0.2. It was observed that when using 
this threshold the measured Ct values were always in the exponential phase of the reaction. The 
specificity of the amplicons was verified by comparing the theoretical melting value calculated 
by the Primerexpress 1.0 software with that measured by the qPCR instrument. Only samples that 
gave expected melting values within a range of 1 to 2°C of a difference with the theoretical value 
were considered for the calculations of the Ct values. The qPCR ratio is defined as being the 
difference in signal intensity between the 2ndpp and 3rdpp or the dorsal and ventral domains of the 
3rdpp, respectively. It was calculated using the following formula: 
 
ΔΔCt = ΔCt (dorsal or 2ndpp) –ΔCt (ventral or 3rdpp) where ΔCt = Ct gene of interest – Ct 
(housekeeping gene GAPDH or HPRT). 
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Table 2.2. Sequences of primers used for quantitative and conventional PCR 
 
Gene symbol Forward primer Reverse primer 
GAPDH ACCATGTAGTTGAGGTCAATGAAGG GGTGAAGGTCGGTGTGAACG 
HPRT AGTCTGAAGCTCTCGATTTCCTATCA TGAAAGTGGGAAAATACAGCCAA 
CXCR4 TGTAGAGGAAGAAACTGAACATTCCA CCTCGGAATGAAGAGATTATGCA 
Wnt4 AGGTGGTGGGAGACTGTTTAAGTTA GGCTCGTGGAGATGCACAC 
FoxN1 TTGTGGAACTGGAGTCCACG TGTTGGGCATAGCTCAAGCC 
Hoxa3 TTCCCTTTTCTCCTCTGCACC GACAGCCTTTCCAGCAACCA 
Pax1 GGTGGTGAGGTTCATTTTGGTT AATAGCCCTCTTGCCTAGCTCC 
Pax9 CCTCAAAGGGCTTATGGAACAT TCAACAATTGCACGTTTCGAA 
Gcm2 ATCCCAGCACTCTGAGGGC TGAAACACAGAAACTGTCTGGTAGAA 
115106_at GGGTTATTTGTCAACTGAGTCTGAAA ACCCAGCCTGTGTTTGTTGAG 
CCL21 GGCTGCAAGAGAACTGAACAGA CCACCCAGCTTGAAGTTCGT 
168542_f_at TTCTTTTGCTGAGGGCTGGA CCAGTTCTAAACACAGGTTGTACACA 
Angpt2 TTCTGGGAAGGTTGTGGCTGAG CGTGCTTAGAGGAATGTGGTCC 
Apba2 GAGTGTGGTAGCCACAGCCC GGAGCCTAAACATGGCTGCA 
Ypel1 TGGTGCCATTTCTTTGCCC CTTTGCTTTGCCAGCCTTAGTC 
Gphn ATGTGCACCATGCCAAAAGA CTGCTAGGGTGAGTCCTTCCC 
Lmna TGAAGAGGGAAAGTTCGTGCG GGGAAGCGATAGGTCATCAAAGG 
163492_at GTGAAAGATGAGAGACAAGCAAAGG TGTCCCCTCAGCAGCCC 
Prkag2 TTTGGATCTGGAAAGGCTATGC TCCGTTACTTCTTCCCTGCG 
Dmrt2 TGTAGCCAAACAAGTTGGAACG TGAGTGACGGCAGATGAAGG 
Meox2 CGGTCCTGTGTTCCAACTCATC TGCTGCCACTTCTCTTCTCTACG 
Klf16 AAGCCTACCCCACTCCTTGTCTTC TTCCCTGAACTTCCGCCAATGG 
98890_at CATGCACAGTAACAGCCCAACT AGCAGCATGGTGTTGGGAG 
Keo4 TTTGTGTTCTTTGGCCCTTCA AAGCACAGAGCTCAGTGATCCA 
Pim3 GCTTAGTCACACCAGGGTCACA CAGTCTGCTTGCTGGCTCTG 
Zfp297 GATCCCCATGGCAAGGGT TGTGTTGTGGGACAAGGCCT 
Fgf12 TGGAGAAAAGCAAGGACGCTC AAAGGGAGGGAGAAGAAGGGACAG 
Kif3c TCCTTTGCTTTGTGCCTCCAG CCTCCCCCAAGATGTAACTAAGAAG 
Map3k CATGATTGTGCATCGGGACA TGGTCTGTAGGCGTTTGCTG 
103405_at TCACATCCTCTTCCCAACACTTG TTGTCCCCTTTCAGCCCTTC 
160815_at CTGCTCCACTCACCACCTCC CAAGTGAAGTTGCCCAGCAGT 
Pxk AGCTCATTCCTCTGCAGCATC CCGCTGTTTCTCCCTCAGC 
97355_at CATTTGACCATCTTGGGCCT CAGGTCTGACTTCTGGCCTTG 
Clock GATGGCCAGAAAGAATCGCTC CTTCCCTACCGTCTCATCAAGG 
Meox1 ATCTTCCTCCATGGGATGCATT TCTTCCAAGGAGACTGTTGCC 
Ehox GAGTGTACTGGGCCAGTCCG CCATGAGGTCTGCATCACCA 
CD44 GTTCCCGCACTGTGACTCAT TGTCCCATTGCCACCGTTGAT 
Gria1 GTCCGCCCTGAGAGGTCC ATTCCCCTTTATCGTACCACCA 
Colla1 GGACGCCATCAAGGTCTACTG GGTTCGGGCTGATGTACCAG 
Nrxn1 TGAGCTGCAAGTGACACACG GGCAAAGAGAGGATGCTGATG 
CD200 GGATTTTGGTTTTCAGTTCCACTG TGATTTCGGTGACGTTTCCA 
Ebf1 GTCCATGCAGGGATGATGG GAGTTGCGGGTGAAACCTTG 
CD6 CACTTTTGATCCTAAGCCTTAGGAA TCCTGGGTGATAATGGCAGC 
137059_at (EST1)  TGTATGTGCCCAGTGTCTCTGAA CACAACCATCCATAACGCCA 
101154_at (EST2) TTCCTAAACTGGTCTCCAAATTCC AGCAGCAAACACATTGAGGGT 
WIF1 TGTAATTTATGCATCTCTGCCCA CAGTGTGTAGTTGACAGATACTTGCAA 
CXCL13 CCACCTCCAGGCAGAATGAG TTTGTGTAATGGGCTTCCAGAA 
Lmcd1 TTGGATCCCTCAGAAATGCAT TGGATTTATTGTTTCCTAGCTGCAA 
Bmp4 GGACTTCGAGGCGACACTTC GCCGGTAAAGATCCCTCATG 
Fst TCTGTGCCCCAGACTGTTCC GCATCTGGCCTTGAGGAGTG 
130608_at ACACAGTGCCAGGCATACAATC ACTCCTTTAAATCCCTGGCAGAG 
c-myc CACAGCAAACCTCCGCACAG TGTGTGTCCGCCTCTTGTCGT 
107112_at GTGCAAACCTTGGAAGCCTG CCAAGCCGAAGAAGGCAAT 
Khdrbs3 CCTCTCGCTCTGGGAGTGAG GAAGTGGCGGTACCACGTG 
104066_at CCCTGGCTTTCACTGAAAGC GCCAAGACTAGAGTGGAGGAGC 
Flrt3 AGATGACTTGTTGACTCTGAAAGTGAA TGAAAAACGGGCTGTGCTTA 
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Bambi TCACCTGCAGCTCCCTAAGAC CACAGTCAAATGGATTAAGGTGCT 
135615_at CCTCCCCTTATAGACCACACCA TTCATTATTTGTCCCCCTTCAGA 
134352_at CATGTGGGTATGTGCAGGTGA CAGGTAGCGTAAAATCATCTCCAG 
Tec GGTTTGAGTGCCAGCCATG ACAACCACCCTGGCTTTCTG 
168351_at TCAGTGGGAGAAAGTGCTTGC TGAGGACATCTTTCAGCAGTCAG 
116782_at TCTACCTCCCCAGGATAGGCA TGTTGGTAGAGCAATGGCTTAGC 
Msx2 GACATATGAGCCCCACCACCT CTTGCGCTCCAAGGCTAGAA 
117279_at ATGCTTGTTCGTGCACCAAAG TGGTAGCTCACAAACGTCCATAAC 
Pr1 CGTCGTACAGAGGCACCCTT TGACCTTGACACTGCCTCTTAGG 
Lnpep GGTTCAAAAATGAGTGATTCCCTTT CTTTGAATCTTAGGAGAGAAGCTTTCTT 
136661_at AGCACCCTGGCTACTTTTGC TGTGAATTCTCTGACGTTGAATGA 
Rbm9 TTTTGGAGCCTCTGTGGGAC ATGGCAGTGAAACCTGGCTT 
Sh3glb1 GAGCAGGCCTAAAGATTACGTTG ACACAAGAGGACCCACCCAG 
Srpk2 GCCTACTAATGGTTTGTATCCTGGA CCCATGAATGAGAAGGCCA 
Csnk1d TTGTCTGCCCTTCACAGCAA CGCATGTCCACCTCACAGAT 
Phlda2 TCACCGAAGATATTCCCGTTG TGGTGGGTTGGAAGCAGGTA 
Spock2 ACAGACGGAACCCAAGCACT AGCTACCCGCTTCTCAGCC 
Nkd1 TGAAGGCTGGCTAAATATTAGTGGA GCCCACACCCTAAGGCATTAT 
Slc19a1 GGGCCACCTGTTAGCTTATCC AGGGAGCTGCCCTTGAGTG 
Sytl4 ATCCCACAAGGTCCAAGTGACT TAAGGATATCTCTGTCCAACAAGTGC 
Tnfrsf19 AAAGGTTTGTATTGGAAAGCGATAAC AAGGAAAGAGACACAATCATGGCT 
Galnt3 AGATATGGGAGATTCGGAAGGAC TGCGTCACATGGCACTAAGTTT 
Hs2st1 ATACTTGTTCCTTCATGGCGTATCT GCAAATCCTACCCACATCACAG 
Tbx3 GTTTTGTCTGGGAGGGAGCA TTCAAAGCAACAGCAGCCTG 
Sp8 ACCATTAGATTTAGCTCAGCACCA CTGAGAAGGAAGCAGCAACATG 
Fgf8 GGAAGCTAATTGCCAAGAGCA CTCGTACTTGGCGTTCTGCA 
Fgf10 AAGCTTGCAGAGTCCAAAAATAGAA CCGAATTCATTTTGTATTTATCTCTGTT 
Tbx1 TGCAGTGTAGACGACCGAGAGA AACCGTTTATGAAATCGGCG 
Foxa1 TGCCCAGATATGAAGACCTCG CCTTGTAACTTGGCCAGTCAGG 
Foxa2 GGTTGTACTGATGTTGAAAAGAGGAA TCACCATGTCCAGAATGGGAT 
Sfrp2 GGCCTGAGAATCGGCATCTA AGTTCTGTAGCTGGGATGGGAA 
CXCL12 CCTCGACGGGCTAGCAGTAT CGTTTTCAAATTATCTGGGAGAAAGA 
 
 
2.2.4 Immunohistochemistry 
 
As negative controls, test reactions were included whereby the primary antibody was either 
replaced with normal (non-immune) rabbit Ig, goat anti-CXCR3 antibody (demonstrated to not 
work under the used conditions) or mouse IgG according the animal specie that served for the 
generation of the tested antibody or instead omitted on purpose. In addition, for β-galatactosidase 
immunoreactivity, non-transgenic embryos were examined in parrallel as controls. All control 
reactions were revealed to be negative.  
 
• Seven micrometers of Cyrosections of frozen tissue mounted on SuperFrost plus slides 
(Menzel-Gläser, Braunschweig, Germany) were allowed to dry completely over night. 
• One liter of the following saponin/PBS solution was prepared (per 1L: 0.1% of saponin 
(Sigma, Buchs,CH), 1% of filtered Fetal calf serum (Invitrogen, Basel, CH) completed with 
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PBC (see section 2.1.6) to 1L). Importantly the saponin reagent was pre-prepared by diluting 
1g of saponin into a final volume of 10ml of PBS and filtered (20-40µm) through a syringe 
before being added to the saponin/PBS solution. In addition, the well mixted saponin/PBS 
solution was systematically verified to have a pH between 7.2 and 7.4. 
• The sections were fixed in a Kopplin Jar filled with approx. 70ml of ice cold (-20°C) acetone 
(Merck, Dietikon, CH) by being incubated for 5min at -20°C. Once the sections were fixed, 
the slides were allowed to dry at room temperature for 10min to evaporate the remaining 
acetone. Alternatively, the sections were fixed in a Kopplin jar filled with approx. 70ml of an 
pre-prepared 4% paraformaldehyde (Sigma, Buchs, CH), diluted in water by being incubated 
for 15min at RT. Importantly, in case of the use of the 4% paraformaldehyde solution, this 
solution  was incubated at 60°C in a waterbath for dissolving the paraformaldehyde, filtered 
and was cooled down to room temperature before the sections were fixed.  
• The sections were then incubated in freshly prepared solution of 70ml Na/Az/peroxide 
solution (0.1 % NaAz (Sigma, Buchs, CH), 0.3% Peroxide (Sigma, Buchs, CH) completed 
with Saponin/PBS solution) for 10min in order to inactivate endogenous peroxidase activity 
of the fixed tissue. The sections were then rinsed once with approx. 70ml of Saponin/PBS 
solution. When using biotinylated antibodies, the Activin/Biotin blocking kit (Vector 
Laboratories, Peterborough, UK) was employed according the manufacturer's instructions to 
block all unspecific Activin binding. 
• Heighty microliter of primary antibody solutions (primary antibody diluted at the 
appropriated final concentration (i.e 1-5µg/ml) with the saponin/PBS solution) were added to 
each section. Importantly, before adding the primary solution, the surface surrounding the 
sections was carefully wiped with a tissue wipe to remove all remaining liquid. The slides 
were then incubated in a closed humid chamber box with a paper sponged with water and left 
for 2 hours at room temperature. 
• The sections were washed 3 times with Saponin/PBS solution for 5min each. All remaining 
liquid around the sections was removed using a tissue wipe, before the 80µl of the secondary 
antibody solution (secondary antibody diluted at the appropriated final concentration (i.e 
5µg/ml for horadish peroxidase conjugated antibodies and 1µg/µl for biotinylated 
antibodies)) were added to the sections. The slides were then incubated in the humid chamber 
box for 30min at room temperature. 
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• The sections were then washed 3 times with the Saponin/PBS solution for 5min each. When 
using a biotinylated antibody, all surrounding liquid around the sections was removed and 
subsequently 80µl of Streptavidin-horadish peroxidase conjugated at the concentration of 
1µg/ml (Sigma, Buchs, CH) was added to the sections. In such case, the sections were then 
incubated for an other 20min in the humid chamber box and subsequently washed 3 times 
with the Saponin/PBS solution for 5min each. 
• Next, the sections were stained for 1-20min in a Kopplin Jarr filled with AEC (3-amino-9-
ethylcarbazole) solution. The duration of time for staining depends on the intensity of the 
specific signal to be expected. The AEC solution was always freshly prepared by dissolving 1 
AEC tablet (Sigma, Buchs, CH) in 2.5ml of DMF (dimethylformamide) (Fluka, Buchs, CH) 
in an erlenmeyer and by adding 70ml of an acetate buffer (50mM, pH 5.0) as well as of 30µl 
of an 30% peroxide solution (Sigma, Buchs, CH). The acetate buffer contained per 1L, 74ml 
of 0.2N acetic acid (Merck, Dietikon, CH), 176ml of sodium acetate 0.2M (Sigma, Buchs, 
CH) and 750ml of water. Importantly, the AEC solution was always filtered (i.e through 
blotting) to remove precipitates. 
• The slides were then rinsed in water and counterstained with filtered Mayer's Hemalaun 
solution (Merck, Dietikon, CH) for 5-10s before being rinsed extensively with water. 
• The slides were mounted with Crystal/Mount (Biomeda, Foster City, CA) under a coverslip 
(Menzel-Gläser, Braunschweig, Germany) and were left at room temperature in a box. 
Importantly, all remaining bubbles were removed before the slides were allowed to dry in the 
box. The sections were then analysed under a microscope and pictures of the sections were 
taken with the help of an CCD camera mounted on top of the microscope (Nikon AG, Egg, 
CH). 
 
2.2.5 In situ hybridization on crysections (ISH) 
 
The protocol was essentially adapted from (Schaeren-Wiemers and Gerfin-Moser, 1993). As 
positive control an antisense probe of the recombination activating gene 1 (RAG1) was examined 
on a section from an E15.5 embryo whereas the negative control was a sense probe of the 
examined gene. 
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Probe preparation:  
 
The sense and antisense dioxigenin (DIG, Roche Molecular Biochemicals, Basel, CH) labeled 
cRNA probes were generated by standard in vitro transcription (IVT). Nrxn1 antisense and sense 
template for IVT was generated by inserting a purified PCR product into the pGEM-T easy 
vector (Bioconcept, Allschwil, CH) using the following PCR primers: 
 
Nrxn1 forward primer: 5'-ACGAAGTTAAAATTCAGTACCCATTTC-3' 
Nrnx1 reverse primer: 5' GATGTAGTCAGTTTATGCCAGGTAGTG-3' 
 
The DNA sequence of that amplicon is located within the affymetrix probe source sequence for 
the Nrxn1 probe set (114766_at) of the MGU74Bv2 microarray (see section 2.2.10 for cloning, 
purification,and OD measurement). The orientation of the insert was verified using appropriate 
restriction enzymes as described in section 2.2.10. 
 
• For producing the labeled cRNA of the probe, 1µg of the purified plasmid containing the 
PCR insert (i.e Nrxn1 amplicon) was used as template, to which were added the following 
reageants: 2µl of an 10x IVT buffer, 2µl of DTT (0.1M), 2µl of DIG-NTP mixture (10mM 
mixture: UTP-DIG (3.33mM), UTP (6.66mM), ATP (10mM), GTP (10mM), CTP (10mM)) 
(Roche, Basel, CH), 1µl of SuperaseIn (Ambion, Huntingdon, UK), 1µl of T7 RNA 
polymerase (20U/µl) (Roche, Basel, CH). The mixture was completed to 20µl with milli-Q 
18.2 water. 
• The reaction was briefly spined and incubated for 3 hours at 37°C in a thermal cycler. For the 
digestion of the DNA template, 2µl of DNase I (10U/µl,) (Roche, Basel, CH) was added to 
the reaction and was then incubated for an other 1 hour at 37°C. 
• The labeled cRNA probe was then purified using Rneasy mini columns (Qiagen, 
Hombrechtikon, CH) according to the manufacturer's instructions. One microgramm of the 
purified cRNA probe was then analysed by gel electrophoresis (using a 1% agarose/ethidium 
bromide (0.25µg/ml) gel) for the verification of the expected size in bp of the probe. 
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Sections:  
 
• For the ISH, 15µm sections were cut using a cryotome (Leica, Glattbrugg, CH) and was 
mounted onto a SuperFrost Plus slide (Menzel-Gläser, Braunschweig, Germany). The 
sections were then allowed to dry for 20min at room temperature. 
• The sections were then fixed in a freshly made 4% formaldehyde PBS solution for 10min. 
The sections were then subsequently washed 3 times in PBS for 5min each. 
• The sections were then acethylated for 10min in a triethanolamine solution (3.5ml of 
triehtanolamine (Sigma, Buchs, CH) and 296.5ml of DEPC-treated H2O). Seven hundred and 
fifty microliters of acetic anhydride (Sigma, Buchs, CH) was then added dropwise over the 
sections using a stirrer. The sections were then washed 3 times in PBS for 5min each using a 
shaker. 
 
Prehybridization:  
 
For the prehybridization, the sections were prehybridized in a humid chamber with 1ml of the 
hybridization buffer over night (O.N.). The hybridization buffer was prepared in advance, stored 
at -20°C and contained 50% formamid (deionized), 5x SSC, 1x Denhards, 100µg/ml salmon 
sperm DNA, 100µg/µl tRNA and DEPC-treated H2O (Invitrogen, Basel, CH).Hybridization:  
• For the hybridization the dioxigenin labeled RNA probe was added to the hybridization buffer 
as such as to have a final concentration of 200-400ng/ml. The mixture containing the probe 
was then incubated at 85°C for 5min before being chilled on ice. 
• Eighty microliters of the mixture were added to the sections, which were mounted under a 
coverslip (Menzel-Gläser, Braunschweig, Germany) and sealed with Rubber Cement 
Fixogum (Marabu, Milton Keynes, UK) for avoiding evaporation of the hybridization 
solution. The slides were then transferred into a Quadriperm dish (Heraeus, Frankfurt, 
Germany) and placed into a humid chamber box containing a tissue wipe soaked with 5xSSC 
(see section 2.1.6). Next, the sections were allowed to hybridize over night at 68°C. 
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Post hybridization:  
 
For the post-hybridization, 2L of a Maleic acid autoclaved solution (100mM maleic acid, 
150mM, NaCl, pH 7.5, only sterile) were prepared in advance, as well as the B3 buffer (per 
500ml: 50ml 1M Tris HCl pH 9.5, 5ml 0.5M MgCl2, 10ml 5M NaCl) which was filtered through 
a 0.45µm filter. 
 
• The coverslips of the slides incubated over night at 68°C O.N have been carefully removed 
with forceps and with the help of some 5x SSC buffer. The sections were then subsequently 
washed with 0.2x SSC at 70°C for 60min, 0.2x SSC at room temperature for 5min and in 
maleic acid solution for 5min. 
• The sections were incubated for 60min into a blocking solution (1% blocking reagent from 
Roche Molecular Biochemicals, Basel, CH) in maleic acid solution). 
• For the detection of the hybridized labeled cRNA probe on the sections , 80µl of anti-DIG 
antibody solution (dilution 1/2500 in blocking solution) were added to each section. The 
sections were then incubated for 1hour at room temperature. The sections were then rinsed in 
maleic acid buffer for 10min, and subsequently washed 2x30min in buffer B3 for 5min. 
• Each section was then immerged into 1ml of staining solution (per 25ml: 112.5µl of NBT and 
87.5µl of BCIP (Roche Molecular Biochemicals, Basel, CH) and completed with B3 buffer) 
for appropriate duration (2-48 hours) according to the intensity of the staining signal. 
Importantly, the slides had to be protected from light, as the staining solution is very sensitive 
to light. Once the desired staining intensity was reached, the sections were washed in PBS 
containing 1mM of EDTA (Sigma, Buchs, CH) for 10min to stop the staining. 
• Individual section was then counterstained for 20s with Methylene Green (0.01 % in PBS) 
(Merck, Dietikon, CH). Each section was mounted with 60°C pre-warmed Kaisers glycerol 
gelatin (Sigma, Buchs, CH) under a coverslip. After having carefully removed all bubles, the 
sections were allowed to dry at room temperature. All sections were analysed under a 
microscope and pictures of the sections were taken using a CCD camera mounted on top of 
the microscope (Nikon AG, Egg, CH). 
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2.2.6 Total RNA extraction and RT-PCR for non-microdissected tissues 
 
2.2.6.1 isolation of Total RNA 
 
• The extracted tissue was homogenized in 1ml of Trizol reagent per approx. 100mg tissue 
using a Polytron homogenizer for 20-30s. If the total RNA was isolated from cell cultures or 
from purified thymocytes or TECs (see section 2.2.13), 1ml of Trizol reagent was 
resuspended with 104-106 cells. In case of less than 104 cells, the protocol for microdissected 
tissue was followed (see section 2.2.1.2). Hundred microliters of BCP (see 2.2.1.2) were 
added to the mixture, which was then vigorously shaken for 30s. 
• Next, the mixture was incubated at room temperature for 5min, centrifuged at 12,000g for 
15min at 4°C in a microcentrifuge. The aqueous phase was transferred into a new 1.5ml tube 
and 500µl of isopropanol (Sigma, Buchs, CH) was added. The mixture was then left for 
15min at room temperature for the allowing the RNA to precipitate. 
• The precipitated RNA was then centrifuged at 12,000g for 15min at 4°C. The supernatant was 
removed, the RNA pellet was then washed with 75% ethanol (Fluka, Buchs, CH) and 
centrifuged at 7,500g for 5min. 
• The supernatant of the sample was removed and the pellet was allowed to dry for 5min under 
a hood. The RNA pellet was then resuspended in 20µl of milli-Q 18.2. 
• The concentration of the total RNA in the sample was measured by optical density (OD) 
using the following formula: 
Concentration (µg/ml) = 40 x OD260 x dilution. The OD260/OD280 ratio of the samples were 
always found to be above 1.8. 
• Five hundred microgramms of the total RNA was then analysed by gel electrophoresis (on a 
nondenaturing 1% agarose/ethidium bromide 0.5µg/ml) for verifying the quality of the RNA. 
All samples considered were found to have intact RNA. The samples were then store at -80°C 
until further processed. 
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2.2.6.2 Reverse transcription 
 
As negative control, a test reaction has been included included whereby the reverse transcriptase 
was omitted on purpose . 
 
• For the preparation of the reverse transcription, 9µl of total RNA was added to a 0.5ml 
microtube containing the following master mix solution (per 9µl: 4µl of 5x First strand buffer 
(Invitrogen), 2µl DTT 0.1M (Invitrogen, Basel, CH), 1µl dNTP 10mM, 1µl DNase I 10U/µl 
(Roche, Basel, CH), SuperaseIn 20U/µl (Ambion, Huntingdon, UK). Importantly, the total 
RNA did never exceed 5µg of RNA to ensure a maximum of efficiency of synthesis. The 
mixture was then gently mixed and incubated in a thermal cycler for 30min at 37°C for 
digesting genomic DNA contaminants. 
• One microliter of the oligo dT (500ng/µl) or alternatively 1µl of random hexamers N6 
(500ng/µl) was added to the mixture. Importantly, in case of the analysis of microdissected 
tissue by qRT-PCR, 1µl of a pool (500ng/µl) of specific 18mers primers, which were located 
3' dowstream of the analysed PCR gene sequence to be examined was added instead to 
increase the efficiency of the reverse transcription. 
• Next, the samples were incubated in a thermal cycler for 5 min at 70°C to allow the 
secondary structure of the RNA to denature and for inactivating the DNAse I. The samples 
were then chilled on ice for 2 min for annealing the desired primer before the secondary 
structure was renatured. 
• One microliter of Superscript II or III (200U/µl) (Invitrogen, Basel, CH) was added to each 
sample. After having pipetted up and down the mixture and briefly spined down the mixture, 
the samples were incubated in a thermal cycler for 1 hour at 42°C when using the Superscript 
II reverse transcriptase. Importantly, when using Superscript III enzyme, the reaction was 
incubated at 50°C. The reactions were then stored at -20°C until further processed. 
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2.2.6.3 Conventional PCR amplification 
 
As positive control, a test reactions was included whereby the used cDNA originates from a 
tissue known to express the examined gene. As negative control, a test reaction containing the 
sample without the adjonction of reverse transcriptase was analysed. 
 
• Each lyophilized oligonucleotide (Invitrogen, Basel, CH) to be stored was diluted with TE 
water for a final concentration of 100µM and aliquoted in samples of 10µΜ with milli-Q 18.2 
water. 
• Twenty microliters of a primer mixture (per 20µl: 1µl (2-10ng/µl) of cDNA template, 2µl of 
forward primer (10µM), 2µl of reverse primer (10µM) and 15µl of milli-Q 18.2 water) were 
pipetted into a 96 well PCR plate (Life Systems Design, Merenschwand, CH) or alternatively 
into a 0.2ml PCR microtube (Vaudaux-Eppendorf, Schonenbuch, CH). 
• Thirty microliters of the PCR master mix solution (per 30µl: 5µl of 10x buffer (Sigma), 1µl 
of dNTP 10mM, 0.4µl of Jumpstart DNA polymerase (2.5U/µl) (Sigma, Buchs, CH), and 
23.6µl of milli-Q 18.2 water) was added to mixture. The 96 well plate was then briefly spined 
at 700rpm in an adapted centrifuge (Vaudaux-Eppendorf, Schonenbuch, CH). In case of the 
use the of 0.2ml microtubes, the samples were briefly spined in a conventional 
microcentrifuge. 
• The plate or the microtubes was then transferred to a thermocycler using the following PCR 
conditions: 2min at 94°C and subsequently for 30s at 94°C and 30s at 55°C, 1min at 72°C, 
respectively for the denaturation, the annealing and the elongation of the amplicons. These 
subsequent steps were repeated 39 times. 
 
Analysis: 
 
For the analysis of the amplicons, 10µl of each PCR reaction was examined by gel 
electrophoresis using a 2% agarose gel containing 0.25µg/ml of ethidium bromide (Sigma, 
Buchs, CH). The GelDoc2000 system (Biorad, Reinach, CH) was used for verifying the 
specificity of amplification and for taking pictures of the amplicons. 
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2.2.6.4 Nested PCR (for microdissected tissue) 
 
Two different primer pairs have been designed for each tested gene as such as a primary PCR 
was done using primers (referred as outer primers) defining a DNA sepecific sequence of above 
200bp in size. The amplicon of this PCR was subsequently amplified in a second PCR using 
primers (inner primers) whose sequence were designed as such to prime to the amplicon of the 
first PCR. The amplicon size of the second PCR was approx. 100bp. Positive and negative 
control were used as described above in section 2.2.6.3. 
 
First PCR: 
 
• Twenty two and a half microliters of a master mixture (per 22.5µl: 0.5µl of outer primers 
(5µM each), 2.5µl of 10x PCR buffer (Sigma, Buchs, CH), 0.5µl of dNTP 10mM, 0.1µl Jump 
start DNA polymerase (Sigma, Buchs, CH) and 18.9µl of milli-Q 18.2 water) were added for 
each reaction to a 96 well PCR plate (Life Systems Design, Merenschwand, CH). 
• Two and a half microliters of cDNA were deducted from the reverse transcribed reaction 
(section 2.6.2) and then added to each reaction. Once all samples were loaded into the 96-well 
plate, the plate was sealed with an appropriate foil (Life Systems Design, Merenschwand, 
CH). The plate was then  briefly spined at 700rpm for a few seconds in a centrifuge 
(Vaudaux-Eppendorf, Schonenbuch, CH). 
• Next, the plate was transferred to a thermocycler (Vaudaux-Eppendorf, Schonenbuch, CH) 
using the following PCR conditions: 2min at 94°C and subsequently for 30s at 94°C and 40s 
at 55°C, 1min at 72°C, respectively for the denaturation, the annealing and the elongation of 
the amplicons. These subsequent steps were repeated 19 times before being incubated at 72°C 
for 10min. At the end of the PCR, the samples were kept at 4°C until further processed. 
 
 
Second PCR (nested PCR): 
 
• Twenty two and a half microliters of a qPCR master mixture (per 22.5µl: 0.75µl of inner 
primers (10µM each), 12.5µl of 2x SybrGreen master mix (Applied Biosystems, Rotkreuz, 
CH) and 9.25µl of milli-Q 18.2 water) were used per reaction. 
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• Two and a half microliters of the first PCR reaction were then deducted and added to each 
reaction. Once all samples were loaded into a qPCR 96-well plate (Applied Biosystems, 
Rotkreuz, CH), the plate was sealed with an appropriate foil (Applied Biosystems, Rotkreuz, 
CH). The plate was then briefly spined at 700rpm for a few seconds in a centrifuge 
(Vaudaux-Eppendorf, Schonenbuch, CH). 
• Next, the plate was transferred to a qPCR 5700  instrument Applied Biosystems, Rotkreuz, 
CH) using the following PCR conditions: 2min at 94°C and subsequently for 30s at 94°C and 
40s at 55°C, 1min at 72°C, respectively for the denaturation, the annealing and the elongation 
of the amplicons. These subsequent steps were repeated 19 times before being incubated at 
72°C for 10min. At the end of the PCR, the samples were kept at 4°C until further processed. 
• The analysis of the samples was examined as described in section 2.2.3 (quantitative PCR). 
 
2.2.7 Transfection and purification of hWIF-IgG 
 
For the transfection, a plasmid containing a fused sequence of the hWIF1 and human 
Immunoglobulin (hIgG) (kindly provided by Dr.J.Hsieh (New York, USA)) was transfected into 
HEK293 cells. As a control, the same plasmid but containing only the hIgG sequence was taken 
along in parallel (kindky providen by Dr.J.Hsieh). The plasmid that served as template for the 
production of the fused protein hWIF-IgG was previously shown to generate a functional Wnt 
inhibitor factor 1 when transferred into HEK293 cells (Hsieh et al., 1999). Therefore, all our 
transfection were established in HEK 293 cells. The purification of the hWIG-IgG conditioned 
media was either done by affinity or by size-filtration. 
 
• The HEK293 cells were in a 175cm2 flask grown to 1/3 of confluency in 40ml of IMDM 
media supplemented with 2% FCS as described in section 2.1.3 (see also section 2.1.4) and 
subsequently replaced with fresh FCS-supplemented media. Importantly, if the hWIF-IgG 
products were purified by affinity, the supplemented FCS was replaced with 
Immunoglobulin-depleted FSC. This FCS was depleted by affinity purification on G 
sepharose columns (Sigma, Buchs, CH). 
• Approximately 1.7ml of a prepared transfection mixture (per 175cm2 flask: 1650µl of serum 
free IMDM media, 66µl of Fugene reagent (Roche, Basel, CH) and 22µg of DNA plasmid 
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(ranging between 1-2µg/µl) was added dropwise to the media of each flask . Each flask was 
then gently homogenized in a circular and horizontal fashion. 
• All flasks were placed back in the incubator (37°C, 5% CO2). The flasks were left in the 
incubator for 48-66 hours according to the confluency of the cell layers. The media of each 
flask was collected in 50ml Falcons tubes (BD Biosciences, Allschwil, CH) and spined for 
5min at 2000rpm in a centrifuge (Vaudaux-Eppendorf, Schonenbuch, CH). The media were 
subsequently filtered through an 0.2-0.4µm meshwork using a syringe. 
 
 
Affinity purification of conditioned media: 
 
• The collected media was loaded on G sepharose prepared columns (Sigma, Buchs, CH) for 
the affinity purification of hWIF-IgG containing media according to manufacturer's 
instructions. Importantly, the flow through were re-loaded twice on the columns before being 
extensively washed with PBS. 
• For the elution of the affinity purified of hWIF-IgG, the columns was subsequently eluated 
with 10ml of 100mM glycine (Sigma, Buchs, CH) solution adjusted to pH 2.7. The eluates 
were subsequently collected in 1ml fraction directly from the column in 1.5ml microtubes. 
• The eluate fractions were subsequently neutralized to pH 7.0 with appropriate volumes of 1M 
Tris HCl (Sigma, Buchs, CH) adjusted to pH 9.0. Importantly, this step was achieved within a 
minute in order to avoid an eventual irreversible denaturation of the purified protein. The 
column was extensively rinsed with PBS and the different fractions were stored at 4°C. 
• Ten microliters of each fraction was measured by optical density (OD) at 280nm, in order to 
reveal with fractions were containing the high yields of affynity purified hWIF-IgG. The 
fractions that contained the two highest yields were pooled together in a new 1.5ml tube. The 
pooled volume was loaded onto vivaspin2 (cut off 50KDa) columns (Sartorius, Dietikon, CH) 
for concentrating the purified hWIF-IgG containing solution for approximately 20 times and 
for exchanging the neutralized eluate solution for a PBS buffer. This was achieved according 
the manufacturer's instructions. 
• The concentrated solutions were stored at 4°C. One microliter was deducted of each samples 
and subsequently diluted in 249µl of PBS. Five microliters of the diluted solution was then 
analysed by SDS-page electrophoresis and by Western blot for the verification of the size of 
the produced and purified protein (see section 2.2.8). 
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• For the evaluation of the concentration of purified hWIF-IgG in the samples, the 
Bicinchoninic acid (BCA) protein assay kit (Pierce, Rockford, IL) was used according the 
manufaturer's instructions. Importantly, to evaluate the concentration of the sample, a 
standard curve was generated using the following references concentrations of BSA diluted in 
PBS: 250µg/ml, 125µg/ml, 50µg/ml, 25µg/ml, 5µg/ml and blank diluted in PBS. 
• One microliter of the examined sample was diluted with 249µl of PBS for the evaluation of 
its concentration in purified hWIF-IgG, from which 25µl was deducted and loaded into 96 
Elisa plate(BD Biosciences, Allschwil, CH), as well as 25µl per well for each of the different 
concentrations of BSA for generating a standard reference curve. Each well was completed 
with a mixture of the BCA reagent according to the manufacturer's instructions. The Elisa 
plate was closed with an adapted Elisa cover plate (BD Biosciences, Allschwil, CH) and was 
then incubated so that it floated in a 60°C waterbath for 30 min to allow the measurement of a 
concentration down to 5µg/µl. The Elisa plate was allowed to cool down at room temperature 
for 15min. 
• Next, the Elisa plate was placed in an Elisa reader (Bucher Biotec AG, Basel, CH) and set to 
562nm for its reading. The software of the instrument automatically allowed to generate a 
graph of the standard linear curve from the different BSA concentrations. Hence, from a 
linear regression of the standard curve, the concentration of the sample containing the 
purified hWIF-IgG could be deduced. 
 
Purification of conditioned media by size-filtration: 
 
• The conditioned media (40ml) was loaded on two vivaspin20 (cut off 30kDa) columns 
(Sartorius, Dietikon, CH) and filtered according to the manufacturer's intrsuctions.  
Importantly, the columns were rinsed at least twice with 20ml fresh PBS and then once with 
20ml of fresh IMDM serum free media pinning at 3000g at 4°C for 30min. The retained 
IMDM solution (containing the hWIF-IgG) was collected in a 5ml tube and stored at 4°C 
until used for FTOC. The solutions were never stored more than 2 days at 4°C. 
• Next, the conditioned media was diluted to a quarter or to an eight with fresh 10% FCS 
supplemented IMDM media. 
• For verifying that the control hIgG conditioned media contained a comparable amount of 
protein as the hWIF-IgG conditioned media, the protein concentration of each respective 
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sample was determined using the BCP protein assay as described above. For this BCA assay, 
the respective samples were diluted 250 times in PBS (1µl in 250µl of PBS). 
 
2.2.8 Western blot for hWIF1-IgG 
 
SDS-Page Gel: 
 
• For preparing an SDS-PAGE Gel, a separating gel solution (per gel: 2.5 ml 1.5M Tris-HCl 
pH 8.8 (Sigma, Buchs, CH), 50µl of 20% sodium dodecyl sulfate (SDS) (Eurobio, 
Courtaboeuf, FR), 4.5ml of 30% Acyrlamide/Bis solution, 29:1 (3.3% C, Biorad, Reinach, 
CH), 2.9ml of mill-Q water, 50µl of 10% of ammonium of persulfate (Sigma, Buchs, CH) 
and 10µl of TEMED (Eurobio, Courtaboeuf, FR) was prepared. Importantly, TEMED and 
APS were always added as last reagents to the solution as it polymerization occurs few 
minutes after their adjonction. This solution was then loaded into an assembled mini-Protein 
3 Electrophoresis glass plate system (Biorad, Reinach, CH). Next, 1ml of water was loaded 
onto the poored solution and the gel was left at room temperature to allow the separating gel 
to polymerizate. 
• The stacking gel solution (per gel: 0.625ml 1M of Tris HCl pH 6.8, 25µl of 20% SDS, 
0.650ml of 30% Acrylamide/Bis solution, 29:1 (3,3% C, Biorad, Reinach, CH), 3.675ml of 
milli-Q water, 25µl of 10% APS, 5µl of TEMED) was loaded onto the polymerized 
separating gel after having removed the overlayed water that was poored on top it, and 
subsequently an appropriated comb was inserted into the poored gel. The Gel was then 
incubated for 15min at room temperature to allow its polymerization. 
• Once polymerized, the entire apparatus was mounted into an Electrophorsis support 
containing 1L of running buffer solution (per 1L of 10 times concentrated running buffer: 
144g Glycine (BioRad, Reinach, CH), 30g Tris base (Sigma, Buchs, CH), 50ml of 20% SDS 
and completed with milli-Q water to 1L). 
• The loaded samples were heated at 100°C for 5min in protein sample buffer (per 8ml of 2 
times concentrated sample buffer: 1ml of 0.5M Tris HCl pH 6.8, 0.8ml of Glycerol (Sigma, 
Buchs, CH), 0.2ml of 1% Bromophenol blue (Sigma, Buchs, CH), 0.4ml of 
β−mercaptoethanol (Sigma, Buchs, CH) and 4.8ml of milli-Q water). In addition, 5µl of a 
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colored marker (Sigma, Buchs, CH) was loaded in one of the lanes and the gel eletrophoresis 
was run at 150V for 1hour. Importantly, two identical gels were prepared to allow 
subsequently a western blot for hWIF and for hIgG, respectively. 
 
Transfer: 
 
• The separating gels were separated from the stacking gel using a razor blade and were washed 
twice with water. 
• For the transfer, a nitrocellulose membrane of identical dimension as the separating gel was 
placed on top of each gel, as well as two blotting paper on each respective side of the gel in a 
"sandwitch" manner and then inserted into a transfer plate apparatus and subsequently in a 
electrophoris support (BioRad, Reinach, CH), according the manufacturer's instructions. 
• One liter of transfer buffer solution (per 1L: 14.4g of Glycine, 3.03g of Tris base, 150ml of 
methanol (Fluka, Buchs, CH) and completed to 1L with milli-Q water) was poured into the 
apparatus and subsequently surrounded by ice. Importantly a stirrer was placed at the bottom 
of the apparatus to allow an constant homogenization during the transfer. The electrophoris 
was run at 100V for 1hour. 
• Once the transfer was finished, the nitrocellulose membranes were washed twice with TPBS 
(PBS with 0.1% Tween 20 (Sigma, Buchs, CH) for at leat 5min onto a shaker. 
• The remaining separating gels were considered for an Blue Coomassie staining (BioRad, 
Reinach, CH) according to the manufacturer's instructions for verifying the efficency of the 
transfer.  
 
Western Blot: 
 
• The washed nitrocellulose membranes were then incubated into 10ml of blocking blotto 
solution (5% of fat less milk powder (Coop, Basel, CH) and 10ml of TPBS) for 1 hour at 
room temperature onto a shaker. 
• The membranes were subsequently incubated overnight at 4°C with either 10ml of primary 
antibody solution (20µl of rabbit anti-hWIF1 aliquot, see section 2.1.5, or with goat anti-
hIgG-HRP conjugated (Sigma, Buchs, CH), diluted with blotto solution).  
• The membranes were washed 3 times with TPBS solution for 5min at room temperature. 
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• The membrane were incubated with anti-hWIF1 and subsequently incubated in 10ml of 
secondary antibody solution (goat anti-rabbit IgG at 0.15µg/ml, see section 2.1.5, diluted with 
fresh blotto solution). The membrane were then washed 3 times with TPBS for 5min. 
• Next, the membranes were stained with AEC solution (see immunohistochemistry section 
2.2.4 for its preparation) for 20min on a shaker at room temperature before being rinsed with 
PBS. 
 
2.2.9 Fetal thymic organ culture (FTOC) 
 
• Thirteen and a half days of mouse gestation embryos were carefully extracted from 
euthanized timed pregnant mice and placed into a IMDM medium (Invitrogen Corporation, 
Basel, CH) in a 10 cm Petri dish (BD Biosciences, Allschwil, CH) on ice. 
• The embryos were then opened in the upper part so that the hear and the lungs were exposed 
in order to be able to extract the developing thymic lobes with the help of fine 
microdissection forceps and a binocular instrument (Leica, Glattbrugg, CH). The thymic 
lobes were placed in a 3cm Petri dish filled (BD Biosciences, Allschwil, CH) with IMDM 
medium on ice.  
• The "shiny" sides of Track-Etch membranes (Nucleopore #PC MB 13 mm, 0.8 µm pores) 
(SPI supplies, West chester, USA) were placed into each well of an 24-well plate (BD 
Biosciences, CH) filled with 500µl of FTOC medium (IMDM medium supplemented with 
10% FCS and ) including either 0, 10, 20 or 40µg of respectively affinity purified hWIF-IgG 
or hIgG (see section 2.2.7). Alternatively the FTOC medium was supplemented to one fourth 
or one eighth of its volume with concentrated condioned IMDM media containing either 
hWIF-IgG or hIgG (see section 2.2.7). Importantly, the Track-Etch membranes were boiled in 
water for 30 min and kept sterile in dry Petri dish under a hood. 
• Eight isolated thymic lobes were placed on top of each of those membranes by aspirating and 
expelling seperately each lobe into a 200 µl micropipette tip after having been rinsed once in 
IMDM fresh media. The 24-well plate was then covered with its respective plate-cover and 
incubated at 37°C in a 5% CO2 adjusted cell culture incubator for 10 days. Importantly, the 
respective media of each well was replaced with fresh media every 2 days. 
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2.2.10 Staining Protocol for flow cytometry 
 
• The isolated cells were counted and resupended at a concentration of 10 x 106 cells/ml (1x106 
cells/100µl). The cells were resuspended in PBS/BSA/Az solution (PBS containing 0.1% 
BSA and 0.02% Na2Azide (Sigma, Buchs, CH)). All stains were based on a cell concentration 
of 1.0x106 cells per sample.  
• The cells were distributed in 100µl aliquots of polystyrene 4ml tubes. 
• The used antibodies were diluted prior to use in PBS/BSA/Az solution to the desired 
concentration. Twenty microliters of diluted antibody was resuspended with the 1 x 106  cells 
(100µl). The mixture was then incubated on ice for 15min. 
• Three milliliters of PBS/BSA/Az solution were added to the mixture and subsequently spined 
at 1200rpm for 5min in a centriguge (Vaudaux-Eppendorf, Schonenbuch , CH). The 
surpernatant was gently poured off. Next, the cells were resuspended in 100µl of 
PBS/BSA/Az solution. 
• Twenty microliters of diluted 2nd antibody (appropriate concentration in PBS/BSA/Az 
solution) and added where necessary to the samples. The samples where then subsequently 
incubated on ice for 15min. 
• The samples were analysed by Flow cytometry using a FACSCalibur instrument and its Cell 
Quest software (BD Biosciences, Allschwil, CH). 
 
 
2.2.11 Immunofluorescent analysis using confocal microscopy 
 
• For the cryosectioning, 5µm sections were cut with a Leica cryotome (Leica, Glattbrugg, CH) 
and mounted on SuperFrost plus slides (Menzel-Gläser, Braunschweig, Germany). The slides 
were incubated for at least 2 hours at room temperature. 
• The sections were fixed with ice cold mixture of aceton (-20°C) for 5min. 
• The sections were blocked for unspecific protein binding by being incubated in PBS 
supplemented with 10% of FCS (Invitrogen, Basel, CH) for 1hour at room temperature. 
• The sections were incubated at an appropriate dilution with the primary antibody in 10% 
FCS/PBS solution overnight at 4°C. 
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• The sections were subsequently washed 3times with PBS for 5 min each and were incubated 
with appropriate dilution of the secondary antibody conjugated to a fluorochrome (see section 
2.1.5). 
• The sections were subsequently washed cells 3 times with PBS for 5min each. The sections 
were then mounted in a drop of Moviol mounting media (Calbiochem, Luzern, CH) under 
coverslips (Menzel-Gläser, Braunschweig, Germany). The sections were then left at room 
temperature for at least 2 hours. 
• The sections were analysed using confocal microscopy (Carl Zeiss AG, Feldbach, CH) 
according the manufacturer's instructions. 
 
2.2.12 Rapid amplification of cDNA ends (RACE) 
 
EST1 and EST2 DNA sequences have both been extended using smart 5' and 3' rapid amplication 
of cDNA ends (RACE) methods using the Smart RACE kit (Biosciences, Allschwil, CH). EST1 
was further extended using the marathon RACE kit (Biosciences, Allschwil, CH). Both protocols 
will be here described. 
 
2.2.12.1 Smart RACE 
 
The following primers or primer mixture were used in the smart RACE: 
 
Smart II oligonucleotide (10µM): 5'-AAGCAGTGGTATCAACGCAGAGTACGCGGG-3' 
10x Universal Primer mix (400µl): 
(0.4µM): 5'-CTAATACGACTCACTATAGGGCAAGCAGTGGTATCAACGCAGAGT-3' 
(2µM): 5'-CTAATACGACTCACTATAGGGC-3' 
Nested Universal Primer (50µl): 
(10µM): 5'-AAGCAGTGGTATCAACGCAGAGT-3' 
T7 Primer (10µM): 5'- GTAATACGACTCACTATAGGG-3' 
 
The above Smart II was used as an adaper for 5' RACE (Rapid Amplification of cDNA Ends), as 
well as the oligonucleotide dT-T7 oligonucleotide described in linear amplification section 2.2.2. 
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The "outer" and "inner" gene specific primers (see nested PCR section 2.2.6.3) were also used for 
generating the RACE products of respectively EST1 and EST2 genes. The used protocol was 
essentially adapted from the Ambion RACE protocol (Ambion, Huntingdon, CH). 
 
Reverse transcription: 
 
• For reverse transcribing the mRNA, 10µg of total RNA template (i.e Ad. Lymph nodes for 
EST1 and Ad. Brain for EST2) were pipetted into a RNase free 0.5ml tube (Vaudaux-
Eppendorf, Schonenbuch, CH). Subsequently, 4µl of a dNTP 10mM mixture (Roche, Basel, 
CH) were added to the solution, as well as either 1µl of SmartII oligo (10µM) for 5' RACE 
reaction or 1µl of dT-T7 oligo (10µM) for the 3'RACE reaction. 
• To each of the respective mixture, 1µl of reverse outer primer (10µM) for 5'RACE reaction or 
respectively 1µl of forward outer primer (10µM) for a 3' RACE reaction was added. 
Subsequently, 4µl of 5x First strand buffer, 2µl of DTT (0.1M) (Invitrogen Corporation, 
Basel, CH), 1µl of SuperaseIn (20U/µl) (Ambion, Huntingdon, UK) and 1µl of Superscript II 
(200U/µl) (Invitrogen Corporation, Basel, CH) were added to the mixture. The mixture was 
then filled to 20µl with milli-Q 18-2 water, gently mixed and briefly spined before being 
incubated at 42°C for 1 hour. 
• The reaction products were stored at-20°C until further processed with the first PCR step. 
 
First PCR: 
 
• One microliter of the reverse transcription of each respective reaction was pipetted into a 
0.2ml microtube. Subsequently, 5µl of 10x PCR buffer (Sigma, Buchs, CH), 4µl of dNTP 
10mM (Roche, Basel, CH), as well as either 2µl of reverse outer primer (10µM) for 5'RACE 
or 2µl of forward outer primer (10µM) for 3'RACE reactions. 
• Five microliters of the 10x Universal Primer Mix (BD Biosciences, Allschwil, CH) for 
5'RACE or 2µl of T7 primer (10µM) for 3'RACE respectively. Then, 1.25U of Jumpstart 
DNA polymerase (Sigma, Buchs, CH) was added to each mixture and completed to 50µl with 
milli-Q-18.2 water. 
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• After having been briefly spined, the microtubes were transferred to a thermocycler using the 
following PCR conditions: 3min at 94°C and subsequently for 30s at 94°C, 30s at 60°C and 
3min at 72°C for the denaturation, the annealing and the elongation of the amplicons, 
respectively. These subsequent steps were repeated 34 times and the reactions were incubated 
at 72°C for 7 min before being kept at 4°C until further processed. 
 
Second PCR (nested PCR): 
 
• For the subsequent PCR, 1µl of the first PCR reaction was added to a 0.2ml microtube, as 
well as 5µl of 10x PCR buffer (Sigma, Buchs, CH), 4µl of dNTP 10mM, 2µl of reverse inner 
primer (10µM) for 5'RACE or 2µl of forward inner primer (10µM) for the 3'RACE, 
respectively. 
• The reactions were then completed with 2µl of Nested Universal Primer for 5'RACE or 2µl of 
T7 primer (10µM) for 3'RACE, as well as 1.25U Jumpstart DNA polymerase and adjusted to 
50µl with milli-Q 18.2 water. The subsequent steps were done as in the first PCR. 
• The amplicons were analysed by gel electrophoresis on a 1% agarose/ethidium bromide 
0.25µg/ml gel. The PCR products that could clearly be distinguished within an eventual 
smear and more than 300bp were then isolated and cloned as described in section 2.2.11. 
 
 
 
2.2.12.2 Marathon RACE 
 
For this RACE, the Marathon clontech RACE kit (BD Biosciences, Allschwil, CH) was used 
according the manufacturer's instructions. As it was strongly recommended to use, mRNA was 
used as starting material instead of total RNA. The mRNA was isolated from total RNA (Ad. 
Lymph Node for EST1 and Ad. Brain for EST2) as these tissues were shown to express these 
genes at high levels respectively. For the marathon RACE, specific outer and inner primers using 
primerexpress 1.0 software (see section 2.2.6.3) were designed but the annealing temperature was 
set to 68°C instead of the default setting of 60°C. 
Messenger RNA extraction: 
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For the isolation of mRNA or polyA RNA from total RNA, the oligotex mRNA Spin-Column kit 
(Qiagen, Hombrechtikon, CH) was used according the manufacturer's instructions for an amount 
of less than 250µg of total RNA. The purified mRNA was then subsequently concentrated using 
YM-50 Microcon columns (Millipore AG, Volketswil, CH) according to the  manusfacturer's 
instructions and collected in 10µl of milli-Q 18.2 water and measured by optical density to 
determine its concentration as described in section 2.2.6.1. For verifying the quality of the 
purified and concentrated mRNA approx. 0.5µg of mRNA was analysed by gel electrophoresis 
using a 1% agarose/ethidium bromide (0.25µg/ml) gel.Proceed with first strand synthesis. 
 
First strand synthesis: 
• For the first strand synthesis, 1µg of mRNA (1-4µl) was pipetted into a 0.5ml RNase free 
tube (Vaudaux-Eppendorf, Schonenbuch, CH), as well as 1µl of cDNA synthesis Primer 
(10µM) and completed to a final volume of 5µl with milli-Q 18.2 water. The mixture was 
then incubated at 70°C for 2min in a thermocycler and was  cooled on ice. 
• The following reagents were subsequently added to the mixture: 2µl of 5x First strand buffer, 
1µl of dNTP (10mM), 1µl of AMV Reverse transcriptase (20U/µl) and 1µl  of milli-Q 18.2 
water. The reaction was then incubated at 42°C for 1 hour in an thermal cycler. 
 
Second strand synthesis: 
• For the second strand synthesis, 48.4µl of milli-Q 18.2 water was added to the 10µl of First 
strand synthesis reaction. Subsequently, 16µl of 5x second strand buffer, 1.6µl of dNTP 
(10mM), 4µl of 20x Second strand enzyme cocktail were added and the mixture was gently 
homogenized by pipetting up and down. The mixture was then briefly spined and incubated at 
16°C for 1.5 hour in a thermal cycler. 
• For generating blunt ends of synthesis dsDNA, 2µl (10U) of T4 DNA polymerase were then 
added to the mixture and the reaction was incubated at 16°C for 45min. To stop the reaction, 
4µl of the EDTA/Glycogen mix were added to the mixture. 
• For the purification of the dsDNA, 100µl of phenol:chloroform:isoamyl alcohol (25:24:1, 
Sigma, Buchs, CH) was added to the reaction. The mixture was then homogenized thoroughly 
and transfered to a Phase Lock Gel Heavy, 0.5 ml tubes (Vaudaux-Eppendorf, Schonenbuch, 
CH) for a safe separation of the organic phase from the acqueous phase. The mixture was 
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spined for 10min at 14,000rpm for the phase separation. The aqueous layer was then loaded 
into a new 0.5ml tube and was subsequently completed with 0.5 volumes of 4M Ammonium 
Acetate and 2.5 volumes of 95% ethanol (Fluka, Buchs, CH). The mixture was thoroughly 
homogenized before being spined at 14,000rpm for 20min at RT. The supernatant was 
carefully removed and the dsDNA pellet was washed by being overlayed with 300µl of 80% 
of ethanol (Fluka, Buchs, CH). The pellet was then spined at 14,000 rpm for 10min at 4°C in 
microcentrifuge. After all supernant was removed, the pellet was allowed to dessicate for 
10min at room temperature under a hood. The pellet was then resuspended in 10µl of milli-Q 
water and stored at -20°C until it was further processed. 
 
Adaptor Ligation: 
 
• Five microliteres of the purified dsDNA were pipetted into a new 0.5ml tube and 
subsequnently, 2µl of Marathon cDNA Adaptor (10µM), 2µl of 5x DNA ligation buffer 
(Clontech), 1µl T4 DNA Ligase (1U/µl) were added to the mixture. After the reaction was 
briefly mixed and spined, it was incubated at 16°C overnight. 
• The reaction was then incubated at 70°C for 5min for inactivating the ligase. One microliter 
of the reaction was diluted with either 50 or 250µl of Tricine-EDTA buffer while the  
undiluted adaptor-ligated cDNA was stored at -20°C. The respective diluted dsDNA was 
incubated at 94°C for 2min for denaturation and subsequently placed on ice for 2min before 
being briefly spined. 
 
First PCR: 
 
• For the first PCR reaction, 5µl of the respective diluted adaptor-ligated dsDNA were 
deducted and transferred to a 0.2ml microtube and subsequently, 5µl of the 10x PCR reaction 
buffer (Sigma, Buchs, CH), 1µl of dNTP (10mM), 1µl of Advantage 2 polymerase (50x), 1µl 
of AP1 primer (10µM) as well as 1µl of reverse outer primer (10µM) for 5'RACE or 1µl of 
forward outer primer (10µM) for 3'RACE were added. The reaction was filled to 50µl with 
milli-Q 18.2 water. Importantly, as negative control, the reverse outer primer was omitted in a 
parrallel reaction. 
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• The microtubes were then transferred to a thermocycler using the following PCR conditions: 
1min at 94°C and subsequently 30s at 94°C, 10min at 70°C, respectively for the denaturation, 
the annealing and the elongation of the amplicons. These subsequent steps were repeated 4 
times. Next, the reactions were subsequently incubated for 20s at 94°C and 10min at 68°C. 
These latter subsequent steps were repeated 24 times and then incubated at 4°C until further 
processed for a second PCR. 
 
Second PCR (nested PCR): 
 
• For the second PCR, 5µl of the first PCR reaction diluted with 245µl of Tricine-EDTA buffer 
were transferred to a new 0.2ml microtube. Subsequently, 5µl of 10x cDNA PCR reaction 
buffer (Sigma, Buchs, CH), 1µl of dNTP (10mM), 1µl of Advantage 2 polymerase (50x), 1µl 
of AP2 nested primer (10µM), 1µl of the reverse inner primer (10µM) for the 5'RACE as well 
as 1µl of the forward inner primer (10µM) for the 3'RACE were added to the mixture. The 
reaction was filled to 50µl with milli-Q 18.2 water. Importantly, similarly as for First PCR, as 
negative control reaction, the reverse inner primer was omitted in a parrallel reaction. 
• The subsequent steps were done as in First PCR. 
• For the analysis of the First and second PCR, 5µl of each reaction was examined by gel 
electrophoresis using in a 1.2% agarose/ethidium bromide (0.25µg/ml) gel. The distinguisable 
PCR products (possibly within a smear) that had a lenght of more than 300bp were then 
subsequently cloned and sequenced as described in section 2.2.13. 
 
 
2.2.13 Cloning & Sequencing of EST RACE products 
2.2.13.1 Cloning 
 
PCR product extraction from agarose Gel: 
 
• For an extraction of the desired PCR products from the gel, a piece of gel as small as possible 
containing the amplicons was cut as out of the gel using a sterile razor blade under UV light 
(set at minimal energy). The piece of the gel was then placed into a 1.5ml tube that has been 
weighted before in order to be able to measure the amount of gel extracted. 
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• The subsequent purification of the amplicons from the piece of gel was done using the 
GelElute Purification kit (Sigma, Buchs, CH) according the manufacturer's instructions. The 
purified amplicons were eluted in 30µl of TE buffer (see 2.1.6). 
 
 
 
Ligation of PCR products into pGEM plasmids: 
 
• For the ligation of the PCR product into a plasmid, 3µl of the purified amplicons were 
subsequently mixed with 1µl of linearized pGEM-T Easy vector ready for ligation mix 
(50ng/µl), 5µl of Rapid ligation buffer and 1µl of T4 DNA Ligase (3U/µl). All reagents are 
coming from a pGEM-easy vector system kit (Catalys AG, Wallisellen, CH). The sample was 
then incubated at 16°C overnight. 
 
Generation of competent bateria: 
 
• For the preparation of competent bacteria, an inoculation of a single colony of DH5α bacteria 
in 100ml of LB medium (Sigma, Buchs, CH) was incubated at 37°C overnight in a shaker at 
200rpm (Vaudaux-Eppendorf, Schonenbuch, CH). Five milliliters of the inoculation was 
mixed with 500ml of LB medium. The bacteria were subsequently grown at 37°C in a shaker 
at 200rpm until an approx optical density (OD600) was measured to be between 0.4 and 0.6. 
The bacteria culture was then chilled on ice for 30min and centrifuged at 3000rpm for 15min 
at 4°C. After the supernatant has been carefully removed, the bacteria pellet was resuspended 
in 100ml of ice-cold CaCl2 sterilized solution (60mM CaCl2, 15% Glycerol, 10mM Pipes) 
adjusted to pH7.0) and subsequently centrifuged at 3000rpm for 15min at 4°C. 
• The supernatant was removed and the pellet was resuspended in 10ml of CaCl2 solution. 
Subsequently, 1ml aliquots of the suspension were frozen at -70°C. 
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Transformation of competent bacteria: 
 
• An aliquot of 1ml of the competent DH5α bacteria was thawn on ice. Subsequently, 100µl of 
that aliquot were transferred to a new 1.5ml tube on ice and as well as 5µl of the ligation 
reaction were added to the mixture and the tube was briefly shaken by hands before left on ice 
for 30min. 
• The mixture was then subsequently incubated for 1min at 42°C and been placed back on ice 
for 2min for the required Heat-shock. For allowing the bacteria to recover properly, 900µl of 
SOC medium (Sigma, Buchs, CH) was added to the mixture, which was then incubated at 
37°C for 30min. In the mean time, 40µl X-Gal (10-20mg/ml) (Sigma, Buchs, CH) and 20µl 
of Isopropyl-Thio-B-D-Galactopyranoside IPTG (8-10mg/ml) (Sigma, Buchs, CH) was 
spread over and subsequently distributed on a 15cm agar plate (BD Biosciences, Allschwil, 
CH) containing ampicillin at 50-100µg/ml (Sigma, Buchs, CH) using a sterilized spatula. 
• The plate was then incubated approx. 20min in the dark (as X-gal is sensitive to light) for 
allowing the added fluid to penetrate the agar. Subsequently, 200µl of bacteria from the SOC 
medium were spread over the plate and distributed with a steriziled spatula.  
• For allowing the bacteria clones to grow, the plate was then incubated overnight at 37°C. The 
plate was stored at 4°C until subsequent clones were inoculated. 
 
Inoculation: 
 
• For the inoculation, 10 individual clones of white colonies were respectively picked up using 
a sterile tip from the agar X-Gal and IPTG containing plate and transferred to a 5ml of LB 
buffer (Sigma, Buchs, CH) containing polypropylene tube (10ml) (BD Biosciences, 
Allschwil, CH). Importantly, the blues colonies were ignored as the likelyhood of these 
colonies to contain a PCR product as insert is much smaller in comparison to a white colony. 
Namely, because of the fact that is more likely to pick up a blue colony of bacteria that 
contains an empty vector rather than a plasmid inserted with a PCR product which does not 
change the frameshift reading of the plasmid β-galactosidase. 
• Five microliters of from an Ampicillin solution (100mg/ml) were then added to each tube. 
Each of the mixtures was shaken over night at 250rpm in an incubator at 37°C overnight. The 
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tubes were then centrifuged at 4000rpm for 10min at 4°C. The supernatant was discarded and 
the remaining pellet was further processed for a miniprep purification of the plasmid. 
 
Miniprep: 
 
• For the Miniprep, a Kit (Macherey-Nagel, Oensingen, CH) was used to extract from each 
individual clone inoculation, the pGEM-T easy plasmid containing as an insert a PCR or 
RACE product. The purification was done according the manufacturer's instructions. Each of 
the purified plasmid was eluted in 50µl of the elution buffer. 
• The concentration of the different purified plasmids was measured by optical density using 
the following formula: concentration (µg/ml) = 50 x OD260 x dilution). 
• For a verification of the size of the PCR or RACE plasmid insert, a appropriate digestion of 
the plasmid was done as following: 5µl of 10x EcoR1 buffer (Bioconcept, Allschwil, CH), 
1µg of purified plasmid (pGEM with insert), 1µl of restriction enzyme EcoR1 (10U/µl). The 
reactions were filled to 50µl with milli-Q 18.2 water. Importantly, the pGEM-T easy vector is 
designed as such as to have two EcoR1 restriction sites at the 5' and at the 3' end of the insert. 
The reactions were then incubated at 37°C for 2 hours. Subsequently, 10µl of the digested 
plasmid was analysed by gel electrophoresis using a 1.2% agarose/Ethidium bromide 
0.25µg/ml gel. Importantly, in case of unexpected bands due to extra restriction sites of 
EcoR1 within the insert, the subsequent sequencing step of the insert always confirmed these 
EcoR1 sites. 
 
2.2.13.2 Sequencing of the pGEM insert 
 
• In order to be able to sequence the RACE insert of the pGEM plasmid, the following PCR 
reaction was prepared in a 0.2ml microtube: 4µl of Terminator Ready 3.0 Reaction Mix 
(Applied Biosystems, Rotkreuz, CH), 1µl of T7 primer (10µM) (see section 2.2.12.1 for its 
seequence) and 500ng of the purified plasmid. The reaction was completed to 10µl with milli-
Q 18.2 water. For avoiding any evaporation, two drops of Chill-out 14 red wax (Genetic 
Research instrumentation, Braintree, UK) were added on top of the mixture. 
• The microtubes were then transferred to a thermocycler using the following conditions: 2min 
at 96°C and subsequently for 15s at 96°C, 5s at 50°C and 4min at 60°C, respectively for the 
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denaturation, the annealing and the elongation of the transcribed products. These subsequent 
steps were repeated 24 times. The reaction was then stored at 4°C until purified. 
• For the purification of the transcribed products, the reaction without the wax was pipetted into 
a new 0.5ml tube and completed to 20µl with milli-Q 18.2 water. The subsequent mixture 
was then loaded onto DyeEx 2.0 spin column (Qiagen, Hombrechtikon, CH) and purified 
according the manufacturer's instructions. 
• For the sequencing, 5µl of the purified transcribed products were deducted and pipetted into a 
new 0.2ml microtube and 20µl of fresh Formamide (Sigma, Buchs, CH) was added to the 
mixture. The mixture was homogenized by pipetting up and down before being incubated at 
96°C for 2min. The mixture was then placed on ice until sequenced using a ABI 310 
instrument (Applied Biosystems, Rotkreuz, CH) according to the manufacturer's instructions. 
 
The sequenced RACE products were analysed and aligned using the Seqman 5.0 software 
(DNASTAR, Madison, USA). All sequences were then blasted to the mouse genome at the NCBI 
database server (National center for biotechnology information) for a sequence verification. 
Importantly, only clones of EST1 and EST2 RACE products that were confirmed to belong to the 
same cluster or identical chromosomical location as of the affymetrix source sequence, which 
serves as a reference for the generation of the probe sets of these respective ESTs, were 
considered. Moreover, as the sequencing allows to sequence only approx. 700bp, the RACE 
products longer than 700bp were sequenced in more than one step by repeating the above steps 
but replacing the T7 primer with an appropriate specific primer. 
 
2.2.14 LacZ staining 
 
• For the cryosection, the tissue was cut from an O.C.T block at -20°C as described in section 
section 2.2.1, and mounted onto a Superfrost Plus slide (Menzel-Gläser, Braunschweig, 
Germany). The section was allowed to dessicate at room temperature for 1 hour. 
• The sections were subsequently fixed 15 min at room temperature with 4% paraformaldehyde 
(Sigma, Buchs, CH) diluted in PBS (see section 2.1.6). 
• The sections were then washed three times for 5 min with PBS and incubated in a Kopplin 
Jarr filled with LacZ buffer (Per1L: 1mM MgCl2, 0.1% Triton-100, 0.01% NP-40, 0.02% 
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deoxycholate (Sigma, Buchs, CH) for 10 min. Next, the sections were briefly rinsed with 
fresh LacZ solution. 
• The sections were incubated in a LacZ solution containing 0.05% of X-gal (Sigma, Buchs, 
CH), as well as the K4Fe(CN)6 and the K3Fw(CN)6 reagents at a final concentration of 3mM. 
The sections were subsequently incubated at 37°C overnight on a shaker and protected from 
light. 
• The stained sections were washed 3 times for 5min before being counterstained for 1min with 
nuclear fast red solution (Sigma, Buchs, CH). The sections were then extensively rinsed with 
PBS and were each mounted with Moviol mounting media (Calbiochem, Luzern, CH) under a 
coverslip (Menzel-Gläser, Braunschweig, Germany). 
• The sections were then analysed under a microscope and pictures of the sections were taken 
with the help of an CCD camera mounted on top of the microscope (Nikon AG, Egg, CH). 
 
2.2.15 Isolation of thymocytes and TECs 
 
2.2.15.1 Isolation of the entire pool of thymocytes from adult thymus 
 
The thymocytes were obtained from adult thymic tissue of 3-4 weeks old mice by disrupting the 
isolated thymic tissue between two frosted microscope slides (Menzel-Gläser, Braunschweig, 
Germany). The collected cells were transferred into a 15ml tube (BD Biosciences, Allschwil, 
CH) containing PBS supplemented with 0.5% FCS and the tube was left for 15min on ice to 
allow the cells to settle. The cell suspension was then centrifuged at 1200rpm for 5min. The 
supernatant was carefully discarded and the cell pellet was resuspended in a appropriate buffer 
according to its further processing, which was either a cell sorting (see section 2.2.15.2) or an 
total RNA extraction (see section 2.2.6). 
 
2.2.15.2 Isolation of single positive mature thymocytes from adult thymus 
 
The procedure was essentially done as described by Balciunaite and colleagues (Balciunaite et 
al., 2002). Cells were sorted from adult thymus for CD3 high and then respectively for CD4 and 
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CD8 molecules. The respective sorted cells (CD4+CD8- and CD4-CD8+) were then pooled 
together for an total RNA extraction and RT-PCR see section 2.2.6. 
 
2.2.15.3 Isolation of MTS24+ and MTS24- thymic epithelial cells from adult thymus 
 
The procedure was essentially done as described by Gill and colleagues (Gill et al., 2002). Cells 
were sorted from adult thymus for MHCII positive cells and subsequently for the MTS24 marker. 
MTS24+ and MTS24- sorted cells were used for an total RNA extraction and RT-PCR (see 
section 2.2.6). 
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3.Results 
3.1 Overview 
The precise molecular control of early thymus development remains ill-defined. Thus, we 
intented to contribute to a better understanding of the events in thymus organogenesis by 
identifying the genetic programs that determine thymic epithelial cell fate commitment and 
differentiation. As endodermal contributions of the ventral aspects of the 3rd pharyngeal pouch 
(3rdpp) suffice to establish a normal cortical and medullary epithelial stroma, we investigated the 
gene expression profile of these cells (Gordon et al., 2004; Le Douarin and Jotereau, 1975). To 
this end, we compared epithelial cells of the 3rdpp with cells of the 2nd and the 4thpp and we 
compared cells from the ventral aspect of the 3rdpp with cells from the dorsal circumference of 
the same pouch to identify genes that are associated with the commitment of epithelial cells to a 
thymus cell fate. With the help of laser capture microdissection (LCM), RNA from these distinct 
endodermal linings of the different pouches were isolated and faithfully amplified for microarray 
analysis. 
 
To achieve an isolation of intact RNA, both the preparation of the tissue sections for LCM and 
the recovery of small RNA amounts were optimized starting with a protocol previously 
established in the laboratory for extracting RNA from tissue cryosections. The protocols for 
amplification of cDNA into cRNA were also adopted from methods for other purposes (e.g. 
microarray analysis) (Klur et al., 2004). Following hybridization or gene microarrays and the 
analysis of the data, several candidate genes could be selected that fulfil the following criteria: (i) 
preferential or exclusive expression in the 3rdpp when compared to the 2ndpp, and (ii) an abundant 
expression of the candidate gene in the ventral aspect of the 3rdpp when compared to its dorsal 
part. The different candidate genes fulfilling these criteria have subsequently been examined first 
by quantitative PCRs (qRT-PCRs) using the cDNA which served as the template to generate the 
probes for the microarray analysis (direct confirmation of the microarray analysis). Next, a 
selection of verified candidate genes were analysed by qPCRs from tissue samples isolated 
independently. This step was taken to verify the correctness of the genes analysed by microarray 
as potential candidate genes. The candidate genes further considered were in particular CCL21, 
Klf16, Fgf12, CD44, WIF1, Nrxn1, Phlda2, Bmp4, Fst, c-Myc and Sp8. Gene products for which 
antibodies were available (i.e. CCL21, Meox2, CD44, Phlda2, WIF1, Fst), were further 
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investigated by immunohistochemistry (IHC) on tissue sections from E10.5, E11.5 and E12.5 to 
see whether the observed differential in gene transcription of the candidate genes would also hold 
true at the level of protein expression. For several of the candidate genes (Bmp4, Fst, WIF1, 
Nrxn1, Phlda2, c-Myc, Flrt3, Sp8) a thorough expression profile was done with RT-PCR analysis 
for several E16.5 tissues and organs taken from adult animals. Candidate genes for which the full 
sequence was not yet known, molecular methods were applied to identify the entire leading 
frame. To test the role of Wnt inhibitor factor 1 (WIF1) in thymus development, recombinant 
WIF1 protein was used in fetal thymic organ cultures (FTOC) and the development of their 
thymus was analysed in detail. Finally, for two of the candidate genes, Phlda2 and Sp8, knock-
out mice made available for us were analysed for thymus development. The following section of 
this thesis will describe these results in detail. 
 
3.2 Laser microscopy, RNA isolation and faithful amplification  
 
3.2.1 RNA isolation from embryonal sections prepared for LCM 
 
It is paramount that RNA isolated by LCM for microarray analysis is of the highest quality. Since 
nanograms of RNA could not be easily and directly measured at the onset of this PhD work, 
alternative approaches were taken to assess the RNA quality. To this end, two embryonal sagittal 
cryosections (10µm thick) from embryos at E16.5 were pooled and total RNA was extracted to be 
tested by gel electrophoresis. In contrast to previously published methods staining with 
Haematoxylin was replaced by Toluidine Blue so as to decrease the time for staining to only 10 
seconds (s) and the following dehydration steps were shortened to 10s. These changes have been 
introduced to minimize the length of incubation during which the sections are in an aqueous 
phase, as this appears to degrade RNA integrity within minutes (Murakami et al., 2000). These 
preliminary experiments also tested whether the dehydration steps could also affect RNA 
integrity but the total RNA recovered from the sections revealed that dehydration did apparently 
not affect RNA quality (Fig.3.1A lane 1&2). The chosen methods were also safe for tissues taken 
at different developmental stages, e.g. E10.5 and E11.5 (Fig.3.1 A and B). Taken together, these 
results could reveal that intact RNA (Fig.3.11A) can be isolated from sections prepared for LCM. 
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Figure 3.1. Intact RNA can be isolated from sections prepared for LCM. Total RNA isolated from sections (10µm) 
stained with Toluidine blue. Comparison of RNA isolated from dehydrated (lane1) and not dehydrated (lane2) tissue 
sections that had been isolated from embryos of E16.5 (left panel A) and E11.5 (right panel B). 
 
3.2.2 FoxN1 expression in the third pharyngeal pouch 
 
Using β-galactosidase as a knock-in into FoxN1 locus, expression of FoxN1 as detected by LacZ 
activity was established to occur at E11.25 while significant levels of FoxN1 mRNA could only 
be detected by in situ hybridisation (ISH) as early as E11.5 (Gordon et al., 2001; Manley et al., 
2004; Moore-Scott et al., 2003; Moore-Scott and Manley, 2005). However, ISH is not a very 
sensitive method for the detection of gene transcription, therefore the presence of FoxN1 in E10.5 
embryos was evaluated using the more sensitive method of RT-PCR and tissue were taken from 
the 3rdpp. To determine whether the expression of FoxN1 was restricted to the 3rdpp, cells 
microdissected by LCM from the endodermal lining of the 2ndpp and 4thpp from age-matched 
mice were also analysed. For these purposes, total RNA was extracted from approximately 1000 
cells, reverse transcribed (see 2.2.6.2) and amplified using FoxN1 specific primers (see section 
2.2.6.4).The results of this analysis (Fig.3.2) revealed that FoxN1 specific mRNA could be 
detected as early as E10.5 and exclusively in the 3rdpp. Taken together, these experiments 
demonstrated that the methods employed allow for the detection of transcripts in a limited 
number of cells that have been isolated by LCM. 
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Figure 3.2. FoxN1 is expressed as early as E10.5 in the 3rdpp. Part of this figure has previously been published in 
(Balciunaite et al., 2002). II, III and IV indicate the 2nd, 3rd and 4th pharyngeal pouches, respectively. Hoxa3 
expression in the different pharyngeal pouches served as internal positive control for the RT-PCR analysis. 
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3.2.3 Amplification of RNA for microarray analysis 
Presently, any analysis by microarrays requires substantial amounts of template (10µg cRNA) 
which cannot be recovered easily in the experimental systems we had chosen to study. Thus, a 
method had to be employed which allows for a representative amplification of small amounts of 
RNA as typically extracted from a few cells. A linear amplification protocol was therefore 
employed that consists of two cycles of cDNA synthesis each followed by in vitro transcription 
(Eberwine et al., 1992). The first cycle concerns the initial amplification of the mRNA, resulting 
in unlabeled cRNA; while the second cycle achieves further amplification and incorporation of 
the biotinylated nucleotides needed for the labelling step for microarray hybridisation. To 
evaluate whether a modified amplification protocol (Baugh et al., 2001), which has previously 
been shown to perform better than the original protocol established by Eberwine and colleagues 
(Eberwine et al., 1992; Van Gelder et al., 1990) provides a faithful amplification, this protocol 
from Baugh and al. was applied to two different sources but of comparable amount of total RNA 
(10ng). The first sample was extracted from an unseparated juvenile thymus (4-5 weeks old) 
while the second sample was taken by LCM from 1000 cells of the 3rdpp of E11.5 embryos. For 
each of the two samples, RT-PCR was then performed for GAPDH, HPRT, CXCR4, Wnt4, 
FoxN1, Hoxa3, Pax1 and Pax9 on 50ng of cRNA. With the exception of CXCR4, specific 
transcripts for each of these genes could be detected in these tissue samples. As an additional 
control to test the faithfulness of the method, 5000ng of non-amplified total RNA (isolated from 
an juvenile thymus of 4-5 weeks old) corresponding to the approximative equivalent of 50ng of 
cRNA. This molecular basis to this conversion considers the facts that (i) 5% of total RNA 
corresponds to mRNA, and (ii) the average size of the mRNA (approx. 2kb) has been shortened 
by about 5 times when converted into cRNA (approx. 400bp) due to a 3' end bias of the second 
round of linear amplification. Thus, similar levels of amplicon synthesis could be expected for 
the tested genes when comparing the different samples. However, this assumption only holds true 
under the following two conditions: (i) the reverse transcription reaction (RT) of the tested 
samples is of similar efficiency, and (ii) the PCR reaction has not yet reached the plateau level. In 
that regard, a semi quantitative RT-PCR analysis for the highest expressed gene GAPDH on a 
sample containing 5000ng of RNA extracted from an juvenile thymus revealed that after 26 
cycles of PCR the plateau level of the reaction has not been reached yet. Therefore, it was 
decided to cycle 26 times in the PCR for all examined samples. Using the approach mentioned 
above, it was established that for some (GAPDH, HPRT, CXCR4, Wnt4, FoxN1 and Pax1) but 
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not others (Hoxa3, Pax9) the amplification used was faithful with regards to the correct, i.e. 
linear amplification (Fig.3.3). In other words, the fidelity of linear amplification using the Baugh 
protocol was not uniformly given. Thus, we have decided us for an alternative protocol based on 
random PCR to amplify the RNA extracted by LCM. This protocol has been established by 
Roche diagnostics in the purpose to use it for microarray analysis and it was demonstrated in an 
evaluation study of Klur and al. with our contribution that it is more reproducible, requires 
smaller RNA input, and generates cRNA of higher quality than linear amplification (Klur et al., 
2004). 
 
    GAPDH      HPRT     CXCR4      Wnt4       FoxN1     Hoxa3      Pax1         Pax9 
M   1  2   3      1  2  3      1  2   3      1  2  3      1  2  3      1  2  3      1  2  3       1  2  3 M 
 
Figure 3.3. Gene expression analysed by RT-PCR using non amplified and linear amplified RNA templates. 
Lane 1: 5000ng of non amplified total RNA from adult thymus, lane 2: 50 ng of cRNA from E11.5 3rdpp isolated by 
LCM, lane 3: 50ng of cRNA isolated from Adult thymus. M: DNA marker, 100bp: 100 base pairs. 
 
 
 
 
 
 
3.3 Identification of candidate genes for thymic epithelial cell fate 
commitment and function 
 
3.3.1 Differential expression analysis between the 2nd and 3rdpp 
 
To identify genes that are involved in thymus development, a first microarray analysis was 
performed in which at E10.5 the gene expression profile of epithelial cells from the 2nd and 3rdpp 
was compared. Three independent samples were generated for this experiment, taken each from 
the 2nd and of the 3rdpp. The amplified cRNA was tested on the murine genome MGU74v2 
genechip microarrays which allowed to monitor and quantify the expression of more than 36000 
sequences taken from mouse genes and ESTs, respectively. The data obtained was then analysed 
using the Affymetrix microarray suite 5.0 software. 
 
-100bp 
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3.3.1.1 Comparing the expression of FoxN1, Gcm2 and Pax1 using either qPCR or 
microarrays 
 
The qRT-PCR analysis for the expression of FoxN1 Gcm2 and Pax1 by qPCR was used to verify 
the data obtained by microarray analysis (Fig.3.5). It was generally observed that genes that are 
expressed at very low levels (and hence at as close to the limits of detection) will have their PM 
(perfect match) and MM (mismatch) values less reliably reflected (see 2.2.1.6). Consequently, an 
absent call (see 2.2.1.6 for explanation) does not necessarily indicate the real lack of expression 
but signifies that the examined gene might be not expressed highly enough to report a present call 
(see 2.2.1.6 for explanation). An instructive example to this point is the expression of FoxN1, 
which was scored absent when analysing microarrays (see Table3.1, Fig.3.4 for PM/MM pattern) 
but which can reliably be detected by qRT-PCR in all samples generated for the microarray 
analysis (Fig.3.5). The intensity values obtained for FoxN1 from the microarray data were found 
to be much higher in the 3rdpp when compared to the 2ndpp samples with a ratio of 4.19 (Table 
3.1), a value that is generally indicative of differential gene expression. Gcm2 was reported to be 
expressed at E9.5 in the 2nd and 3rdpp but its expression becomes restricted to the 3rdpp by E10.5 
(Gordon et al., 2001). Indeed analysis of cells taken at E10.5 from the 3rdpp confirmed the Gcm2 
expression (Fig.3.5). Gcm2 expression was, however, also observed in one but not all samples in 
the 2ndpp (Fig.3.5). However, in the sample that detected some expression of Gcm2, the qRT-
PCR data revealed an Ct value of above 36 and hence was close to the limit of detection. 
Furthermore, this data did indicate that Gcm2 at E10.5 was expressed at least 5000 fold less (ΔCt 
of 12.3) in the 2ndpp when compared to the 3rdpp (Fig.3.5). Gcm2 is represented on the U74Av2 
microarray by two different probe sets. One probe set (ID 94709_at) provides expression data 
that are in agreement with the qRT-PCR data presented in Table 3.1. In contrast the other probe 
set (ID 94710_g_at) failed to confirm the qRT-PCR data presented in Table 3.1 and Fig.3.5 in 
regard to the expression of Gcm2 in the 2ndpp. 
 
 
 
 
 
 
 
 
109 
Table 3.1 
Comparative analysis of FoxN1, Gcm2 and Pax1 expression using either qRT-PCR or microarrays 
 
Probe ID1 Gene name Gene  
Symbol 
2_1 2_2 3_1 3_2 Microarray  
Ratio 4 
QRT-PCR  
ratio 5 
92674_at Forkhead box N1 FoxN1 A2 A A A 4.19 Ex.36 
94709_at Glial cells missing homolog 2 Gcm2 P3 A P P 3.89 5095.47 
94710_g_at Glial cells missing homolog 2 Gcm2 A A A P 2,98 5095.47 
96595_at Paired box gene 1 Pax1 P A P P 14.38 49.01 
 
Explanations: (1) Probe ID refers to the Affymetrix reference number for a probe set specific for a given gene. (2) 
A= absent, (3) P=present. (4) Microarray ratio is calculated as average intensity 3rdpp/ average intensity 2ndpp and (5) 
qRT-PCR ratio is calculated as 2^(average ΔCt 2ndpp)- (average ΔCt 3rdpp)) where the ΔCt is the difference in Ct 
values between the gene of interest and the housekeeping gene, GAPDH. Samples of the 2ndpp and 3rdpp are 
annotated as 2_1, 2_2, 3_1 and 3_2 respectively. (6) Ex.3 denotes FoxN1 was exclusively found to be expressed in 
the 3rdpp when compared to the 2ndpp. 
 
 
 
 
 
 
 
Figure 3.4.  Microarray analysis: Perfect match (PM) versus Mismatch (MM) pattern for FoxN1, Gcm2 and 
Pax1 expression in the 2ndpp and 3rdpp. Probe 1 for Gcm2 appears to hybridize better than its homolog Probe 2. 
The probe set of FoxN1 appears to not hybridize optimally as the PM signal is not clearly above the MM signal in 
the 3rdpp for that gene. In contrast, Pax1 and Gcm2 PM signal are clearly above their MM signal in the 3rdpp. 
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Figure 3.5. qRT-PCR analysis for the expression of FoxN1, Gcm2 and Pax1 from cDNA generated and 
amplified from tissue of the 2ndpp and 3rdpp, respectively. Data has been normalised to GAPDH expression. The 
ratio “gene of interest cDNA / GAPDH cDNA” corresponds to the calculated difference in signal intensity between 
the examined gene and GAPDH. The errors bars represent the difference in the calculated ratio between two samples 
generated independently.* Gcm2 was only found to be expressed in one of two samples of the 2ndpp. 
 
Microarray analysis did also underestimate the fold difference in the level of expression when 
comparing different probe sets for the same gene (see Table 3.1). Taken together, the quality of 
the microarray data did depend on the hybridization efficiency of each individual probe set, as for 
FoxN1, Gcm2 or Pax1 (see Fig.3.4). 
 
3.3.1.2 Comparison of differential gene expression 
 
The semi-quantitative detection of gene expression (i.e. the P/M/A calls, see 2.2.1.6 for 
explanations) together with the intensity values of each of the gene represented on the MGU74v2 
microarrays were compiled and differences in the intensities between the samples taken from the 
2nd and of 3rdpp were calculated. To evaluate how many genes of the MGu74v2 set are predicted 
to be preferentially if not exclusively expressed in the 3rdpp, the following criteria were 
considered: (i) the intensity ratio 3rdpp/2ndpp should be more than 2, and (ii) at least one of the 
3rdpp samples should have a marginal (M) call. Using these criteria 2533 probe sets fulfilled both 
limitations. Of these 2533 probe sets, 1478 had a present call for both 3rdpp samples, whereas the 
results for 857 probe sets were discordant with regards to their A/M/P calls when comparing the 
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two analysed samples (Fig.3.6). The same criteria for selection were used to investigate genes 
that are expressed at a higher concentration in the 2ndpp when compared to the 3rdpp. This second 
analysis identified 1359 probe sets to be preferentially if not exclusively expressed in the 2ndpp. 
Of these 1359 probe sets, 509 had a present call in both of the 2ndpp samples tested (Fig.3.7). In 
summary, our analysis revealed that of the 3607 gene probe sets (2533+1359) to be differentially 
expressed between the 2nd and 3rdpp, 1987 (1478+509) fulfilled the set selection criteria that is a 
difference in gene expression of 2 and more fold if not of an exclusive expression in either the 2nd 
or the 3rdpp when considering these two pouches. 
 
 
Figure 3.6. Microarray based analysis of differential gene expression comparing epithelial cells of the 2nd and 
3rd pharyngeal pouch. The numbers represent the probe sets identified for each of the categories detailed. 
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Figure 3.7. Microarray based analysis of differential gene expression comparing epithelial cells of the 2nd and 
3rd pharyngeal pouch. The numbers represent the probe sets identified for each of the categories detailed. 
 
 
3.3.1.3 Identification of genes that are upregulated in the third pharyngeal pouch 
 
The next step in the analysis of differential gene expression between epithelia positioned in the 
2nd and 3rdpp concerns the identification of these genes among the 2533 sequences demonstrated 
to be differently expressed between these two sites. To this end, an increased selection stringency 
was used in comparison to the previous microarray analysis so as to identify candidate genes that 
have a higher likelihood to be truly differentially expressed. For this second screen, the three 
following criteria were used for selection: (i) have at least a 6 fold difference in the expression 
level when comparing the 2ndpp with the 3rdpp, (ii) absent call in the microarray analysis for the 
2ndpp, and (iii) a present call in both 3rdpp samples. As expected, this stringent re-analysis of the 
data resulted in a smaller pool of candidate genes, which now corresponded to 133 independent 
genes (Fig.3.8). Eight hundred and two genes fulfilled the first two criteria (i) and (ii) but did not 
score as present in both samples of the 3rdpp while only 21 genes met the first two criteria but did 
not score as present in both of the two 3rdpp samples (not shown). 
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Figure 3.8. Microarray based analysis of differential gene expression comparing epithelial cells of the 2nd and 
3rd pharyngeal pouch. The numbers indicated represent the number of probe sets identified for each of the 
categories detailed. 
 
 
From the 133 genes identified in the second screening, 19 candidates were chosen based on their 
function in transcriptional regulation. Their differential gene expression was then independently 
verified by qRT-PCR. Results of the comparison between the microarray and qRT-PCR are 
summarized in Table 3.2. In addition to these 19 genes, an additional 7 candidate sequences 
(Map3k3, Pxk, Clock, Meox1 and 3 ESTs) were also further analysed by qRT-PCR. These 
sequences did not fulfil the three selection criteria but displayed a significant increase (more than 
three fold) in their expression in the 3rdpp when compared to the 2ndpp (Table 3.3). 
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Table 3.2 
Comparison of gene expression analysed by the microarray and qRT-PCR for 19 selected genes (see text). 
 
Probe ID1 Gene name Gene  
Symbol 
Gene function 2_1 2_2 3_1 3_2 Microarray  
Ratio (4) 
qRT-PCR  
ratio (5) 
115106_at EST EST Unknown A2 A P3 P 74.75 8.49 
103012_at chemokine (C-C motif) ligand 21c  CCL21 Chemotaxis A A P P 62.90 1458.23 
168542_f_at EST EST2 Unknown A A P P 42.37 59.30 
92210_at angiopoietin 2 Angpt2 Antagonist of Angpt1 
signalling in vasculogenesis 
A A P P 40.28 5461.19 
92727_at amyloid beta (A4) precursor protein-
binding A2 
Apba2 Binds to amyloid protein 
precursor 
A A P P 32.05 31.23 
114280_at yippee-like 1 (Drosophila) Ypel1 Induces an epithelial-like 
morphology in fibroblasts 
A A P P 28.88 2.23 
99441_at gephyrin Gphn Plays a role in signal 
transduction 
A A P P 26.88 2957.17 
98059_s_at lamin A Lmna Involved in nuclear 
mechanics 
A A P P 24.13 83.29 
163492_at EST EST Unknown A A P P 23.68 1.86 
110833_at protein kinase, AMP-activated, gamma 2 
non-catalytic subunit 
Prkag2 Responsible for Wolf-
Parkinson-White syndrome 
A A P P 20.29 1.34 
165740_at Double sex and mab-3 related 
transcription factor 2 
Dmrt2 Transcription factor A A P P 19.20 12944.04 
99937_at Mesenchyme homeobox 2 Meox2 Transcription factor A A P P 18.17 Ex.33 
165776_i_at Kruppel-like factor 16 Klf162 Transcription factor A A P P 15.96 Ex.3 
98890_at EST EST Unknown A A P P 13.36 25.37 
109380_at Spfh1 domain, family, member 1 Spfh1 Unknown A A P P 12.22 1.21 
96841_at proviral integration site 3 Pim3 Serine/Threonine kinase A A P P 10.61 3.45 
100899_s_at zinc finger protein 297 Zfp297 Transcription factor A A P P 8.09 3.41 
138087_at fibroblast growth factor 12 Fgf12 Growth factor A A P P 7.41 Ex.3 
93635_at kinesin family 3C Kif3c Unknown A A P P 6.62 24.34 
 
Explanations: (1) Probe ID refers to the Affymetrix reference number for a probe set specific for a given gene. (2) 
A= absent, (3) P=present. (4) Microarray ratio is calculated as average intensity 3rdpp/ average intensity 2ndpp and (5) 
qRT-PCR ratio is calculated as 2^(average ΔCt 2ndpp)- (average ΔCt 3rdpp)) where the ΔCt is the difference in Ct 
values between the gene of interest and the housekeeping gene, GAPDH. Samples of the 2ndpp and 3rdpp are 
annotated as 2_1, 2_2, 3_1 and 3_2 respectively. (6) Ex.3 denotes the gene was exclusively found to be expressed in 
the 3rdpp when compared to the 2ndpp. 
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Table 3.3 
Comparison of gene expression as analyzed by microarray and qRT-PCR for 7 additional genes (see text). 
 
Probe ID1 Gene name Gene  
Symbol 
Gene function 2_1 2_2 3_1 3_2 Microarray  
Ratio (4) 
qRT-PCR  
ratio (5) 
94947_g_at mitogen activated protein kinase kinase 
kinase 3 
Map3k3 Regulates SAPK and 
ERK pathways 
A2 A A P3 10.19 0.46 
103405_at EST EST Unknown A A P A 9.90 57.68 
160815_at EST EST Unknown A A A A 7.51 2.87 
97325_at PX domain containing serine/threonine 
kinase 
Pxk Phosphorylation in 
intracellular signalling 
A A M M 6.95 62.47 
97355_at EST EST Unknown A A M A 6.24 2.36 
92257_at Circadian locomoter output cycles kaput Clock Transcription factor A A P P 5,04 0,57 
98419_at mesenchyme homeobox 1 Meox1 Transcription factor A P P P 3.99 9541.50 
 
Explanations: (1) Probe ID refers to the Affymetrix reference number for a probe set specific for a given gene. (2) 
A= absent, (3) P=present. (4) Microarray ratio is calculated as average intensity 3rdpp/ average intensity 2ndpp and (5) 
qRT-PCR ratio is calculated as 2^(average ΔCt 2ndpp)- (average ΔCt 3rdpp)) where the ΔCt is the difference in Ct 
values between the gene of interest and the housekeeping gene, GAPDH. Samples of the 2ndpp and 3rdpp are 
annotated as 2_1, 2_2, 3_1 and 3_2 respectively. (6) Ex.3 denotes the gene was exclusively found to be expressed in 
the 3rdpp when compared to the 2ndpp. 
 
 
Conformational analysis for the 26 genes examined by qRT-PCR using the cDNA previously 
employed for the microarray analysis revealed that 12 candidate genes (48%) remained 
differently expressed when comparing epithelia form the 3rdpp with cells taken from the 2ndpp. 
Among these 12 genes, three, Fgf10, Meox2 and Klf16, were present exclusively in the 3rdpp and 
9 genes, CCL21, Angpt2, Gphn, Dmrt2, Zfp297, Meox1 and 3ESTs were observed with a 
preferential expression in the 3rdpp (Fig.3.9).  
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Figure 3.9. qRT-PCR data for 6 genes found either exclusively (panel A) or preferentially (panel B) expressed 
in the 3rdpp. Data has been normalised to GAPDH expression. The ratio “gene of interest cDNA / GAPDH cDNA” 
corresponds to the calculated difference in signal intensity between the examined gene and GAPDH. The errors bars 
represent the difference in the calculated ratio between two samples generated independently.* Klf16 was only found 
to be expressed in one of two samples of the 2ndpp. 
 
 
 
 
 
Interestingly, when comparing the microarray with that of the qPCR data for the 26 genes target 
genes identified by microarray, only 3 out of the 24 genes classified by microarray analysis as 
being exclusively expressed in the 3rdpp epithelium could be confirmed by qPCR as such while 
11 of those genes were noted to be preferentially expressed in the 3rdpp. Hence, qRT-PCR 
analysis appeared to be more sensitive when compared to the microarray analysis (Fig.3.10). This 
is not a surprise as a qRT-PCR reaction produces for a given gene much more copies of a target 
sequence than can be found in any sample loaded onto the microarrays for hybridization. As a 
consequence, the resulting signal intensity for a given gene, in particular for low-expresser, is 
much more likely to be detected by qRT-PCR than by microarrays. 
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Figure 3.10. Comparative analysis between microarray (A) and qPCR (B) for the 26 candidate genes, 
identified by microarray analysis to be upregulated if not exclusively expressed in the epithelium of the 3rdpp 
when compared to the 2ndpp. The number of genes in each category is represented in brackets. 
 
 
 
3.3.1.4 Independent confirmation of candidate genes 
 
To verify that Fgf12, Klf16, Meox1&2, CCL21, Angpt2, Dmrt2 and Gphn are differentially 
expressed between 3rdpp and 2ndpp, epithelium was anew isolated from either the 2ndpp and the 
3rdpp of E10.5 by use of LCM. An analysis by qRT-PCR confirmed that FoxN1, Gcm2; Meox2 
and Klf16 are exclusively expressed and Fgf12, CCL21, Angpt2, Dmrt2 are preferentially 
expressed in the epithelium lining the 3rdpp (Table 3.4 & Fig.3.11). However, Meox1 and Gphn 
could not be verified by qRT-PCR analysis (Table 3.4 & Fig.3.11) to be differentially expressed. 
In summary, this independent qRT-PCR analysis verifies the differential expression on 
independent cDNA source 6 candidate genes initially picked up by the gene array analysis. 
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Table 3.4 
Independent confirmation of expression of candidate genes 
 
Probe ID1 Gene name Gene 
Symbol 
qRT-PCR 
ratio2 
99937_at Mesenchyme homeobox 2 Meox2 515,6 
165776_i_at Kruppel-like factor 16 Klf16 8,2 
138087_at Fibroblast growth factor 12 Fgf12 1172,1 
103012_at Chemokine (C-C motif) ligand 21c  CCL21 6,4 
98419_at Mesenchyme homeobox 1 Meox1 0,9 
92210_at Angiopoietin 2 Angpt2 3,8 
165740_at Double sex and mab-3 related 
transcription factor 2 
Dmrt2 6,7 
99441_at Gephyrin Gphn 1,2 
 
Explanations: (1) Probe ID refers to the Affymetrix reference number for a probe set specific for a given gene. Gene 
expression was analysed by qRT-PCR in two samples generated independently, which are each derived from either 
the 2nd or the 3rdpp. (2) The qRT-PCR ratio is defined as the average fold difference in signal intensity comparing the 
samples taken from the 3rdpp and the 2ndpp. 
 
 
Figure 3.11. Expression analysis by qPCR for 8 target genes identified by microarray to be differentially 
expressed comparing the 2ndpp and 3rdpp. Exclusive (A) , preferential (B) and unchanged (C) expression in the 
3rdpp when compared to the 2ndpp. Data has been normalised to GAPDH expression. The ratio “gene of interest 
cDNA / GAPDH cDNA” corresponds to the calculated difference in signal intensity. The errors bars represent the 
difference in the calculated ratio between two samples independently generated. 
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3.3.1.5 Immunohistochemical analysis for CCL21 and Meox2 expression in the 3rd 
pharyngeal pouch 
 
To verify the expression of CCL21 (Chemokine C-C motif ligand 21) and Meox2 (Mesenchyme 
homeobox 2) at the protein-level, immunohistochemistry (IHC) was carried out on tissues of 
E10.5 embryos. CCL21 is a chemokine that has been shown to be involved in the recruitment of 
T-cell precursors to the fetal thymus (Liu et al., 2005). This findings have been demonstrated 
from CCL21-deficient plt/plt mice whose fetal thymus colonization was partially defective in 
these mice. Furthermore, fetal thymus colonization could be markedly diminished by neutralizing 
antibodies specific for CCL21 and CCL25 in FTOC experiments (Liu et al., 2005). Hence, these 
findings indicate that CCL21 suggest that the combination of CCL21 and CCL25 plays a major 
role in fetal thymus colonization. The exclusive expression of the chemokine ligand CCL21 in 
the 3rdpp when compared to the other pouches was confirmed by IHC (Fig.3.12A). Moreover, this 
expression was confined to the anterior aspect of the 3rdpp (Fig.3.12A). At E11.5, the expression 
of CCL21 appeared to extend into the immediate mesenchymal surrounding but remained 
restricted to the anterior aspects of the 3rdpp (Fig.3.12B). 
 
 
 
Figure 3.12. Immunohistochemistry (IHC) for CCL21 on coronal sections of the pharyngeal region at E10.5 
(A) and E11.5 (B). BaIII and BaIV signify the third and fourth branchial arches. Anterior is at the bottom and 
Posterior is at the top of the images. The images have been taken with a magnification of 20x. 
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Meox2 is a transcription factor, which has revealed from knockout studies to have a crucial role 
in the differentiation and morphogenesis of the limb muscles (Mankoo et al., 1999). Interestingly, 
Meox1 and Meox2, both revealed to be expressed in the 3rdpp (Fig.3.11), have demonstrated to 
function together and upstream of Pax genes in the development of somites (Mankoo et al., 
2003). However in contrast to CCL21, any role for Meox genes in the development of the thymus 
has been attributed so far. At E10.5, Meox2 could be weakly detected by IHC in the 1st and 2ndpp 
(Fig.3.13A&B). In contrast, Meox2 is strongly expressed in the ventral aspect of the 3rdpp and in 
the entire 4thpp. The expression of Meox2 in these sites was at E10.5 considerably stronger in the 
endodermal lining of the 3rdpp and 4thpp when compared to the surrounding mesenchyme. At 
E11.5, Meox2 expression was observed throughout the entire 3rdpp (Fig.3.13C&D). 
 
 
 
 
 
Figure 3.13. Immunohistochemistry for Meox2 expression in sagittal sections of the pharyngeal region at 
E10.5 (A&B) and at E11.5 (C&D). BaIII and BaIV denote the third and fourth branchial arches, respectively. 
Anterior is at the top and posterior is at the bottom of the image, ventral is positioned on the right and dorsal on the 
left. The images have been taken with a magnification of 10x (A&C) or 20x (B&D). 
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3.3.2 Differential expression analysis between the dorsal and ventral aspect of 
the 3rdpp 
 
As outlined in the introduction, the ventral aspect of the 3rdpp gives rise to the thymic epithelium 
while the dorsal aspect constitutes the parathyroid anlage (Gordon et al., 2001). Thus, comparing 
the gene expression in epithelial cells from the ventral with that of the dorsal circumference of 
the 3rdpp at E10.5, we sought to identify sequences that correlate with the commitment of 
endodermal cells to a thymic cell fate. For each of these restricted anatomical sites, two 
independent cDNA samples were generated by LCM (Fig.3.14). The material was then processed 
to generate cDNA, which was then faithfully amplified for the purpose of microarray analysis. 
 
 
 
 
 
 
 
 
 
Figure 3.14. Laser capture microdissection of the dorsal and ventral aspects of the 3rdpp at E10.5. A The 
sagittal section of the pharyngeal region was stained with toluidine blue to reveal the third pharyngeal pouch. B The 
sagittal section of the pharyngeal region after the isolation of epithelial cells positioned at the dorsal and ventral 
poles of the 3rdpp. BaIII and BaIV indicate the third and fourth branchial arches, respectively. 
 
 
3.3.2.1 Comparing the expression of FoxN1, Gcm2 and Ehox using either qRT-PCR or 
microarrays. 
 
Since epithelial cells in separate parts of the 3rdpp give rise either to the thymus or the 
parathyroids, the expression of the tissue specific transcription factors FoxN1 and Gcm2 were 
used to monitor the origin of the tissue taken. The qRT-PCR analysis of the samples generated 
revealed that the expression of FoxN1 was already restricted to the ventral aspect of the 3rdpp 
(Table 3.5 and Fig.3.15). In contrast, Gcm2 was expressed in the dorsal aspects of the 3rdpp at a 
higher concentration but its transcripts could also be detected in limited amounts in the ventral 
aspect of the 3rdpp using qRT-PCR (Table 3.5 and Fig.3.17). 
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The gene expression microarray data for the samples of the ventral aspect of the 3rdpp suggested  
that FoxN1 was absent in all of the examined samples (Table 3.5 & Fig.3.16). In fact, this result 
was in agreement with previous microarray analysis using cDNA from the entire 3rd pharyngeal 
pouch, as evidenced by Table 3.1 and Fig.3.4. On the other hand, one of two Gcm2 probe sets 
revealed a preferential expression in the dorsal aspect of the 3rdpp when compared to its ventral 
counterpart as confirmed by qRT-PCR (Table 3.5, Fig.3.15 and Fig.3.16). In contrast, an other 
probe set reported very limited and strict expression of Gcm2 in the dorsal circumference of the 
3rdpp (Table5 & Fig.16). This discrepancy in the expression data for Gcm2 is likely to be 
explained by differences in hybridization efficiencies between these probe sets (Fig.3.16) since 
verification by qRT-PCR clearly detailed the presence of Gcm2 transcripts although 
preferentially in the dorsal circumference but in both aspects of the 3rdpp. 
 
Moreover, an other transcription factor called Ehox (Embryonic homeobox) has been revealed by 
ISH analysis to become restricted by E10.5 in the pharyngeal region to the ventral end of the 2nd 
and 3rdpp (Jackson et al., 2003). However, Ehox is not represented on the MGU74v2 microarray 
set. Therefore, to verify this finding and to further test whether the cDNA samples generated for 
the purpose of a comparative microarray analysis between the dorsal and ventral aspect of the 
3rdpp are in agreement with published data, the expression of Ehox was examined by qRT-PCR in 
these samples. In contrast to the ISH finding, the qRT-PCR analysis revealed that Ehox was 
preferentially (9.09 fold) but not exclusively expressed in the ventral part when compared to its 
dorsal counterpart (Fig.3.15). This result could be confirmed on independently generated cDNA 
samples, although with a smaller difference in expression (7.07 fold) by an other member of the 
lab (Mr.K.Na, result not shown). 
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Table 3.5 
Comparative analysis of microarray and qPCR data for the expression of FoxN1 and Gcm2 
 
Probe ID1 Gene name Gene  
Symbol 
D_1 D_2 V_1 V_2 Microarray  
Ratio (3) 
qRT-PCR  
ratio (4) 
92674_at Forkhead box N1 FoxN1 A2 A A A 3.35 Ex. V5 
94709_at Glial cells missing homolog 2 Gcm2 P2 P P P 0.36 0,1609 
94710_g_at Glial cells missing homolog 2 Gcm2 M2 A A A 0.42 0,1609 
 
Explanations: (1) Probe ID refers to the Affymetrix reference number for a probe set specific for a given gene. (2) A; 
M and P denote absent, marginal and present calls, respectively. The ratio is defined as the average fold difference in 
signal intensity between two samples independently generated taken from the dorsal and the ventral epithelium of the 
3rdpp, as measured by qRT-PCR (4) or microarray analysis (3). Samples 1 and 2 of the dorsal and ventral aspects of 
the 3rdpp are annotated as D_1, D_2, V_1 and V_2, respectively. (5) Ex.V denotes that the gene was exclusively 
found to be expressed by qRT-PCR in the ventral epithelium of the 3rdpp. 
 
 
 
 
Figure 3.15. Expression of FoxN1, Gcm2 and Ehox expression in the ventral and dorsal aspects of the 3rdpp as 
analysed by qRT-PCR. qPCR was performed on amplified cDNA and the data are normalised to GAPDH 
expression. The ratio “gene of interest cDNA/ GAPDH cDNA” correspond to the calculated difference in signal 
intensity between the gene of interest and GAPDH. The errors bars represent the difference in the calculated ratio 
between two samples generated independently. 
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Figure 3.16. Perfect match (PM) versus mismatch (MM) pattern for the expression of FoxN1 and Gcm2 in the 
in the dorsal and ventral aspect of the 3rdpp. Probe set 1 for Gcm2 clearly shows that the difference between PM 
and MM signal intensity in the dorsal aspect is higher than in its ventral counterpart while this difference in signal 
intensity is less obvious to notice for probe set 2 between the dorsal and the ventral aspect of the 3rdpp. Hence, probe 
set 1 for Gcm2 hybridizes more efficiently in comparison to probe set 2. FoxN1 probe set does not hybridize 
efficiently enough to notice a considerable difference between the PM and the MM signal in the ventral aspect of the 
3rdpp and was therefore called absent by the microarray software. This finding results most likely from sensitivity 
issues since qRT-PCR analysis clearly detailed the presence of FoxN1 transcripts in the ventral aspect of the 3rdpp. 
 
 
 
3.3.2.2 Comparison of differential gene expression 
 
Next, the number of genes that are represented by 36785 probe sets of the MGu74v2 microarrays 
was analysed that are preferentially or exclusively expressed in the ventral aspect of the 3rdpp. To 
this end, the following criteria were applied to filter the data: (i) the signal intensity ratio ventral 
vs. dorsal in the 3rdpp had to be more than 2, (ii) at least one of the ventral samples needed to give 
a present or a marginal call. Using these criteria, 630 of the 36788 probe sets scored positively 
(Fig.3.17). If these stringent criteria were chosen and that in addition both ventral 3rdpp samples 
had to be called present, than 326 probe sets were differentially expressed between the two 
circumferences with a higher concentration in the ventral aspect (Fig.3.17). 
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Figure 3.17. Diagram detailing the number of genes preferentially or exclusively expressed in epithelium of 
the ventral aspect of the 3rdpp. The numbers indicated reveal the number of probe sets fulfilling the different 
criteria (see text). Genes preferentially expressed in the ventral aspect of the 3rdpp will be distinguished in section 
3.2.2.3 from genes exclusively expressed in this circumference. 
 
 
The same selection criteria were also used to identify genes that are preferentially or exclusively 
expressed in the dorsal aspect of the 3rdpp (Fig.3.18). Here, 541 probe sets were more abundantly 
expressed in the dorsal aspect of the 3rdpp, with 223 of these detected in both samples under 
investigation. Taken together, 1171  probe sets (630 and 541) are differentially expressed 
between the ventral and dorsal aspect of the 3rdpp. In contrast, approximately three fold as many 
probe sets (3892 probe sets) were identified to be differentially expressed when comparing the 
gene expression profile between the second and the third pharyngeal pouch endoderm (see 
3.3.1.2). 
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Figure 3.18. Diagram detailing the number of genes preferentially or exclusively expressed in epithelium of 
the dorsal aspect of the 3rdpp. The numbers indicated reveal the number of probe sets fulfilling the different criteria 
(see text). 
 
 
 
3.3.2.3 Identification of genes specifically upregulated among ventral epithelial cells of the 
third pharyngeal pouch 
 
The 630 probe sets (Fig.3.17) identified as being expressed in ventral epithelial cells of the 3rdpp 
were next subjected to an additional filter in that only probe sets were further considered that 
displayed an absence (A call) of expression in both samples of the dorsal epithelium. This third 
criterium thus excluded probe sets that were not exclusively expressed in the ventral aspects of 
the third pharyngeal pouch. Using this additional third criterium, 391 probe sets fulfilled now all 
three conditions and approximately a fifth of the probe sets concerned genes (85 genes) involved 
in transcription and were therefore verified by qRT-PCR (Fig.3.19A).  
 
To allow the detection of genes, which may be marginally expressed in epithelial cells of the 
ventral part of the 3rdpp but were reported as absent (A call) in expression by the microarray 
analysis and hence did not fulfil the second criterium (see Table 3.6), I applied three additional 
criteria (iv), (v) and (vi) (see Table 3.6) to the samples that fulfilled the criteria (i) and (iii) stated 
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above and reminded in Table 3.6. Using this extended list of criteria, 468 probe sets were 
identified (Fig.3.19A). Thirty-three genes from this list were subsequently verified by qRT-PCR.  
 
To identify additional target genes expressed preferentially but not exclusively in the ventral 
epithelium of the 3rdpp, two other criteria (vii) and (viii) (see Table 3.6) were applied to the list of 
probe sets that had a signal intensity ratio “ventral/dorsal 3rdpp” of more than 2 (criterium i). 
Using the criteria (i), (vii) and (viii), the analysis identified a list of 205 probe sets (Fig.3.19A). 
From this list, 22 genes possibly involved in transcription were selected and verified by qRT-
PCR.  
 
Finally, the microarray data set was also analysed by an additional software, dchip 1.3 (see 
Fig.3.19B). Using the default criterium (ix) of this software which relies on the model-based 
expression index (MBEI) for two or more independent samples (Li and Wong, 2001), 541 probe 
sets were identified to be expressed either preferentially or exclusively expressed in the ventral 
aspect of the 3rdpp (Fig19B). Among these probe sets, 7 genes were analysed by qRT-PCR. These 
genes are involved in transcriptional regulation and had not been identified using the Affymetrix 
microarray suite 5.0 software with the criteria (i) to (vi) or, alternatively, (vii) and (viii). 
 
 
 
 
Table 3.6 
Criteria used as filters for the analysis of the microarray data. 
 
(i) signal intensity ratio ventral/dorsal 3rdpp more than 2 
(ii) at least one of the samples of the ventral aspect of the 3rdpp display a M or P call 
(iii) A call for both samples of the dorsal aspect of the 3rdpp  
(iv) A call for both samples of the ventral aspect of the 3rdpp 
(v) signal intensity ratio ventral/dorsal 3rdpp more than 3 
(vi) signal intensity of more than 5 for both samples of the ventral aspect of the 3rdpp 
(vii) present call for both samples of the ventral aspect of the 3rdpp 
(viii) at least one of the samples of the dorsal aspect of the 3rdpp display a M or P call 
(ix) lowest value of the 90% confidence interval of the signal intensity ratio ventral/dorsal 
3rdpp more than 1.2 
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A Affymetrix       B dchip 
Figure 3.19. Microarray based analysis of differential gene expression among epithelial cells of the ventral and 
dorsal aspects of the 3rdpp using either the Affymetrix 5.0 (A) or the dchip 1.3 (B) software. The description of 
the different criteria which have been used to filter and to identify genes being either preferentially, exclusively or 
marginally expressed in the ventral circumference of the 3rdpp are described here above in Table 6. The numbers 
represented in each pool mention the numbers of probe sets identified when using the indicated criteria (combined or 
alone) whereas the numbers above the arrows represent the number of candidate genes taken subsequently for a 
verification by qRT-PCR. Indeed, many candidate genes (39 out of 140 genes) identified when using the Affymetrix 
software and the criteria I to VI or, alternatively, VII and VIII were also observed in the list of genes filtered with 
criterium IX of the dchip software. Nevertheless, 7 genes were only identified with the help of the criterium IX and 
were therefore added to the list of candidate genes retained for a verification by qRT-PCR of their differential 
expression. 
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Figure 3.20. Comparative between microarray (A) and the qRT-PCR (B) data analysing 147 candidate genes. 
Exclusive expression denotes genes that were found to be only expressed in the ventral but not in the dorsal 
epithelium of the 3rdpp. Absence of expression denotes the lack of expression as analysed by either microarray or 
qPCR in one or both of the tested samples from the dorsal and ventral epithelium, respectively. The number of genes 
in each category is represented in brackets. 
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Taken together, 147 candidate genes (Annex 1) were identified by the different filters (see Table 
3.6) applied to the microarray data set. Eighty-seven of these candidate genes were predicted by 
the microarray analysis to be exclusively expressed in the ventral aspect of the 3rdpp when 
compared to the dorsal circumference and 34 genes displayed an absence (A) of expression call 
in the dorsal and the ventral epithelium of the 3rdpp (see Fig.3.20A and Annex1). Twenty-two of 
the 147 candidate genes identified by the set of filters were predicted by the microarray analysis 
to have an increase in expression in the ventral epithelium when compared to its dorsal 
counterpart. This increase of expression corresponded for 3 (Bmp4, Tmem16A and an EST) of 
these 22 genes to an 5 to 10 fold and to an 3 to 5 fold for 9 others (Galnt3, Flrt3, Asah2, Bambi, 
Six1, Gata3, c-Myc and 2 two ESTs), see Fig.3.20A and Annex1 for details. The remaining ten 
genes (Lef1, Khdrbs3, Sema6d, Capn6, Hs2st1, Sh3glb1, Pcp4 and three ESTs) of these list of 22 
genes displayed an increase of 2 to 3 fold in their expression. Finally, 4 genes (Tnfrsf19, Tbx3, 
Gpm6b and Meox2), which were revealed by the differential analysis using the dchip1.3 software, 
had an increase lower than 2 when comparing ventral with dorsal epithelium(see Fig.3.20A and 
Annex1). 
 
The expression of these 147 candidate genes was next verified by qRT-PCR. This analysis 
confirmed 45 candidate genes (30%) to be truly differentially expressed with 12 of these present 
only in the ventral aspect of the 3rdpp (Fig.3.20B and Fig.3.21A). Two genes (Lmcd1 and Bmp4) 
in this list were at least 10 fold more abundant in the ventral aspect of the 3rdpp (see Fig.3.20B 
and Fig.3.21B), while transcripts for 7 genes (Fst, c-Myc, Tmem16A, Khdrbs3, Flrt3 and 2 ESTs) 
were expressed 5 to 10 fold more frequently in the ventral epithelium of the 3rdpp when compared 
to the dorsal aspects (see Fig.3.20B and Fig.3.21C). A 3 to 5 fold increase in the ventral epithelia 
was observed for 15  candidate genes (Bambi, Tnfrsf19, Galnt3, Tec, Msx2, Hs2st1, Tmem37 and 
5 ESTs) and an increase of 2 to 3 fold was noted for an other 9 candidate genes (Magel2, 
Sh3glb1, Srpk2, Tbx3, Meox2, Slc19a1, Sytl4, Csnk1d and an EST) as shown in Fig.3.20B and 
Fig.3.21D+E. 
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Figure 3.21. qRT-PCR analysis for 45 candidate genes identified to be specifically upregulated in ventral 
epithelia of the 3rdpp. A. Genes exclusively expressed in the ventral circumference. B-E Genes expressed 
preferentially in ventral epithelia with more than a 10 fold (B); with a 5-10 (C); with a 3-5 fold (D); and a 2-3 fold 
difference (E). Data are normalised to GAPDH expression. The ratio “gene of interest cDNA/ GAPDH cDNA” is the 
calculated difference in signal intensity between the gene of interest and GAPDH. The errors bars represent the 
difference in the calculated ratio between two samples generated independently. * indicates that the examined gene 
was only found to be expressed in one of two samples of the ventral aspect of the 3rdpp or the dorsal circumference 
of the 3rdpp for Lmcd1. 
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Table 3.7 lists the 47 genes confined by qRT-PCR to be differentially expressed and provides 
details as to their function as well as to their microarray and qRT-PCR data. It was noticed that 
among 34 genes predicted by the microarray analysis to have an absence of specific expression in 
neither the ventral or the dorsal epithelia of the 3rdpp, 4 candidate genes (Ebf1, CD6, CXCL13 and 
EST1) were only identified by qRT-PCR to be exclusively expressed in the ventral circumference 
of the 3rdpp. From the 87 candidate genes identified to be exclusively expressed in ventral 
epithelia by microarrays only 8 could be confirmed by qRT-PCR (Table 3.7). Nevertheless, 19 of 
those 87 candidate genes were revealed by qRT-PCR to have a preferential expression in the 
ventral circumference of the 3rdpp (Table 3.7). Taken together, qRT-PCR is more sensitive to 
identify differential gene expression among epithelia of the ventral vs. the dorsal aspect of the 
3rdpp than microarrays. 
 
Table 3.7 
Candidate genes differentially expressed in epithelia of the ventral aspect of the 3rdpp when compared to 
epithelia of the dorsal aspect of the 3rdpp as revealed by microarray and qRT-PCR analysis. 
 
Probe ID1 Gene name Gene 
Symbol 
Biological function D1 D3 V1 V3 Microarray 
ratio (3) 
qRT-PCR 
ratio (4) 
109403_at CD44 antigen CD44 Cell adhesion A2 A P2 P 7,76 Ex.V5 
104548_at Pleckstrin homology-like domain, 
family A, member 2 
Phlda2 Inhibitor of placental 
growth 
A A P A 2,09 Ex.V 
92943_at Glutamate receptor, ionotropic, AMPA1 
(alpha 1) 
Gria1 Glutamate transporter A A P M2 13,78 Ex.V 
94305_at Procollagen, type I, alpha 1 Col1a1 Cell adhesion A A M A 9,96 Ex.V 
114766_at Neurexin I Nrxn1 Calcium regulator A A P P 2,37 Ex.V 
101851_at CD200 antigen CD200 myeloid cell regulator A A P P 1,73 Ex.V 
92535_at Early B-cell factor 1 Ebf1 B-cell regulator A A A A 3,61 Ex.V 
163423_at Wnt inhibitory factor 1 Wif1 Wnt signalling inhibitor A A M A 3,65 Ex.V 
92203_s_at CD6 antigen CD6 T cell activator A A A A 8,93 Ex.V 
102025_at Chemokine (C-X-C motif) ligand 13 CXCL13 Chemotaxis A A A A 2,50 Ex.V 
137059_at EST EST1 Unknown A A A A 8,44 Ex.V 
101154_at EST EST2 Unknown A A P P 2,92 Ex.V 
117331_at LIM and cysteine-rich domains 1 Lmcd1 Inhibitor of Gata6 
activation 
A A A P 4,97 18,51 
93455_s_at Bone morphogenetic protein 4 Bmp4 Tgfb2 signalling P P P P 7,82 13,50 
98817_at Follistatin Fst Tgfb2 signalling inhibitor A A P P 10,40 9,71 
130608_at EST EST3 Unknown A A P A 2,42 8,00 
104712_at Myelocytomatosis oncogene c-Myc Transcription factor P P P P 3,01 5,60 
107112_at Transmembrane protein 16A Tmem16A Unknown A P P P 5,18 5,21 
164237_at KH domain containing, RNA binding, 
signal transduction associated 3 
Khdrbs3 Posttranscriptional 
regulation 
A A M M 2,21 5,13 
104066_at EST EST4 Unknown A A P M 2,51 5,10 
167905_f_at Fibronectin leucine rich transmembrane 
protein 3 
Flrt3 Modulator of Fgf-Mapk 
signalling 
P P P P 3,81 4,98 
162531_at Bmp and activin membrane-bound 
inhibitor, homolog (Xenopus laevis) 
Bambi Inhibitor of Tgfb2 
signalling 
P A P P 3,17 4,39 
135615_at EST EST5 Unknown A A P P 4,60 4,32 
160670_at Tumor necrosis factor receptor 
superfamily, member 19 
Tnfrsf19 Induces JNK pathway and 
NFKB signalling 
A P P P 1,95 4,32 
134352_at EST EST6 Unknown A A P P 10,76 4,01 
99011_at UDP-N-acetyl-alpha-D-
galactosamine:polypeptide N-
Galnt3 Involved in 
posttranslational 
P P P P 4,57 3,94 
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acetylgalactosaminyltransferase 3 modification 
103539_at Cytoplasmic tyrosine kinase, Dscr28C 
related (Drosophila) 
Tec Intracellular signalling A A P P 3,48 3,76 
168351_at EST EST7 Unknown A A P P 2,34 3,68 
116782_at EST EST8 Unknown P A P P 7,28 3,58 
102956_at Homeo box, msh-like 2 Msx2 Transcription factor A A P P 2,91 3,36 
117279_at EST EST9 Unknown A A P P 4,95 3,32 
102306_at Heparan sulfate 2-O-sulfotransferase 1 Hs2st1 Sulfotransferase activity P P P P 2,60 3,31 
95465_s_at Transmembrane protein 37 Tmem37 Calcium transporter A A P P 4,74 3,27 
133727_at Leucyl/cystinyl aminopeptidase Lnpep Protein metabolism A A P P 4,31 3,27 
110311_at Naked cuticle 1 homolog (Drosophila) Nkd1 Inhibitor of Wnt signalling A A A A 5,81 3,14 
104375_at Sparc/osteonectin, cwcv and kazal-like 
domains proteoglycan 2 
Spock2 Extracellular matrix A A P P 3,19 3,10 
136661_at EST EST10 Unknown A A A P 3,92 2,92 
92681_at Melanoma antigen, family L, 2 Magel2 Regulation of transcription A A P P 1,77 2,64 
103569_at SH3-domain GRB2-like B1 (endophilin) Sh3glb1 Inducer of apoptosis P P P P 2,52 2,45 
163582_at Serine/arginine-rich protein specific  
kinase 2 
Srpk2 Activator of apoptosis A A P P 2,11 2,33 
103538_at T-box 3 Tbx3 Transcription factor M A P P 1,73 2,08 
99937_at Mesenchyme homeobox 2 Meox2 Transcription factor P P P P 1,24 2,03 
94419_at Solute carrier family 19 
(sodium/hydrogen exchanger), member 
1 
Slc19a1 Folate carrier A A P P 2,70 2,01 
161026_s_at Synaptotagmin-like 4 Sytl4 Inhibitor of exocytosis A A P P 2,22 1,99 
97264_r_at Casein kinase 1, delta Csnk1d Modulator of the 
mammalian clock 
A A A A 4,64 1,87 
 
Explanations: (1) Probe ID refers to the Affymetrix reference number for a probe set specific for a given gene. (2) A; 
M and P denote absent, marginal and present calls, respectively. The ratio is defined as the average fold difference in 
signal intensity between two samples independently generated taken from the dorsal and the ventral epithelium of the 
3rdpp, as measured by qRT-PCR (4) or microarray analysis (3). Samples 1 and 2 of the dorsal and ventral aspects of 
the 3rdpp are annotated as D_1, D_2, V_1 and V_2, respectively. (5) Ex.V denotes that the gene was exclusively 
found to be expressed by qRT-PCR in the ventral epithelium of the 3rdpp. 
 
When re-screening the three different pools of genes differentially expressed i.e. marginal, 
preferential and exclusive expression in the ventral aspect of the 3rdpp (see Fig.3.19A), three 
genes involved in gene transcription, delta like 1 (Dlk1), transforming growth factor 2 and the 
forkhead protein G1 (FoxG1) and transforming growth factor beta 2 (Tgfβ2) were noticed. These 
3 genes, which demonstrated a clear increase of expression in the ventral circumference of the 
3rdpp (Fig.3.22) when compared to their dorsal counterpart, were indeed not in the list of the 47 
candidate genes verified by qRT-PCR but their differential expression was confirmed in an 
independent microarray analysis of the ventral and the dorsal aspect of the 3rdpp. 
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Figure 3.22. Perfect match (PM) versus Mismatch (MM) pattern for Dlk1, Tgfβ2 and FoxG1 in the dorsal and 
ventral aspect of the 3rdpp. These three genes reveal a considerable increase in the ventral aspect of the 3rdpp when 
compared to the dorsal counterpart. 
 
 
 
Finally, the gene for trans-acting transcription factor 8 (Sp8) appears to be up regulated in the 
ventral aspects of the 3rdpp as confirmed by qRT-PCR (Fig.3.23). Since more than 8000 mRNA 
sequences (including Sp8) are not represented in the MGU74v2 microarrays in comparison to the 
newly generated set of microarrays, consideration of Sp8 to play a possible role in early thymus 
development was based on the following data: (i) Sp8 is upstream of Fgf8 and downstream of 
Fgf10 during the development of the limb (Kawakami et al., 2004), and (ii) Fgf8 and Fgf10 are 
required for normal thymus development (Abu-Issa et al., 2002; Frank et al., 2002b; Revest et 
al., 2001b). Analysis by qRT-PCR for the expression of Sp8 but not Fgf8 and Fgf10 revealed 
respectively more abundant transcripts in the ventral aspect of the 3rdpp when compared to its 
dorsal counterpart (Fig.3.23).  
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Figure 3.23. Expression analysis by qRT-PCR for Sp8, Fgf8 and Fgf10 in the dorsal and ventral aspect of the 
3rdpp. Data are normalised to GAPDH expression. The ratio “gene of interest cDNA/ GAPDH cDNA” is the 
calculated difference in signal intensity between the gene of interest and GAPDH. The errors bars represent the 
difference in the calculated ratio between two independent samples generated independently. 
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3.3.2.4 Independent verification by qRT-PCR of some candidate genes 
 
Next, candidate genes were verified by qRT-PCR using samples taken from both the ventral and 
the dorsal aspects of the 3rdpp (newly generated). This analysis (Fig.3.24) confirmed the 
exclusive expression of FoxN1, WIF1 (antagonist of Wnt signalling), CD44 (Fig.3.24B) and 
CD200 (delivers an inhibitory signal for the macrophage lineage) (Fig.3.24A) in the ventral 
aspect of the 3rdpp. In contrast to previous analysis (Fig.3.21), Nrxn1 (Neurexin1, involved in 
cell-cell interaction) transcripts could also be detected in the dorsal aspect of the 3rdpp, albeit at 
very low concentrations (Fig.3.24A). This discrepancy was brought about by the low 
concentration of cDNA initially used as repeat experiments with a 15-fold higher concentration 
resulted in the marginal detection of Nrxn1  transcripts (data not shown). Differential expression 
was also noticed for Gcm2 (an internal control of the analysis), Ehox (embryonic homeobox 
gene), Lmcd1 (Lim and cysteine-rich domains 1) and Fst (Follistatin, a regulator of Bmp 
signalling) and c-Myc (an oncogene). In contrast, neither CD6 (involved in T-cell activation), 
Gria1 (Glutamate receptor) nor the two ESTs could be confirmed to be differentially expressed 
between the ventral and the dorsal aspects of the 3rdpp (data not shown). The absence of detection 
of these genes (CD6, Gria1 and the two ESTs) in the ventral aspect of the 3rdpp is most likely due 
to sensitivity issues since lower amounts of enriched or amplified cDNA was used for this qRT-
PCR analysis than in the previous analysis. In fact, a gel electrophoresis analysis used 
systematically in the purpose to verify the quality of the enriched cDNA by random PCR 
revealed that after 21 cycles of PCR for samples of this qRT-PCR (Batch3), the amount of 
amplified cDNA was considerable lower in comparison to samples of previous analysis (Batch1 
& 2) for an identical PCR cycling number (see 2.2.1.3 and Fig.2.1). In regard to Bmp4 
expression, this analysis in contrast to previous examinations (Fig.3.21) did not detect any Bmp4 
transcripts in the dorsal aspect of the 3rdpp (Fig.3.24B). This may also be due to the fact that less 
intake of cDNA has been used for this analysis than previously. Notably, this analysis revealed 
considerable much lower levels of expression for CD44 and Fst (Fig.3.24B) than observed in 
previous analysis (Fig.3.21). Taken together, these data show that most of the differential 
expression between the ventral and the dorsal aspect of the 3rdpp of the candidate genes examined 
can be verified independently, although the fold difference in level of expression can differ or the 
absence of detection can be noticed if lower amounts of enriched cDNA is used as template for 
PCR. 
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Figure 3.24. Expression analysis of candidate genes by qRT-PCR for a verification of their differential 
expression between the dorsal and ventral aspects of the 3rdpp. The cDNA used as template for the qPCR step 
has been previously enriched in particular for the genes examined by PCR using specific primers of these genes (A) 
or unspecifically by using random primers (decamers) (B), see material and method. Data are normalized to HPRT 
(A) and to GAPDH (B) expression. The ratio “gene of interest cDNA / GAPDH or HPRT cDNA” is the calculated 
difference in signal intensity. HPRT was used for the nested qPCR (A) instead of GAPDH because HPRT levels of 
expression are much lower than GAPDH. Hence for PCR cycling reasons the former one is more suited for the 
enrichment of the cDNA when using specific primers. 
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3.3.2.5 Expression of candidate genes in the 2nd, 3rd and 4thpp 
 
Next, the expression of the candidate genes CD44, WIF1, Phlada2, Nrxn1, Sp8, Bmp4, Fst, c-
Myc and Flrt3 was examined for the 2nd, 3rd and 4thpp by qRT-PCR (see Fig.3.25). Of these 
candidates, only WIF1 was exclusively detected in the 3rdpp while the others displayed variable 
expression levels also in 2ndpp and 4thpp. For example, CD44 was more abundantly expressed in 
the 2ndpp when compared to the 3rdpp and could be detected in the 4thpp. The expression of Bmp4, 
an agonistic ligand for the Tgfβ2 signaling appears to progressively increase in its expression 
from the 2ndpp caudally to the 4thpp, whereas Fst, an inhibitor of Tgfβ2 signalling, displayed a 
gradient in this area, which was highest at the 2thpp. The concentration of Sp8 and Flrt3 specific 
transcripts were not much different in all 3 pharyngeal pouches examined. 
 
Figure 3.25. qRT-PCR analysis for the expression at E10.5 in the 2nd, 3rd and 4thpp for several candidate genes 
identified by microarray as being differentially expressed between the dorsal and ventral domains of the 
3rdpp. Approximately 1000 cells were isolated by LCM from coronal sections for an RNA extraction of the 2nd, 3rd 
and 4thpp. Data have been normalized to GAPDH. The ratio “gene of interest cDNA / GAPDH cDNA is the 
calculated difference in signal intensity between the examined gene and GAPDH. 
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3.3.2.6 Verification by Immunohistochemistry (IHC) the upregulation of some confirmed 
candidate genes 
 
The differential expression of the candidate genes CD44, WIF1, Phlda2, Fst was next assessed at 
the protein level by histochemistry (IHC). 
 
 
CD44: 
 
The IHC analysis confirmed at the protein level the expression pattern of CD44 to be restricted to 
the 3rdpp and the 2ndpp. Moreover, CD44 could only be detected in the ventral aspects of the 3rdpp 
(Fig3.26 A&B). Since CD44 expression occurs in different splice forms, we next investigated 
wether the CD44 variants typically expressed in keratinocytes and thymic epithelial cells i.e 
CD44v.6 and CD44v10 were detected at E10.5 within the area of the 3rdpp (Fig.3.26 C&D), 
which gives already rise to the thymus (Ponta et al., 2003). In fact, CD44v10 demonstrated a role 
in the emigration of mature thymocytes in the thymus (Esser et al., 2004). IHC revealed that both 
splice variants of CD44 could be easily detected in the ventral aspects of the 3rdpp but absent 
from the 2ndpp (Fig.3.26 C&D and data not shown). 
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Figure 3.26. Pharyngeal expression of CD44 and the splice variants CD44v6 and CD44v10 at E10.5. Common 
CD44 expression (A: 10x magnification, B: 40x magnification). Expression of CD44v6 (C) and CD44v10 (D). 
Ventral is left and dorsal is at the right, anterior is up and posterior is down in each figure. BaIII &  BaIV indicate the 
branchial arches III & IV, respectively. The arrows point respectively to the respective 2ndpp (2pp) and 3rdpp (3pp). 
 
 
 
 
WIF1(Wnt inhibitor factor 1): 
 
The IHC analysis for WIF1 on E10.5s confirmed the upregulation of WIF1 expression in the 
ventral aspect of the 3rdpp (Fig.3.27). Moreover, WIF1 was preferentially expressed there in the 
posterior aspect of the ventral aspect. In contrast to the qRT-PCR analysis (Fig.3.25), WIF1 
expression was also detected by IHC in the 2ndpp and 4thpp as well as the surrounding 
mesodermal cells. The pattern of WIF1 also changed between E10.5 and E12.5. At E11.5, WIF1 
was expressed in the entire 3rdpp, and at E12.5 WIF1 protein was only detected in some of the 
thymic epithelial cells of the thymus primordium (Fig.3.27). 
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Figure 3.27. Pharyngeal WIF1 expression during early thymus development. WIF1 expression at E10.5 (A: 
magnification 20x, B: magnification 40x) and at E11.5 (C: magnification 40x). WIF1 expression at E12.5 on sagital 
sections of the thymus (D). Ventral is on the left and dorsal on the right, anterior is up and posterior is down of the 
respective images. BaIII &  BaIV indicate the branchial arches III & IV, respectively. The arrows point respectively 
to the respective 2ndpp (2pp), 3rdpp (3pp) and 4thpp (4pp). 
 
 
Phlda2: 
 
Phlda2 (Pleckstrin homology-like domain, family A, member 2) also known as Imprinted, 
placenta and liver gene, IPL; or Tumor suppressor cDNA3, Tssc3 was expressed at E10.5 in the 
endodermal lining of the 2ndpp, 3rdpp and 4thpp but not in the adjacent mesoderm and branchial 
clefts as predicted by the qRT-PCR analysis (Fig.3.25). However, an exclusive expression of 
Phlda2 in the ventral aspect of the 3rdpp, as suggested from the qRT-PCR analysis could not be 
confirmed by IHC as revealed by Fig.3.28. Again, a preferential expression for Phlda2 in the 
posterior part of the ventral aspect of the 3rdpp was observed (see Fig.3.28). 
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Figure 3.28. Pharyngeal Phlda2 expression during early thymus development. Phlda2 expression at E10.5 (A: 
magnification 20x, B: magnification 40x). Ventral is on the bottom and dorsal is up, posterior is on the left and 
anterior is on the right of the respective images. BaIII &  BaIV indicate the branchial arches III & IV, respectively. 
The arrows point respectively to the respective 2ndpp (2pp), 3rdpp (3pp) and 4thpp (4pp). 
 
 
 
 
 
 
 
 
 
 
Fst (Follistatin): 
 
The investigation of Fst expression on E10.5s (Fig.3.29), revealed that Fst was expressed 
throughout the entire pharyngeal region albeit at a lesser degree in the mesenchyme. A particular 
emphesis in expression was noticed for the entire 3rdpp but a differential pattern between the 
dorsal and ventral aspects could not be appreciated. Althought in contrast to the qRT-PCR data 
(Fig.3.21), analysis of Fst protein concentrations by IHC may just not be sensitive enough to 
uncover a difference of 5-fold. This explanation also holds true for the lack of a Fst gradient 
between the 2ndpp and 4thpp. An expression pattern similar to that at E10.5 was also noted for Fst 
at E11.5 (Fig.3.29). 
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Figure 3.29. Pharyngeal Fst expression during early thymus development. Fst expression at E10.5 (A: 
magnification 20x, B: magnification 40x) and at E11.5 (C: magnification 20x, D: magnification 40x). Ventral is on 
the left and dorsal on the right, anterior is up and posterior is down of the respective images. BaIII &  BaIV indicate 
the branchial arches III & IV, respectively. The arrows point respectively to the respective 2ndpp (2pp) and 3rdpp 
(3pp). 
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Sp8 (trans-acting transcription factor 8): 
 
The expression pattern for Sp8 was inspected in detail by taking advantage of mice where LacZ 
(β-galactosidase) was knocked-in to its locus (Treichel et al., 2003). As antibodies specific for 
Sp8 are not available, an lacZ staining as well as an IHC for LacZ on E10.5 tissue sections from 
such homozygous mice (kindly provided by Dr. Mansouri) could not detect any signals in the 
pharyngeal region (Fig.3.30). The strong staining of LacZ in the posterior region of the brain and 
in the somites (Fig.3.30) are in agreement with previous reports (Treichel et al., 2003). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.30. Pharyngeal Sp8 expression during early thymus development. Sp8 expression at E10.5 in 
homozygous mice deficient for Sp8 by lacZ staining (A: magnification 10x, B: magnification 20x) and by IHC for β-
galactosidase (C: magnification 10x, D: magnification 20x). Ventral is on the left and dorsal on the right, anterior is 
up and posterior is down of the respective images. BaIII &  BaIV indicate the branchial arches III & IV, respectively. 
The arrows point respectively to the respective 2ndpp (2pp) and 3rdpp (3pp). 
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3.3.2.7 Nrxn1 expression in the common thymus-parathyroid primordium at E10.5 and in 
E12.5 thymus 
 
The spatial expression Nrxn1 was detailed by in situ hybridization (ISH) as specific antibodies 
are not available for this gene product. As demonstrated in Fig.3.31A, Nrxn1-specfic transcripts 
could be detected throughout the 3rdpp providing an expression profile different from that 
expected from the qRT-PCR data (compare to Fig.3.24). The reason for this discrepancy remains 
unknown. At E12.5, Nrxn1 expression was robustly expressed throughout the thymus 
(Fig.3.31B). As this Nrxn1 expression appears to be common to all cells of the thymus at that 
stage, this finding would suggests that Nrxn1 is also expressed in immature thymocytes. In 
agreement with this data is the observation that Nrxn1 was also found to be expressed by qRT-
PCR in adult thymocytes (see section 3.2.2.12). 
 
 
 
Figure 3.31. ISH analysis for Nrxn1 in the common thymus-parathyroid primordium. A) Expression of Nrxn1 
in the 3rdpp at E10.5, magnification (40x). B) expression of Nrxn1 in the thymus at E12.5 magnification (10x). BaIII 
and BaIV stand respectively for third and fourth branchial arches. Anterior is at the botton, posterior at the top, 
dorsal is left and ventral is right. 
 
3.3.2.8 Expression of Nrxn1 isoforms in the ventral aspect of the 3rdpp 
 
In humans, the Nrxn1 gene generates two separate transcripts, α-Nrxn1 (~9kb) and β-Nrxn1 
(~5.3kb) from two different promoters as described (Rowen et al., 2002). Sequence comparisons 
at the genomic and at the RNA level in silico for mouse Nrxn1 revealed that it contains 24 exons. 
Twenty-three of those (exons 1-17 and 19-24) are used for the α-Nrxn1 transcript and 7 (exon 18-
24) for the β-transcript. Thus, exon 18 is specific for β-transcripts whereas the first 17 exons are 
specific for α-Nrxn1. To detail a differential expression, specific primers for α-Nrxn1 (exon16) 
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and for β-Nrxn1 (exon 18) transcripts, were chosen for a qRT-PCR analysis. This analysis 
revealed that β-Nrxn1 but not α-Nrxn1 transcripts are expressed in the ventral aspect of the 3rdpp 
(Fig.3.32). In contrast, α-Nrxn1 but not β-Nrxn1 could be detected in adult thymic tissue 
(Fig.3.32). 
 
 
Figure 3.32. Differential expression of Nrxn1 isoforms. The qRT-PCR each was designed for single exon specific 
amplification to identify α-Nrxn1 (exon16), β-Nrxn1 (exon18) and both isoforms (exon19). Number in brackets 
indicate approximately the number of kilo base pairs separating the PCR amplicon from the polyA tail of Nrxn1. 
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3.3.2.9 Expression of candidate genes during thymus development 
 
The thymic expression of Nrnx1,WIF1, Bmp4, Fst, c-myc, Phlda2, Sp8 and Flrt3 was next 
examined by qRT-PCR at E10.5, E12.5, E16.5, E18.5 and in adult mice and compared to the 
level of FoxN1expression (Fig.3.33). At E10.5, Nrxn1 and FoxN1 expression were comparable 
while at E12.5 and beyond the expression level of FoxN1 was always considerably higher than of 
Nrxn1, although in contrast to FoxN1, Nrxn1 transcripts have also been detected in thymocytes 
(Fig.3.34). The thymic expression of WIF1 which has not been detected in adult thymocytes but 
in primary TECs (Fig.3.34) was always detected at lower levels than FoxN1 and declined 
progressively between E12.5 and E18.5 at much higher rates than FoxN1. In contrast, the thymic 
expression of Flrt3, also not found to be expressed in adult thymocytes but in primary TECs, 
(Fig.3.34) was noticed at higher levels than FoxN1 between E10.5 and E16.5, while at 
comparable levels than FoxN1 beyond E18.5. 
 
Figure 3.33. Thymic expression analysis by qRT-PCR for some candidate genes at different embryonal stages 
of development and in adult mice. The extracted tissue at E10.5 (ventral aspect of the 3rdpp) and at E12.5 has been 
extracted by LCM while at other stages of development unseparated thymus have been removed with the help of 
forcepts. Data are normalized to GAPDH. The ratio “gene of interest cDNA/ GAPDH cDNA is the calculated 
difference in signal intensity. 
 
 
In regard to the thymic expression of Bmp4 and Phlda2, although the transcripts of these genes 
were detected in thymocytes (Fig.3.34), their thymic expression was detected at considerable 
higher levels at early stages of development (E10.5 to E12.5) than at E18.5 or in adult mice. In 
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contrast, the thymic expression of Fst and c-Myc also detected in thymocytes (Fig.3.34) was 
found to be at comparable levels of expression during development. 
 
3.3.2.10 Expression of candidate genes in adult thymic epithelial cells and thymocytes 
 
To assess the expression of Nrxn1, WIF1, Bmp4, Fst, c-myc, Phlda2 and Flrt3 adult thymic 
tissue, we next analysed by qRT-PCR MTS24+ and MTS24- primary adult TECs, unseparated 
thymocytes and single positive thymocytes (Fig.3.34). WIF1 was expressed in adult primary 
sorted TECs but only in those devoided of MTS24 expression. Fst was more abundantly 
expressed in MTS24+ TECs when compared to MTS24- TECs. In contrast, transcripts for Nrxn1, 
Phlda2 and Flrt3 were more numerous in MTS24- TECs (Fig.3.34).  
 
 
Figure 3.34. Expression of candidate genes by qRT-PCR in different cellular compartments of the adult 
thymus. Data are normalized to GAPDH. The ratio “gene of interest cDNA / GAPDH cDNA is the calculated 
difference in signal intensity. 
 
Among unseparated adult thymocytes, WIF1 and Flrt3 could not be detected. Nrxn1 and Phlda2 
were typically expressed in immature thymocytes only, while Bmp4, Fst and c-Myc transcripts 
were found in both mature and immature thymocytes. Attemting to quantify the expression of the 
different candidate genes in separate cell types, Nrxn1 appeared to be more abundantly expressed 
in TECs than in thymocytes, while Bmp4 and Phlda2 levels were higher in thymocytes. In 
contrast, Fst and c-Myc appeared to be at comparable levels of expression. 
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3.3.2.11 Expression of candidate genes in thymic epithelial cell lines 
 
The expression of Nrxn1, WIF1, Bmp4, Fst, c-myc, Phlda2 and Flrt3 candidate genes was also 
examined in established cortical (c) and medullary (m) TEC cell lines (Fig.3.35). While Fst, c-
myc, Phlda2 and Flrt3 could be detected in all cell lines tested, Nrnx1, WIF1 and Bmp4 were 
differentially expressed among these cells lines. Nrxn1 and WIF1 were found to be present only 
in cTECs with the latter not detected in some of the cortical TECs. 
 
 
Figure 3.35. Expression of some candidate genes in different established TEC cell lines. Data have been 
normalized to GAPDH. The ratio gene of interest / GAPDH cDNA is the calculated difference in signal intensity 
between the examined gene and GAPDH. 
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3.3.2.12 Expression of candidate genes in embryonal and adult tissues 
 
 The expression of Nrxn1, WIF1, Bmp4, Fst, Phlda2, Sp8 as well as the two candidate ESTs 
(Affymetrix ID: 137059_at and 101154_at) were next analysed by conventional RT-PCR in 
different organs of embryonic E16.5 (Fig.3.36) and in adult mice (Fig.3.37). Nrxn1, Bmp4 and 
Fst could be detected almost in all tissues examined at E16.5 and in adult mice, ableit at different 
concentrations (Fig.3.36 and Fig.3.37). In contrast, WIF1, Phlda2, Sp8 and the two ESTs were 
found to have a more restricted pattern of expression at E16.5 and in adult mice with the notable 
expression of EST1 which has not been detected in any of the tissues analysed at E16.5. In regard 
to WIF1 and Sp8, the thymic expression of these genes was not detected at E16.5 and in adult 
mice by this RT-PCR for sensitive issues since their thymic expression could be detected by 
qRT-PCR, although at very low levels in E16.5s as well as in adult mice (Fig.3.33 and results not 
shown). 
 
 
Figure 3.36. Expression of candidates genes in E16.5 mouse tissues.. RT-PCR analysis of RNA from kidney (K), 
heart (H), brain (B), gut (G), skin (S), liver (Li), lung (Lu), thymus (T) and Limb (Lb).  
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Importantly, it may appear that certain PCR products were revealed to have migrated longer 
during the eletrophoresis than others for given genes (e.g WIF1 and EST2 in Fig.37). Hence, 
these short PCR products (lowest in the electrophoresis gel) are most likely primer-dimers and 
indeed in such a case, the specific PCR products are than the clear upper ones in the gel. 
 
 
 
 
Figure 3.37. Expression of candidates genes in adult mouse tissues. RT-PCR analysis of RNA from liver (Li), 
kidney (K), salivary glands (Sg), mammary glands (Mg), testis (Te), lung (Lu), skin (Sk), muscle (Mu), heart (H), 
small and large gut (G), brain (Br), thymus (Th), bone marrow (Bm), spleen (Sp) and lymph node (Ln). 
 
 
 
 
 
 
 
3.3.2.13 Extension of EST mRNA sequences 
 
To detail the two candidate ESTs (EST1 and EST2) further, full length cloning and sequencing 
was carried out using 5’ and 3’ rapid amplification of cDNA ends (RACE) methods. This 
provided for EST1 a sequence of 1444 bp, which, however does not yet represent the full length 
message. The poly-A tail of that sequence is placed right at its 3’end (Fig.3.38). The sequence 
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obtained for EST2 using 3’ and 5’ RACE spanned 1065 bp including the polyA signal (Fig.3.39). 
Sequence and alignment analysis for EST1 indidated that this gene belongs to the gene cluster of 
the ATP-binding cassette MHCI transporter (TAP1) situated on the mouse chromosome 17. In 
fact, EST1 5’ and 3’ extended sequence encodes for the full peptide sequence of the ATP-binding 
cassette of the TAP1 transporter. In addition, this analysis revealed that the very 5' end of EST1 
mRNA sequence matches to the beginning of exon 7 of TAP1 (TAP1 encodes 11 exons). In 
contrast to TAP1 which has its polyA tail at the 3’end of exon11, EST1 has its polyA tail 
dowstream of exon 10 (597 bp) in intron10 of TAP1, which is indeed located 5’of exon 11 of 
TAP1. Ten different clones of EST1 have confirmed these findings which show that EST1 in 
contrast to TAP1 does not take usage of exon11 and splices differentially its exon10. The 
sequence analysis demonstrated that EST2 is located on chromosome 3 but appears to represent a 
novel, yet not already defined gene transcript. An open reading frame analysis for the so far 
established sequences for EST1 and EST2 predicts a 88 and a 42 amino acid sequence length, 
respectively, suggesting further that parts of the complete sequence are still missing. 
 
 
 
Figure 3.38. Part of the mRNA sequence for EST1. The polyA tail of EST1 is beginning at position1444. The 
Affymetrix Genechip source sequence (public database ID: AA267973) of EST1 is outlined in pink whereas the rest 
of the sequence has been revealed by 5’ and 3’ RACE methods. 
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Figure 3.39. Part of the mRNA sequence for EST2. The polyA tail of EST2 is beginning at position1444. The 
Affymetrix Genechip source sequence (public database ID: AA517023) of EST2 is outlined in turqoise. pink whereas 
the rest of the sequence has been revealed by the 5’ RACE method. 
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3.3.2.14 Effect of WIF1 on thymopoeisis in fetal thymic organ culture 
 
Next, a potential role of WIF1 in thymopoesis was assessed using E13.5 FTOC. Thymic lobes 
were treated in vitro for 10 days with affinity purified human WIF1-IgG (2,10 and 20 mg/ml), a 
fusion protein composed of the human IgG heavy-chain and the hWIF1 full lengh. In fact, hWIF1 
displays at the cDNA level 93% homology to its mouse orthologue. This fusion protein has been 
demonstrated to be biologically active as it could inhibit Wingless signaling in vitro (Hsieh et al., 
1999). Control FTOCs were incubated with affinity purified human IgG at the concentration of 
20mg/ml. Moreover, FTOCs were also cultured either in FTOC media (IMDM media with 10% 
FCS) without any supplementation, or in the presence of Bmp4 at the concentration of 100ng/ml 
to expand immature thymocytes (Hager-Theodorides et al., 2002). After 10 days in culture, 
thymocytes were harvested, measured for their cellularity, stained for the surface expression of 
CD44/CD25 and CD4/CD8, and analysed by flow cytometry. The thymocyte cellularity of these 
FTOCs has revealed that in the presence of the lowest concentration of WIF1 (2µg/ml), FTOCs 
was at considerable higher values (3.5x105 cells) than control FTOC (2.5x105 cells). In contrast, 
the cellularity of thymocytes (approx 2.5 x105 cells) in the presence of 10µg/ml of hWIF-IgG was 
comparable to control FTOC (hIgG), while in the presence of 20µg/ml of hWIF-IgG, this 
cellularity was considerable lower (1.5x105 cells) than control FTOCs (hIgG) (see Fig.3.40A). To 
purify hWIF-IgG, a pH of 2.9 was required for elution from the column, which may have altered 
the biological activity of the fusion protein. FTOCs were therefore grown alternatively in freshly 
conditioned media from hWIF1-IgG transfected HEK293 cells. As controls, FTOCs were 
cultured in media supplemented with either conditioned media for hIgG transfected HEK293 
cells, with Bmp4 (100ng(ml), or no further additions. In fact, FTOCs were incubated in different 
dilutions of the conditioned media (dilution factor of 2,4 or 8 with FTOC media) for hWIF-IgG 
or for hIgG (Fig.3.40B). 
155 
 
 
Figure 3.40. FTOC cellularity following culture with WIF1. A FTOCs were incubated in the presence of affinity 
purified human WIF-1-IgG (hWIF 2,10 or 20µg/ml). Control FTOCs were incubated in the presence of affinity 
purified human IgG (hIgG 20µg/ml), of PBS (10µl, volume of affinity purified hWIF1-IgG or hIgG), or of Bmp4 
(100ng/ml). B FTOCs were incubated in conditioned media for hWIF1-IgG (hWIF: diluted with FTOC media with a 
dilution factor of 2, 4, or 8). Control FTOCs were incubated in conditioned media for human IgG (hIgG: diluted 2,4 
or 8 times with FTOC media). For (A) and (B), 6 thymic lobes were pooled for each analysis. If error bars are 
displayed than samples have been made in duplicates and error bars show the difference between these samples. 
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Similarly, as FTOCs treated with hWIF-IgG (2µg/ml), the thymocyte cellularity was higher than 
control FTOC (3x105 cells) if the conditioned media was diluted with FTOC media for a dilution 
factor of more than 2 (above 3x105 cells) (see Fig.3.40B). In contrast, as previously observed in 
FTOCs treated with too high concentrations of affinity purified hWIF-IgG (Fig.3.40A), the 
thymocyte cellularity of these FTOCs in the presence of conditioned media for hWIF1-IgG 
(dilution factor equal to 2) was lower (1.5x105 cells) than the control FTOC (approx 2.5x105 
cells). These observations could be due to toxic effects on FTOC by WIF1 at too high 
concentrations. Nevertheless, since FTOCs in the presence of affinity purified hWIF1-IgG or of 
conditioned media for hWIF1-IgG reveal similar data, the affinity purification at pH 2.9 of 
hWIF1-IgG does not seem to have altered the biological activity of WIF1. Taken together, these 
FTOC data (Fig.3.40 A&B) reveal that WIF1 may stimulate the expansion of immature 
thymocytes. However, the analysis for CD44/CD25 and CD4/CD8 surface expression of FTOCs 
treated with affinity purified of hWIF-IgG (Fig.3.41) or with conditioned media for hWIF-IgG 
(Fig.3.42) does not seem to have altered the normal development of thymocytes, as SP 
thymocytes (CD4+CD8-) and (CD4-CD8+) were generated in proportions comparable to control 
FTOC (hIgG). Nevertheless, the analysis for CD44/CD25 surface expression revealed that 
FTOCs in the presence of increasing amounts of affinity purified hWIF-IgG (Fig.3.41A) seem to 
have the tendency to accumulate the subpopulation of DN1 (CD44+CD25-) thymocytes (36.6%, 
42.9% and 46.5%) and seem to have a concurrent decrease of DN4 (CD44-CD25-) thymocytes 
(23.9%, 15.8% and 12.7%). These observations could not be noticed in FTOCs incubated in 
conditioned media for hWIF-IgG (Fig.3.42A). Anyway, these observations do not seem to be 
biologically significant as DN2, DN3 as well as DN (CD4-CD8-), DP (CD4+CD8+) and SP 
(CD4+CD8- or CD4-CD8+) thymocytes were noticed at comparable proportions than in the control 
FTOC (hIgG) (see Fig.3.41). In summary, these data suggest that overexpressing WIF1 does not 
affect the differentiation of thymocytes, however, loss of function analysis using neutralizing 
antibodies for WIF1 in FTOC may in contrast to these FTOCs eventually reveal more defined 
roles for WIF1 in the development of thymocytes.  
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Figure 3.41. Thymopoesis in FTOCs in the presence of affinity purified hWIF1-IgG. Flow cytometrix analysis 
for the cell surface expression of CD44/CD25 among TN thymocytes (A) and CD4/CD8 among all thymocytes (B). 
FTOCs were incubated in the presence of human WIF1-IgG (hWIF: 2,10 or 20mg/ml). Control FTOCs were 
incubated in the presence of human IgG (20mg/ml), of PBS (10ml, volume of affinity purified hWIF1-IgG) or of 
Bmp4 (100ng/ml). 6 thymic lobes were pooled for each analysis. If error bars are displayed than samples have been 
made in duplicates (generated independently) and error bars show the difference between these samples. 
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Figure 3.42. Thymopoesis in FTOCs in the presence of conditioned media for hWIF1-IgG. Flow cytometrix 
analysis for the cell surface expression of CD44/CD25 among TN thymocytes (A) and CD4/CD8 among all 
thymocytes (B). FTOCs were incubated in conditioned media for human WIF1-IgG (diluted with FTOC media at a 
dilution factor of 2, 4 or 8). Control FTOCs were incubated in conditioned media for human IgG (diluted with FTOC 
media at a dilution factor of 2,4 or 8), in FTOC media (IMDM with 10% FCS), or in FTOC media with a 
supplementation of Bmp4 (100ng/ml). 6 thymic lobes were pooled for each analysis. If error bars are displayed than 
samples have been made in duplicates (generated independently) and error bars show the difference between these 
samples. 
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In contrast, FTOC cultures in presence of Bmp4 (100ng/ml) demonstrated an accumulation of 
DN1 (CD44+CD25-) thymocytes and a concurrent decrease of DN3 and DN4 thymocytes 
indicating an initial block in early thymocyte differentiation. Notably, overexpressing Bmp4 (see 
Fig.3.41 and Fig.3.42) appears to favour differentiation of DP thymocytes (CD4+CD8+) into 
CD8+ SP cells (proportion above 20%) rather than into CD4+ SP cells (proportion below 10%). 
This is in contrast to control FTOC, which favoured a differentiation into CD4+ SP cells 
corresponding to approximately 10% for CD8+ SP cells and to 15-20% for CD4+ SP cells). 
Hence, these data could suggest that Bmp4 signalling may have also have a role in the 
differentiation of DP (CD4+CD8+) into CD8+ SP thymocytes. However, these observations are 
most likely not biologically significant, as the FTOC treated with Bmp4 affected drastically the 
cellularity of thymocytes (1x105 cells) in comparison to the control FTOC (2.5x105 cells). 
Nevertheless, these data confirm previous reports on the effect of overexpressing Bmp4 in 
FTOCs in regard to the initial block in early thymocyte differentiation (Hager-Theodorides et al., 
2002; Tsai et al., 2003). 
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3.3.2.15 Confocal analysis of E13 thymus of Phlda2 deficient mice 
 
To reveal an eventual role for the Phlda2 candidate gene in early thymic organogenesis by IHC, 
the thymic expression of the TEC markers K5 and K8 and the expression of CD45 was 
investigated in E13.5 embryos deficient for Phlda2. However, the confocal analysis (see Fig.3.43) 
did not reveal any differences in the expression of these three markers (K5, K8 and CD45) when 
comparing thymic tissue from Phlda2 deficient and wild type mice. The thymus from Phlda2 
deficient embryos appeared to be about twice in size in comparison to that of wild type. These 
data suggest that Phlda2 does not seem to have a non-redundant role in the early differentiation of 
thymic epithelial cells. However, Phlda2 may modulate the expansion of the thymic epithelium, 
as E13.5 embryos deficient for Phlda2 appeared to have a bigger thymus than that of wild type in 
this analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.43. IHC analysis of the thymus in a Phlda2 deficient E13.5. The expression of K5 (red), K8 (green) and 
CD45 (blue) was analysed on thymic sections from E13.5 wild type (A) and Phlda2 deficient (B) littermates. 
 
A B 
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3.3.2.16 Genes confirmed to be preferentially expressed in the dorsal aspect of the 3rdpp 
 
The absence in the expression of a specific gene may also contribute to the cellular fate of a 
specific tissue. I therefore investigated which genes by microarray analysis are either 
preferentially or exclusively expressed in the dorsal aspects of the 3rdpp when compared to the 
ventral circumference and I next verified their differential expression by qRT-PCR. This analysis 
revealed that FoxA1, FoxA2, Sfrp2 and CXCL12 are in addition to Gcm2 upregulated more than 
4-fold in the dorsal part of the 3rdpp when analysed by qRT-PCR (Table 3.8 and Fig.3.44). In 
addition, Tbx1 (which is not represented on MGU74v2 microarrays) was also upregulated at this 
anatomical site. 
 
 
Table 3.8 
Genes preferentially expressed in the dorsal aspect of the 3rdpp as analysed by microarrays and qRT-PCR. 
 
Probe ID1 Gene name Gene  
Symbol 
Biological function  D_1 D_2 V_1 V_2 Microarray  
Ratio (4) 
qRT-PCR  
ratio (5) 
 T-box 1 Tbx1 Transcription factor      4.8 
92697_at Forkhead box A1 FoxA1 Transcription factor P3 P P P 3.98 8.4 
93950_at Forkhead box A2 FoxA2 Transcription factor A2 A A A 7,17 4.0 
93503_at Soluble frizzled related 
protein 2 
Sfrp2 Inhibitor of Wnt signalling P P P P 9.14 15.5 
162234_f_at Chemokine (C-X-C motif) 
ligand 12 
CXCL12 Chemotaxis P P P P 3.83 5.5 
 
Explanations: (1) Probe ID refers to the Affymetrix reference number for a probe set specific for a given gene. (2) 
A= absent, (3) P=present. (4) Microarray ratio is calculated as average intensity 3rdpp/ average intensity 2ndpp and (5) 
qRT-PCR ratio is calculated as 2^(average ΔCt 2ndpp)- (average ΔCt 3rdpp)) where the ΔCt is the difference in Ct 
values between the gene of interest and the housekeeping gene, GAPDH. Samples of the 2ndpp and 3rdpp are 
annotated as 2_1, 2_2, 3_1 and 3_2, respectively. 
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Figure 3.44. Preferential expression of Tbx1, FoxA1, FoxA2, Sfrp2 and CXCL12 in the dorsal aspect of the 
3rdpp in comparison to its expression in its ventral counterpart as measured by qRT-PCR. Data has been 
normalised to GAPDH expression. The ratio “gene of interest cDNA / GAPDH cDNA” corresponds to the calculated 
difference in signal intensity between the examined gene and GAPDH. The errors bars represent the difference in the 
calculated ratio between two samples generated independently.* FoxA2 was only found to be expressed in one of 
two samples of the ventral aspect of the 3rdpp. 
 
3.3.2.17 Expression of candidates genes in the 4thpp 
 
Numerous important genes involved in thymus and parathyroid development such as (Pax1, 
Pax9, Hoxa3 and Shh) were also found to be expressed in the 2nd and 4thpp but rarely found to be 
exclusively expressed in the 3rdpp as FoxN1 or Gcm2. I therefore investigated by microarray 
analysis whether candidate genes revealed to be upregulated or exclusively expressed in either 
the ventral aspect of the 3rdpp when compared to the dorsal circumference, or upregulated in the 
entire 3rdpp when compared to the 2ndpp, are also expressed in the 4thpp. This analysis revealed 
that 22 of the candidate genes were also found to be expressed in the 2ndpp and/or the 4thpp, while 
15 candidate genes (CCL21, Meox2, Msx2, Phlda2, Gria1, Cd6, CD44, WIF1,c-Myc, Fst, 
Lmcd1, Tnfrsf19, Colla1 and the two ESTs) were revealed to be only expressed in the 3rdpp of 
the pharyngeal pouch when compared to the 2ndpp and 4rdpp (see Table 3.9). However, Phlda2, 
Fst could be detected in the 4thpp by qRT-PCR (Fig.3.25) although at very low levels, possibly 
explaining the absence of detection of these two genes by microarray analysis. 
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Table 3.9  
Microarray expression data in the 4thpp for 37 genes confirmed by qRT-PCR to be differentially expressed 
between either the 2nd and the 3rdpp or within the 3rdpp. 
 
Probe ID1 Gene 
Symbol 
 
D_1 
 
D_2 
 
V_1 
 
V_2 
 
 
3_1 
 
3_2 
 
2_1 
 
2_2 
 
4_1 
 
4_2 
 
4_3 
Microarray 
V/D 
Ratio (3) 
Microarray  
3/2 
ratio (4) 
103012_at CCL21 A2 M2 M P2 P P A A A A A 1,13 62,90 
162234_f_at CXCL12 P P P P A P P A P P P 0,26 0,50 
102025_at CXCL13 A A A A A A A A A A A 2,50 1,21 
114280_at Ypel1 P P P P P P A A P P P 1,37 12,22 
165740_at Dmrt2 P P P P P P A A M P P 1,09 19,20 
100899_s_at Znf297 P P P P P P A A A A P 1,09 8,09 
99937_at Meox2 P P P P P P A A A A A 1,24 18,17 
165776_i_at Klf16 P A P M P P A A A A P 2,35 15,96 
102956_at Msx2 A A P P A A A A A A A 2,91 1,50 
92535_at Ebf1 A A A A P A A A A P A 3,61 12,08 
104548_at Phlda2 A A P A A P A A A A A 2,09 2,58 
92943_at Gria1 A A P M A A A A A A A 13,78 1,08 
92203_s_at CD6 A A A A A A A A A A A 8,93 3,27 
109403_at CD44 A A P P P A P A A A A 7,76 1,38 
101851_at CD200 A A P P P A P A A A M 1,73 0,95 
138087_at Fgf12 P A P A P P A A A A A 1,22 7,41 
110370_at Flrt3 P P P P P A P P P P P 6,28 4,56 
163423_at WIF1 A A M A A A A A A A A 3,65 0,21 
93455_s_at Bmp4 P P P P P P P P P P P 7,82 1,92 
98817_at Fst A A P P A A A A A A A 10,40 5,55 
162531_at Bambi P A P P A P A A P P P 3,17 1,64 
93300_at Tgfβ2 A A P P P P P A A P P 3,76 0,42 
104712_at c-Myc P P P P P P A A A A A 3,01 3,84 
117331_at Lmcd1 A A A P A A A A A A A 4,97 18,62 
92210_at Angpt2 P P P P P P A A P P P 1,07 40,28 
160670_at Tnfrsf19 A P P P P A A A A A A 1,95 1,37 
101975_at Dlk1 P P P P P P P P P P P 3,39 2,35 
94305_at Col1a1 A A M A A A A A A A A 9,96 6,56 
104375_at Spock2 A A P P P P P A A A A 3,19 0,70 
99011_at Galnt3 P P P P P P P A P P P 4,57 5,26 
102306_at Hst2nst1 P P P P P P P P P P P 2,60 0,45 
114766_at Nrxn1 A A P P A A A A P A A 2,37 1,99 
137059_at EST1 A A A A A A A A A A A 8,44 7,63 
101154_at EST2 A A P P A A A A A A A 2,92 0,58 
92697_at FoxA1 P P P P P P P P P P P 0,25 0,25 
93950_at FoxA2 A A A A A A A P A A A 0,14 0,36 
93503_at Sfrp2 P P P P P P P P P P P 0,11 0,20 
 
Explanations. (1) Probe ID refers to the Affymetrix reference number for a probe set specific for a given gene. (2) P, 
M, A denotes for Present, Absent and Marginal calls, respectively. Microarray ratio (3&4) is the average signal 
intensity difference between (3) the ventral vs. dorsal (V/D) epithelium of the 3rdpp and (4) between the 3rdpp vs. 
2ndpp (3/2) (4). The examined samples are annotated D_1, D_2 for dorsal, V_1, V_2 for ventral, 2_1, 2_2 for 2ndpp, 
3_1, 3_2 for 3rdpp and 4_1, 4_2 and 4_3 for 4thpp. 
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4.Discussion 
 
 
This thesis reports on the transcriptome of epithelial cells at E10.5 of the 2nd, 3rd and 4thpp of 
mouse embryos. This multiple microarray analysis were carried out to identify genes (referred to 
as candidate genes) that may play a role in the development of the thymus. Numerous genes have 
been identified to be differentially expressed between these different anatomical sites that display 
also a different fate in organ formation. Thus, data from microarray analysis should serve as a 
valuable resource to identify genes involved in the commitment of endodermal cells of the 
ventral aspects of the 3rdpp to a thymic epithelial cell fate. 
 
First, I will start to comment the discrepancies and the confirmation rate between qRT-PCR and 
microarray analysis of the genes identified by microarrays to be differentially expressed within 
the 3rdpp.  Next, candidate genes revealed to have a differential in expression between the ventral 
and the dorsal aspects of the 3rdpp or between the entire 3rdpp and 2ndpp will be discussed 
concerning their potential function if not known in thymus organogenesis. The genes will be 
discussed in separate sections according their category or biological function and will be based 
on findings, which have been previously been reported as well as on data, which have been 
revealed in the result section. Hence, I will begin to discuss the roles of the candidate genes (i.e. 
CCL21, CXCL12 and CXCl3), which are known to be involved in the chemotaxis and I will 
follow with an analysis of those which are known to be transcription factors (i.e. Dmrt2, Znf297, 
Meox2, Klf16, FoxG1, Ebf1, Msx2, Tbx3, FoxA1, FoxA2 and Sp8). Then, I will proceed with 
the examination of candidates genes known to be cell surface antigens (i.e. CD44, CD200 and 
CD6) and comments will be given for those involved in the signal transduction of growth factor 
(Fgf12, Phlda2 and Flrt3), Wnt  (WIF1, Nkd1 and Sfrp2) or Tgfβ (Bmp4, Fst, Bambi and Tgfβ2) 
signalling. This part will also include in separate sections the discussion of c-Myc (regulated by 
Wnt and Tgfβ signalling), Tnftsf19 (involved in NFκB signalling) and Dlk1 (regulates Hes1, 
which is a target of Notch signalling) genes and comments on their eventual roles in the 
development of the thymus will be made. The discussion will provide further details and findings 
on α-Nrxn1 and β-Nrxn1  transcripts, and about its transcriptional regulation and function. 
Finally, this part will comment on candidate genes which are involved in the extracellular matrix 
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(Colla1, Spock2, galnt3 and Hs2st1) to finish with a discussion of the two expressed sequence 
targets (EST1 and EST2) found to be upregulated in the ventral aspect of the 3rdpp when 
compared to the dorsal aspect of the 3rdpp. 
 
4.1 Comparative analysis between data sets from microarrays and qRT-PCR 
 
When comparing the microarray and the qRT-PCR data of the candidate genes, a confirmation 
rate of nearly 33% of the genes identified by microarrays to be differentially expressed and 
verified by qRT-PCR was revealed. In fact, microarray analysis is more susceptible to display 
false positives than qRT-PCR in regard to the information of whether a gene is expressed or not. 
For example, two probe sets of Gcm2 displayed differences in their A, M or P calls between 
either the two samples of the ventral or the dorsal aspects of the 3rdpp (Table 3.5). In addition, the 
difference in signal intensity between two probe sets for a given gene can differ to a considerable 
degree. For example, the expression of Follistatin (Fst) was increased for one probe set by 10.40 
fold in the ventral aspect of the 3rdpp when compared to the dorsal localisation of the same pouch. 
However, a second probe set for Fst revealed only an expression difference of 0.96 fold. In fact, 
the latter probe set displayed an absence of specific expression (A call) for Fst in both samples of 
the ventral aspect of the 3rdpp while the first one could report a specific expression for Fst (P call) 
in both samples of the ventral epithelium of the 3rdpp. These disparate results between two 
different probe sets for a given gene indicate that the reliability of the microarray analysis also 
depends on the individual performance of the different probe sets. Since the great majority of the 
genes are only represented by a single probe set in the microarrays, the difference in 
hybridization performance between individual probe sets can explain, at least partially, why only 
approximately a third of the differential expression of the candidate genes identified by 
microarrays could be verified by qRT-PCR. Finally, the fold difference in expression level 
measured as measured by qRT-PCR was not always consistent with that of the microarray 
analysis. For example, Bmp4 showed an 8 fold increase in the ventral aspect of the 3rdpp by 
microarray and a 14 fold by qRT-PCR when examined on identical source of cDNA (Table 3.7). 
This is most likely due to sensitivity issues. In fact, such differences have been observed in other 
studies of microarray analysis (Buttitta et al., 2003). Thus, microarray analysis is very useful for 
identifying genes differentially expressed between two tissues but a verification of this 
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differential expression by a more sensitive and more reliable method such as qRT-PCR is 
strongly recommended. 
 
In the next sections, the candidate genes whose differential expression was verified by qRT-PCR 
will now be more deeply commented about their eventual function in the thymus within the 
context of their categorical biological activity or signalling pathway. 
 
4.2 Genes that are involved in the chemotaxis and that are upregulated in the 
3rdpp 
 
The chemokine CCL21 (a T-cell chemoattractant) is the only chemokine that has been noticed to 
be upregulated in the 3rdpp when compared to the 2ndpp (Table 3.9) but was not found to be 
differentially expressed between the dorsal and the ventral aspect of the 3rdpp (result not shown). 
An IHC analysis for CCL21 at E10.5 and at E11.5 revealed that its expression in the 3rdpp was 
confined to the anterior domain of the pouch (Fig.3.12), a domain where FoxN1 expression was 
also observed to be restricted to (result not shown). Taken together, these expression data for 
CCL21 are highly indicative for a role of CCL21 in the recruitment of T cells precursors to the 
fetal thymus. This finding is in keeping with a recent report that demonstrates that CCL21 is 
involved in the recruitment of the T-cell precursors to the fetal thymus (Liu et al., 2005). Two 
other chemokines, CXCL12 (Table 3.8) and CXCL13 (Table 3.7) were the only chemokines 
noticed to be differentially expressed between the dorsal and the ventral aspect of the 3rdpp. 
CXLC12 was found to be strongly upregulated in the dorsal aspect of the 3rdpp (Table 3.8 & 
Fig.3.44) whereas CXCL13 was found to be exclusively expressed in the ventral aspect of the 
3rdpp (Table 3.7 & Fig.3.21). Interestingly, CXCL12 is a T-cell chemoattractant that was found to 
be one of the rare chemokines to attract T-cell precursors (DN1 population) with CCL21 and 
CCL25 (Liu et al., 2005). In contrast to CXCL12, CXCL13 was shown to be unable to attract T-
cells (Legler et al., 1998). The colonization of the fetal thymus was not affected by use of anti-
CXCL12 antibodies in FTOC whereas neutralizing antibodies for CCL21 and CCL25 affected 
DN1 entry to fetal thymic lobes (Liu et al., 2005). Hence, as suggested by Liu and colleagues, 
CCL21 and CCL25 chemokines in contrast to CXCL12 have a role in the recruitment of T-cell 
precursors to the fetal thymus. Nevertheless, CXCR4 (the receptor for CXCL12) has been shown 
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to be critical for T-cell progenitor localization within the cortex of the thymus as thymus-specific 
deletion of CXCR4 in vivo results in failed cortical localization of immature thymocytes (Plotkin 
et al., 2003). Furthermore, the expansion of T-cell precursors at the DN3, DN4 and at the DP 
stage has been shown to be affected during embryogenesis in mice deficient for CXCL12 or 
CXCR4 (Ara et al., 2003). Thus, the notification that CXCL12 was found to have an increase in 
expression in the dorsal aspect of the 3rdpp was especially surprising as this anatomical site will 
give rise to the parathyroids, an organ devoided of T cells. Also astonishing is the expression of 
CXCL13 in the ventral circumference of the 3rdpp as CXCL13 was shown to be unable to attract 
T lymphocytes but rather acts as a B-cell chemoattractant (Legler et al., 1998). Collectively, 
these findings suggest that CXCL12, CXCL13 and CCL21 may have a different role in 
organogenesis beside their chemokine function. However, neither CXCL12 nor CXCL13 are 
crucial for thymus development as mice deficient for either of these genes display normal thymus 
organogenesis (Ansel et al., 2000; Ma et al., 1998). 
 
4.3 Differential expression of transcriptional regulators within the 3rdpp 
 
Regular thymus patterning is dependent on several transcription factors including FoxN1, Pax1, 
Pax9, Hoxa3, Six1 and Eya1 (see Introduction). All these genes are encoding for factors whose 
transcripts were detected by microarrays within the 3rdpp (Annex 2). But among these transcripts, 
only those of FoxN1 and Pax1 have previously been reported to be differentially expressed 
between the 3rdpp, the 2nd and the 4thpp (Gordon et al., 2001; Wallin et al., 1996). Ehox is an other 
transcriptional regulator that can be added to this list of genes previously reported to be 
differentially expressed but its function for the thymus needs still to be defined (Jackson et al., 
2003). Notably, Six1 was observed to have a considerable increase of expression in the ventral 
aspect of the 3rdpp when compared to the dorsal circumference of the 3rdpp by microarray 
analysis (Annex 2) but this differential expression could not be confirmed in a qRT-PCR analysis 
(result not shown). In contrast, the transcription factors Ypel1, Dmrt2, Znf297, Meox2 and Klf16 
could be identified to be differentially expressed between the 2nd and the 3rdpp (Table 3.2). Meox2 
and Klf16 expression were confined to the 3rdpp with only the former demonstrating a 2 fold 
increase in expression in the ventral epithelium when compared to the dorsal circumference 
(Fig.3.21). Taken together, these data reveal that among the transcription factors identified to be 
differentially expressed between the 3rdpp, the 2nd and the 4thpp only two genes, FoxN1 and 
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Meox2 as well as Gcm2 demonstrated a clear differential expression within the 3rdpp. 
Interestingly, Meox2 has been demonstrated to physically interact with Pax3, which is required 
for the correct development of the thymus and to regulate Pax3 expression in the limb (Conway 
et al., 1997; Franz, 1989; Mankoo et al., 1999). Similarly, Meox1, an other transcription factor 
which was revealed to be expressed in the 3rdpp (Fig.3.9), has been shown to physically interact 
with Pax1 to act in concert with Meox2 upstream of Pax1 and Pax3 during limb development 
(Mankoo et al., 2003; Stamataki et al., 2001). Taken together, these findings evolve the 
possibility that Pax1 and Pax3 thymic expression might be regulated by Meox1 and Meox2 but 
this has yet to be demonstrated. In addition, Meox2 may also associate with Msx2, one of the 
transcription factors which was shown to be preferentially expressed within the 3rdpp in the 
ventral aspect (Table 3.7 and Fig.3.21) and which has been demonstrated to operate downstream 
of Bmp4 and upstream of FoxN1 in the skin (Andl et al., 2004; Ma et al., 2003). Msx2 and 
Meox2 are genes that are expressed in the epithelium of the 3rdpp but as well in the mesenchymal 
cells in proximity of that pharyngeal pouch (Fig.3.13)(Bleul and Boehm, 2005). Similarly, Meox2 
and Msx2 where both found to be expressed in epithelial and mesenchymal cells of the human 
placenta where both of them have been suggested to regulate the mesenchymal-epithelial 
interaction (Quinn et al., 2000). Since Bmp4 and FoxN1 are both upregulated in the ventral 
circumference of the 3rdpp and that thymic Msx2 expression is affected in mice transgenic for 
noggin under FoxN1 promoter, these findings may predict that Meox2 and Msx2 may act in 
concert to regulate thymic mesenchymal-epithelial interaction (Quinn et al., 2000). 
 
A role for Klf16 and Dmrt2 in the thymus development is less clear as Klf16 (a.k.a. DRPP, 
Dopamine-receptor regulating transcription factor) has been demonstrated to regulate dopamine 
receptors, whereas Dmrt2 is a sex-determining gene (Hwang et al., 2001; Muroya et al., 2000). In 
contrast, the transcription factor Ypel1 may despite a very small increase (2,23 fold, Table 3.2) in 
expression in the 3rdpp when compared to the 2ndpp play an important role in the commitment of 
endodermal cells of the ventral aspect of the 3rdpp to an epithelial cell fate, as transfection of 
mouse fibroblasts with Ypel1 induces an epithelial-like morphology (Farlie et al., 2001). 
However, as the cells of the 2ndpp are also epithelial cells, other factors are most likely required 
that may act in concert with Ypel1 to specify the commitment of endodermal cells of the ventral 
aspect of the 3rdpp to adopt a thymic epithelial cells fate. 
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When comparing the expression of the genes between the ventral and the dorsal aspect of the 
3rdpp by microarrays, the transcription factors Ebf1, Msx2, FoxG1 and Tbx3 were identified to be 
upregulated if not exclusively expressed in the ventral circumference of the 3rdpp (Table 3.7, 
Fig.3.21 and Fig.3.22). FoxG1 has been demonstrated to be positioned downstream of Tbx1 as 
FoxG1 expression is downregulated at E9.5 in the entire pharyngeal region of Tbx1 deficient 
mice (Ivins et al., 2005). Tbx3 was shown to specify the identity of the posterior digits through 
Shh and Bmp signalling (Suzuki et al., 2004). Since Shh and Bmp are two genes that have been 
shown to play a role in the patterning of the thymus to the ventral aspect of the 3rdpp (see 
Introduction), it is therefore conceivable that Tbx3 might be involved in the dorsal-ventral 
patterning. Ebf1 is an early B-cell factor whose expression was even found within the 3rdpp to be 
restricted to the ventral aspect (Fig.3.21). However, mice deficient for Ebf1 have a normal 
thymus (Lin and Grosschedl, 1995). In regard to Msx2, this gene may be involved in the thymus 
in a Bmp4/FoxN1 pathway that was suggested to operate in the epithelial skin development (Ma 
et al., 2003) since both of these genes are expressed in the ventral aspect of the 3rdpp. However, a 
study from Bleul and colleagues showed that blocking thymic Bmp signalling in transgenic mice 
for noggin does not influence FoxN1 expression, although a hypoplastic thymus was found to be 
ectopically located with an altered expression of Msx1 and Bmp4 in these mice (Bleul and 
Boehm, 2005). In that regard, a recent study of Msx1 and Msx2 double deficient mice reported an 
abnormal location of the thymus (Ishii et al., 2005). Furthermore, Msx1 was found to be 
expressed in the 3rdpp (see Annex 2). Taken together, these findings suggest that Msx2 in concert 
with Msx1 play a role in the migration of the thymus/parathyroid primordium from the 
pharyngeal region to the mediastinum. 
 
Expression profiling of the dorsal side of the 3rdpp revealed that FoxA1, FoxA2 and Tbx1 
transcription factors are expressed at least 3 times more when compared to the 3rdpp epithelia of 
the ventral circumference (Table 3.8 & Fig.3.44). FoxA2 was identified as being upstream of 
Tbx1 by binding to a Fox box regulatory element of Tbx1 promoter under Shh signalling in the 
pharyngeal endoderm at E9.5 (Yamagishi et al., 2003). Therefore, FoxA2 and Tbx1 upregulation 
in the dorsal aspect of the 3rdpp are consistent with these findings. In contrast, Shh expression 
was not observed by microarray and by IHC analysis to be differentially expressed between the 
dorsal and the ventral aspect of the 3rdpp (data not shown). Considering this together with the fact 
that Tbx1 deficiency was shown to be responsible for the DiGeorge syndrome, it is nevertheless 
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conceivable that FoxA2 may be required for normal levels of Tbx1 expression in the ventral 
aspect of the 3rdpp and hence be required for the normal development of the thymus (Jerome and 
Papaioannou, 2001; Lindsay et al., 2001; Merscher et al., 2001). 
 
The last transcription factor that was revealed to be differentially expressed between the dorsal 
and the ventral aspect of the 3rdpp is Sp8 (Fig.3.25). Sp8 was initially identified as being a 
potential candidate gene involved in thymus organogenesis when a study in the limb revealed that 
Sp8 lies upstream of Fgf8, a gene when mutated in mice can phenocopy the complete array of 
anomalies of the DiGeorge syndrome (Frank et al., 2002b; Kawakami et al., 2004). In addition, 
Sp8 was revealed to be downstream of Fgf10 and further expression analysis of that study 
presented evidence that during early limb development it is required for maintaining but not for 
initiating Wnt/beta-catenin-dependent FGF, Shh, and BMP-mediated signalling (Bell et al., 2003; 
Treichel et al., 2003). However, embryos deficient for Sp8 revealed that at E10.5 the 3rdpp 
appeared to be normal (Fig.3.30) and that at E18.5 the size and location of the thymic lobes were 
undistinguishable from wild type mice (not shown). In regard to the absence of detection of β-
galactosidase in the pharyngeal region by lacZ and IHC stainings of Sp8 deficient E10.5 
(Fig.3.35), this result was unexpected as Sp8 is expressed according a qRT-PCR analysis in the 
3rdpp at levels about 10 times higher than for example Phlda2 (Fig.3.25), whose protein product 
was clearly detected by IHC (Fig.3.28). An explanation for this unexpected finding is that the 
feedback mechanism that has been proposed to occur for Sp8 in the development of the AER 
(apical ectodermal ridge) might operate as well in the pharyngeal region in order to express 
normal levels of Sp8 (Bell et al., 2003). 
 
4.4 Differential expression of cell surface antigens in the ventral aspect of the 
3rdpp 
 
The differential expression analysis between the dorsal and the ventral aspect of the 3rdpp 
identified three cell surface antigens CD6, CD44 and CD200 to be exclusively expressed in the 
ventral circumference of the 3rdpp (Table 3.7, Fig.3.21). CD6 is an accessory molecule that is 
primarily expressed on thymocytes where it is believed to be involved in T-cell activation and/or 
differentiation and this immunological function of CD6 may contribute to thymocyte survival and 
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selection (Gimferrer et al., 2003; Singer et al., 2002). CD6 expression in the ventral aspect of the 
3rdpp at E10.5 was unexpected as ligands for CD6 (CD166) were shown to be expressed in the 
thymic epithelium as well (Singer et al., 2002). CD44 expression within the pharyngeal region 
was essentially restricted to the 2ndpp and the ventral aspect of the 3rdpp (Fig.3.25 and Fig.3.26) 
but the expression of some CD44 splice variants (i.e. CD44v6 and CD44v10) were exclusively 
found to be expressed in the ventral ciurcumference of the 3rdpp (Fig.3.26). These findings for 
CD44v6 and CD44v10 splice variants are indicative for a role of these isoforms in the thymus. In 
that regard, functional studies demonstrated that only cells expressing CD44 isoforms (CD44v) 
from fetal liver and adult bone marrow could efficiently populate fetal thymic stroma and 
develop into mature T cells (Schwarzler et al., 2001). Furthermore, in fetal thymic organ cultures, 
anti-CD44v antibodies specifically blocked thymocyte development and presented evidence that 
CD44v are required for the initial interaction of haematopoietic progenitor cells with the thymic 
stroma (Schwarzler et al., 2001). Other fetal thymic organ cultures (FTOCs) revealed a role for 
CD44 molecules in the emigration of thymocytes as the adjunction of anti-CD44 antibodies to 
these FTOCs decreased the emigration of mature thymocytes (Esser et al., 2004). However, 
CD44 deficient mice have been reported to have a normal and functional development of the 
thymus (Protin et al., 1999). The presence of regular thymus development and function, despite 
the lack of CD44 in these mice, may reflect the redundant role of CD44, which could eventually 
be compensated by Rhamm, as this latter gene is a product acting as an alternative hyaluronan 
receptor. Rhamm is indeed highly expressed in the 3rdpp at E10.5 (data not shown) and could 
compensate in situ for the loss of CD44 function, which has recently been observed in murine 
models of inflammation (Nedvetzki et al., 2004). Interestingly, the intracellular domain of CD44 
was also recently demonstrated to physically interact with Smad1 (member of the Tgfβ-signaling 
pathway) upon Bmp7 stimulation (Peterson et al., 2004). Smad1 and Bmp7 were both found to 
be highly expressed in the 3rdpp at E10.5 (Annex 2). These findings may predict CD44 as a 
modulator of the Tgfβ signalling pathway, in particular when knowing that the Tgfβ-signaling 
pathway has been demonstrated to be involved in thymus organogenesis (Bleul and Boehm, 
2005; Ohnemus et al., 2002).  
 
CD200 has been shown to deliver an inhibitory signal to cells of the macrophage lineage as these 
cells in mice, which are deficient for CD200, were more numerous. However, the thymus as well 
as the development of its thymocytes in these mutant mice is normal (Hoek et al., 2000). 
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4.5 Differential expression of genes involved in growth factor signalling in the 
3rdpp 
 
A qRT-PCR analysis for the expression of Fgf8 and Fgf10 and their respective receptors, 
Fgfr2IIIb and Fgfr1, has revealed that these genes were expressed in the 3rdpp at levels 
comparable between the dorsal and the ventral circumference of that pouch and are at comparable 
levels of expression in the 2ndpp and 4thpp (Fig.3.23, Annex 2 and result not shown). In contrast, 
Fgf12 was clearly differentially expressed between the 3rdpp and the 2ndpp (Fig.3.9, Fig.3.11 and 
Table 3.4). Expressed in the developing brain, the connective tissue of the limb and the heart, the 
function of Fgf12 still remains unknown (Hartung et al., 1997; Smallwood et al., 1996). 
 
Among the candidate genes that were revealed to be differentially expressed within the 3rdpp and 
that have a potential role to be involved in growth factor signalling of the thymus are the two 
following genes: Phlda2 and Flrt3 (Fig.3.21 and Table 7.3). The Phlda2 (a.k.a. IPL and Tssc3) 
gene lies in an extended imprinted region of distal mouse chromosome 7, which also encodes for 
the insulin-like growth factor 2 (Igf2) gene. Expression of Phlda2 is highest in placenta and the 
yolk sac, where its mRNA is derived almost entirely from the maternal allele (Frank et al., 
2002a). Phlda2 encodes a small cytoplasmic protein with a pleckstrin-homology (PH) domain. 
Mice rendered deficient for Phlda2 do not have a phenotype with the notable exception of an 
enlarged placenta (Frank et al., 2002a). A defect, which could be corrected by an additional lack 
of Igf2 (Frank et al., 2002a). Thus, these findings indicate that Phlda2 can act, at least in part, 
independently of insulin-like growth factor-2 signalling. Igf2 was found by microarray analysis to 
be expressed in the 3rdpp at E10.5 (Annex 2). Mice overexpressing Igf2, revealed the abnormal 
appearance of large clusters of TECs immunoreactive to the monoclonal antibody KL1, which 
specifically recognizes highly differentiated TECs (Savino et al., 2005). Taken together, these 
findings suggest that Phlda2 might be a modulator of Igf2 signalling in the thymic epithelium. On 
the other hand, Phlda2 could be upregulated by Tbx1 as Phlda2 was found to be downregulated in 
the pharyngeal region of Tbx1 deficient E9.5s (Ivins et al., 2005). In fact, the Phlda2 protein 
product was observed within the pharyngeal region to be essentially restricted to the pharyngeal 
endoderm lining of the 2nd, 3rd and 4thpp and not in the surrounding mesoderm (Fig.3.28). Phlda2 
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transcripts were also found to be expressed in immature but not SP thymocytes as well as in 
TECs (Fig3.34). Despite this pattern of expression mice deficient for Phlda2 had a regular thymic 
architecture at E13.5 as assessed by the K5 and K8 markers (Fig.3.43). Based on these data and 
on the fact that Tbx1 deficient mice display thymic hypoplasia suggest that Phlda2 might be 
involved in the expansion process of the thymic epithelium but if such is the case than the 
function of Phlda2 in thymus appears to be redundant (Jerome and Papaioannou, 2001; Merscher 
et al., 2001). 
 
Flrt3 is a gene coexpressed with Fgf8, a gene that was revealed from studies of mice mutant for 
Fgf8 to be involved in the development of the thymus as these mutant mice displayed hypoplasia 
and aplasia of the thymus [Frank, 2002 #57 4](Abu-Issa et al., 2002). Interestingly, Fgf8 
expression is abolished in the pharyngeal endoderm of mice deficient for Tbx1 (Vitelli et al., 
2002). Flrt3 expression can be induced and downregulated by respectively injections of Fgf8 and 
dominant-negative Fgfr1 (a receptor for Fgf8) in xenopus embryos (Bottcher et al., 2004). In that 
regard, Fgfr1 was shown to physically interact with Flrt3 in co-immunoprecipitation analysis 
(Bottcher et al., 2004) and an analysis of the expression of Flrt3 in the thymus revealed that it 
was found to be expressed in adult TECs (Fig.3.34) as well as in TEC cell lines (Fig.3.35), but 
not in thymocytes (Fig.3.34). Taken together, these findings may predict a model where Flrt3 is 
involved in the Fgf8 signalling of thymic epithelial cells and where Fgf8 is downstream of Tbx1. 
 
4.6 Genes involved in Wnt-mediated signalling are differentially expressed in 
the 3rdpp 
 
Wnt signal molecules (including Wnt4 and Wnt5b) are present in the 3rdpp without displaying a 
pattern of differential expression between the dorsal and ventral aspect of the pouch at E10.5 
(Balciunaite et al., 2002). In contrast, three inhibitors of the Wnt signalling pathway (WIF1, Nkd1 
and Sfrp2) were found to be differentially expressed within the 3rdpp at E10.5 by microarray 
analysis (Table 3.7, Fig.3.21 and Fig.3.44). WIF1 and Sfrp2 antagonizes Wnt signalling, whereas 
Nkd1 effect its function via inhibiting dishevelled signal transduction (Hsieh et al., 1999; Hunter 
et al., 2004; Lee et al., 2000; Wharton et al., 2001; Zeng et al., 2000). In fact, WIF1 has been 
demonstrated to physically interact with Wnt4 whereas Sfrp2 competes with membrane-bound 
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frizzled receptors for the binding of Wnts (i.e. Wnt1, Wnt4) (Hunter et al., 2004; Lee et al., 
2000). Since Wnt4 interacts with WIF1 and that Wnt4 has been shown to upregulate the 
expression of FoxN1 in the cTEC1.2 cell line, the upregulation of WIF1 protein levels in the 
ventral aspect of the 3rdpp  (Fig.3.29) may predict a role for WIF1 in modulating Wnt4/β-
catenin/FoxN1 signaling in thymic epithelium (Balciunaite et al., 2002). This antagonizing role 
of WIF1 in Wnt4 signalling could be possibility supported by the contribution of Nkd1 as both 
were observed to be upregulated if not exclusively expressed in the ventral aspect of the 3rdpp. In 
fact, both molecules were reported to be co-upregulated in a murine granulosa cell tumor 
(Boerboom et al., 2006). 
 
An examination of WIF1 protein level of expression by IHC in the pharyngeal region of E10.5s 
revealed that WIF1, in addition to its expression in the 3rdpp, was also detected in the 2nd and 
4thpp (Fig.3.27A&B). However, these results contrast with qRT-PCR data that revealed that 
WIF1 was expressed in the 3rdpp but not in the 2nd or the 4thpp (Fig.3.24). This conflicting set of 
results may be explained by the fact that the anti-WIF1 antibody used in IHC may recognize an 
epitope within the well conserved and large WIF (Wnt inhibitory factor) domain of WIF1, which 
is known to be shared with other proteins (e.g. RYK, receptor-like tyrosine kinase) (Cheyette, 
2004; Patthy, 2000). This explanation is not unlikely because RYK is a coreceptor of the 
canonical Wnt signaling pathway that was revealed by microarray analysis to be clearly 
expressed at E10.5 in the 2nd, 3rd and 4thpp (Annex 2) and since about half of the peptide sequence 
of the mouse recombinant WIF1 used for immunisation corresponds to the WIF domain 
(Cheyette, 2004; Keeble et al., 2006; Lu et al., 2004). Hence, if this is the case, part of the 
staining in the IHCs for WIF1 might have been contributed by the binding of anti-WIF1 antibody 
to other proteins sharing a WIF domain such as Ryk. By E12.5, the expression of WIF1 was most 
likely restricted to some clusters of thymic epithelial cells (Fig.3.27D) as WIF1 was not found in 
adult mice to be expressed by thymocytes but in TECs (Fig.3.34). WIF1 thymic epithelial cell 
expression was noticed to be more prominently expressed in comparison to FoxN1 before E16.5 
(Fig.3.33) suggesting that the WIF1 antagonizing function in Wnt signaling seems to play a role 
in the early stages of thymus organogenesis. When trying to reveal the importance of this role in 
FTOCs of E13.5 thymi in presence of an increasing amount of affinity purified hWIF-IgG in the 
thymus, it was noticed that overexpessing WIF1 at not too high levels in these FTOCs enhanced 
the overall cellularity of thymocytes (Fig.3.40) but did not appear to affect the normal 
175 
development of thymocytes (Fig.3.41 and Fig.3.42). Nevertheless, the Wnt-signalling cascade is 
known to be required for several crucial steps during early embryogenesis and its activity is 
modulated by various agonists and antagonists to provide spatiotemporal-specific signalling 
(Creyghton et al., 2006). Thus, the restricted pattern of WIF1 thymic epithelial expression 
observed at E12.5 may suggest together with the finding that WIF1 can influence the expansion 
of immature thymocytes that Wnt signalling operates in the cross-talk between TECs and 
thymocytes and that this regulation could be tightly modulated spatiotemporally by WIF1. In 
addition, this antagonizing activity of WIF1 could be synergized or sustained by other antagonist 
of the Wnt signalling such as Nkd1, Sfrp2 and Dkk3 (Dickkopf 3) all noticed to be expressed in 
the ventral aspect of the 3rdpp (Fig.3.21, Fig.3.44 and results not shown). The pattern of 
expression of these antagonists do not necessarily have to overlap but could alternatively be 
differentially expressed within the thymus, as it is the case for Sfrp1 and Sfrp2 during the 
metanephric development (Yoshino et al., 2001). In that regard, WIF1 and Dkk3 could be 
coexpressed in the thymus as a study of Wnt antagonists in gastointestinal tissues revealed that 
WIF1 and Dkk3 were both upregulated and coexpressed in the deep gastric glands and colonic 
crypt bases, a region where stem cells reside (Byun et al., 2005). Based on these findings, the 
authors of that study have suggested that WIF1 and Dkk3 could contribute to the maintenance of 
the gastric stem cell pool. In that regard, WIF1 adult thymic expression was noticed by qRT-PCR 
analysis to be close to the limit of detection (Fig.3.33) in contrast to FoxN1, while thymic WIF1 
protein product could not even be detected by IHC in adult mice (result not shown). Thus, these 
results might predict that WIF1 adult thymic expression is much more restricted than FoxN1 
within the epithelium of the thymus. Hence, as proposed for the stomach, WIF1 may eventually 
be expressed in close proximity of rare populations of thymic epithelial such as TEC progenitors 
and may serve to maintain for instance this latter population of cells undifferentiated. If such is 
the case, then WIF1 is predicted to act in a paracrine way on thymic epithelial progenitor cells 
since WIF1 thymic expression was observed in MTS24- TECs but not in MTS24+ TECs 
(Fig.3.34). Taken together, the notification of the differential expression of several Wnt 
antagonist (i.e WIF1, Nkd1 and Sfrp2) within the 3rdpp suggests that Wnt signaling is 
spatiotemporally regulated between the dorsal and the ventral aspects of the 3rdpp and is most 
likely regulated this way as well within the developing thymus. This saptiotemporally regulation 
of these factors might be essential for a proper  patterning and/or differentiation of the thymic 
176 
epithelium. To reveal such an eventual role for WIF1 in thymus organogenesis, mice rendered 
deficient for WIF1 are now being generated in our lab. 
 
4.7 Differential expression within the 3rdpp of genes involved in the Tgfβ  
signalling 
 
Four genes (Bmp4, Fst, Bambi and Tgfβ2), all involved in the Tgfβ signalling pathway were 
identified to be upregulated in the ventral aspect of the 3rdpp when compared to the dorsal 
circumference (Table 3.7 & Fig.3.21). Bmp4 and Tgfβ2 are activators whereas Fst and Bambi are 
inhibitors of the Tgfβ signalling pathway. The expression of these ligands correlates well with the 
presence of several receptors belonging to this family of signalling molecules such as Bmpr1 
(Bmp receptor 1) and Acvr2 (activin receptor 2). In fact, the Tgfβ signalling pathway has been 
previously demonstrated to be implicated in thymus organogenesis (Bleul and Boehm, 2005; 
Ohnemus et al., 2002). These studies were based on the analysis of the thymus from mice 
transgenic for noggin under the control of a genomic fragment of either the Hoxa2 or of the 
FoxN1 promoter. Both of these transgenic mice were reported to have a hypoplastic thymic 
tissue, which was ectopically located when found but functional in thymopoiesis (Bleul and 
Boehm, 2005; Ohnemus et al., 2002). These observations also relate to the present finding that 
Noggin, an antagonist of Bmp4, is expressed in the dorsal but not in the ventral aspect of the 
3rdpp (Patel et al., 2006) and Annex2. Interestingly, Shh deficient mice do have an absence of 
Gcm2 and an expansion of Bmp4 and FoxN1 expression throughout the 3rdpp, which results in an 
subsequent absence of development of the parathyroid glands (Moore-Scott and Manley, 2005). 
In other studies, Shh and Bmp4 proteins were shown to negatively regulate each others 
transcription and resulting in a strict complementarity between these two gene patterns on each 
side of the Hensen's node in chick embryos (Monsoro-Burq and Le Douarin, 2001). Taken 
together, these findings suggest that Shh signalling and Noggin limits Bmp4 signalling 
throughout the entire 3rdpp and are required to pattern the thymus anlage to the ventral aspect and 
the parathyroids to the dorsal circumference of the 3rdpp (Moore-Scott and Manley, 2005; Patel et 
al., 2006). These observations also strongly suggest a direct role for Bmp4 in the thymic 
development. Using overexpressing studies of Bmp4 in thymic organ cultures, it was concluded 
that Bmp4 modulates thymic stroma, alters FoxN1 transcription and regulates thymocyte DN1 
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differentiation via a molecule mechanism engaging Fgf signalling (Hager-Theodorides et al., 
2002; Tsai et al., 2003). However, a role for Bmp4 appears to be redundant since the inhibition of 
Bmp4 signalling by overexpression of Noggin did not affect the normal thymocyte differentiation  
in vivo (Bleul and Boehm, 2005). In keeping with this in vivo observation, FTOCs exposed to 
Noggin display an accelerated rate of thymopoiesis (Hager-Theodorides et al., 2002). To 
elucidate precisely the role of Bmp4 in early thymus organogenesis, mice rendered deficient for 
Bmp4 expression in the thymic epithelium shall be generated as conventional knockout mice die 
between E6.5 an E9.5 (Winnier et al., 1995). 
 
Fst (Follistatin) and Bambi are two inhibitors of the Tgfβ signalling pathway that were identified 
to be expressed in the ventral aspect of the 3rdpp (Grotewold et al., 2001; Nakamura et al., 1991; 
You and Kruse, 2002). The spatiotemporal expression pattern of Bambi closely matches that of 
Bmp4 during mouse embryonic development and this inhibitor is part of a feed-back mechanism 
that is upregulated in response to activation of the Tgfβ signalling pathway (as well as Wnt 
signalling) (Sekiya et al., 2004a) (Grotewold et al., 2001; Sekiya et al., 2004b). Follistatin is a 
secreted and activin-binding protein and as well as an activin (member of the Tgfβ signalling 
pathway) antagonist in vitro that can bind to heparan sulphate proteoglycans and that may 
function in vivo to present activins to their receptors. In that regard, activin (a.k.a. as inhba) was 
revealed by microarrays to be strictly confined to the ventral aspect of the 3rdpp when compared 
to its dorsal counterpart (Annex 2). In the mouse, Follistatin messenger RNA is first detected in 
the deciduum (on embryonic day 5.5), and later in the developing thymus, gut, hindbrain, 
somites, vibrissae, teeth, epidermis, muscle (Matzuk et al., 1995) and Fig.3.36. At E11.5, Fst is 
strongly expressed in the epithelium of the 3rdpp when compared to its surrounding mesoderm 
(Fig.3.29). Interestingly, the progressive decrease of Fst expression from the 2ndpp to the 4thpp 
observed by qRT-PCR (Fig.3.25) contrasts with changing gradient of Bmp4 expression from the 
2ndpp to the 4thpp in the opposite direction (Fig.3.25). Moreover, when analysing Fst expression 
by IHC at E10.5 and E11.5, Fst proteins were noticed to be also detected at considerable levels in 
the extracellular matrix (ECM) between the anterior and posterior endodermal cells of the 3rdpp 
(Fig.3.29). In that regard, Nakamura and colleagues have suggested that Fst binds to heparan 
sulfate side chains of proteoglycans of the ECM to regulate the various actions of activin 
(Nakamura et al., 1991). 
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Other studies on Fst have revealed that Fst is induced by activin signalling in dental epithelium 
and that Fst inhibits the ameloblast-inducing activity of Bmp4 in which the ameloblasts are 
derived from dental epithelium (Wang et al., 2004). In fact, overexpressing Fst in the murine 
dental epithelium resulted in an inhibition of ameloblast differentiation while Fst deficient mice 
display ameloblasts that differentiate ectopically (Wang et al., 2004). These findings may predict 
a role for Fst in the patterning and/or differentiation of the thymus primordium since Fst and 
Bmp4 were both found to be upregulated in the ventral aspect of the 3rdpp when compared to the 
dorsal circumference. In regard to thymic Fst expression, Fst could operate downstream of Tbx1, 
as Fst was shown to be downregulated in the pharyngeal region of Tbx1 deficient E9.5s (Ivins et 
al., 2005). But Fst could also be a downstream target of activin signalling (as in dental 
epithelium) or of Wnt4 signalling (as in mammalian ovary) or of both signalling pathways since 
Wnt4 and Activin were both found to be expressed in the ventral aspect of the 3rdpp (Wang et al., 
2004; Yao et al., 2004). 
 
Fst is also expressed in the adult thymus by primary epithelial cells and thymocytes at 
comparable levels (Fig.3.34) as well as in all examined TEC cell lines (Fig.3.35). Among primary 
epithelial cells, Fst was considerably more abundant in MTS24+ when compared to MTS24- 
TECs (Fig.3.34) and was maintained throughout fetal and post-natal development. These findings 
are compatible with the notion that Fst (together with other inhibitors of Tgfβ-signaling, such as 
Bambi) might be controlled by activin/Bmp4/Tgfβ2 and/or Wnt4 mediated signalling. In that 
regard, Fst may modulate in the developing thymus the actions of several members of the 
transforming growth factor-beta family that were found to be expressed in the ventral aspect of 
the 3rdpp (i.e. Tgfβ2, Bmp4, activin) as defects in mice deficient for Fst are more widespread than 
those seen in activin-deficient mutant mice (Matzuk et al., 1995). However, a function for Fst in 
the thymus has not been reported so far as studies on Fst deficient mice have not been reported to 
have a thymus defect (Matzuk et al., 1995). 
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4.8 Increased expression of c-Myc, a target gene of Wnt and Tgβ  signalling in 
the ventral aspect of the 3rdpp 
 
The c-Myc gene is an oncogene that in conjunction with other gene products promotes cell 
growth and transformation and is essential for vasculogenesis and angiogenesis during tumor 
development and progression (Baudino et al., 2002). c-Myc is upregulated in the ventral aspect of 
the 3rdpp (Table 3.7, Fig.3.21). c-Myc was also demonstrated to play a role in neural crest 
specification as well as the finding that the transcriptional regulation of c-Myc acts in response to 
the activation of the Wnt and of the Tgβ signalling pathways (Barembaum and Bronner-Fraser, 
2005; Hu and Rosenblum, 2005; Paez-Pereda et al., 2003). c-Myc is expressed in the pharyngeal 
region at levels comparable between the 2ndpp, 3rdpp and 4thpp (Fig.3.25). The thymic expression 
of c-Myc remained unchanged over time when analysing unseparated tissue at different 
embryonic stages and in the adult animal Fig.3.33). In the latter, c-Myc is expressed at 
comparable levels by thymocytes and by primary thymic epithelial cells (Fig.3.34). Mice 
deficient for c-Myc die by E10.5 displaying a growth deficiency as well as cardiac and neural 
developmental defects (Baudino et al., 2002). These defects are associated in part with a 
requirement of c-Myc for the expression of the vascular endothelial growth factor (VEGF) 
(Baudino et al., 2002). VEGF on the other hand has been shown to upregulate Tbx1 expression in 
the pharyngeal region. A target deletion of VEGF in TECs revealed an hypovascularized thymus 
(Muller et al., 2005; Stalmans et al., 2003). Moreover, mice deficient for either Tbx1 or for an 
isoform of VEGF (VEGF164) have both defects including the thymus similar than those observed 
in the DiGeorge syndrome (Stalmans et al., 2003). c-Myc has also been shown to be required for 
the expression of Angiopoietin 2 (Agpt2) in embryonal stem and yolk sac cells (Baudino et al., 
2002). Agpt2 is a gene that was found to be upregulated in both the ventral and dorsal epithelial 
cells of the 3rdpp when compared to those of the 2ndpp (Table 3.2 & 3.6, Fig.3.13). Agpt2 is 
involved in the angiogenesis of the parathyroids and is transcriptionally upregulated by PTH 
(Parathyroid hormone), which in fact also upregulates VEGF expression (Carter and Ward, 
2001). It is therefore not a surprise that Agpt2 is expressed in the common thymic-parathyroid 
primordium at E10.5 (Fig.3.13). All these findings suggest that under the control of Wnt and/or 
Tgfβ signalling, c-Myc may possibly be involved in a regulation model of the thymus in which it 
is upstream of Angpt2 and VEGF while the latter one upregulates Tbx1 expression for a proper 
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development of the thymus epithelium and/or blood vessel architecture. To elucidate precisely 
the role of c-Myc in thymus organogenesis mice rendered deficient for c-Myc expression in the 
thymus epithelium need to be generated as conventional mice die by E10.5 (Baudino et al., 
2002). 
 
4.9 Increased expression of Tnfrsf19 in the ventral aspect of the 3rdpp 
 
Tnfrsf19 (a.k.a. Toxicity and JNK inducer Taj or alternatively designated Troy) is a member of 
the tumor necrosis factor receptor superfamily (TNFR) that was revealed to be upregulated (4.32 
fold) in the ventral aspect when compared to the dorsal circumference of the 3rdpp (Fig.3.21). 
Tnfrsf19 is involved in signalling via the nuclear factor kappaB (NFκB) through interaction with 
Traf6, which controls the maturation of a subpopulation of medullary TECs (mTECs) and was 
also expressed in the 3rdpp (see Annex 2) but without a considerable difference between the 
ventral and dorsal side (Akiyama et al., 2005; Kojima et al., 2000; Ohazama et al., 2004). 
Tnfrsf19 was shown to be a target of Wnt signalling (Buttitta et al., 2003). Taken together, these 
findings may predict that Tnfrsf19 is targeted by Wnt signalling to induce or upregulate signal 
transduction via Traf6 and NFκB and hence promote the differentiation of thymic epithelial 
progenitors into a mTEC cell fate. 
 
4.10 Increased expression of Delta-like homolog 1 in the ventral aspect of the 
3rdpp 
 
Delta-like homolog 1 (Dlk1 a.k.a. preadipocyte factor Pref1), which displays as indicated by its 
name a homology to Delta-like 1 (Dll1). Dlk1 is a member of the epidermal growth factor-like 
family and has been shown to be a regulator of adipocyte differentiation (Moon et al., 2002). 
Dlk1 is expressed in the 2nd, 3rdpp and 4thpp (Annex 2) and can be detected at higher levels in the 
ventral aspect of the 3rdpp when compared to the dorsal side (Fig.3.22). Dlk1 is expressed in 
thymic epithelial cells where it influences thymocyte cellularity (Kaneta et al., 2000).  In fact, 
when a dimeric form of Dlk1 is added to a FTOC it increases the overall number of lymphoid 
cells, whereas when a monomeric form of Dlk1 or the presence of anti-Dlk1 antibodies are added 
to a FTOC, the cellularity of lymphoid cells is reduced (Kaneta et al., 2000). Signalling via Dlk1 
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does not apparently influence the developmental choice among the thymocyte lineages in these 
FTOCs (Kaneta et al., 2000). Interestingly, the expression of the hairy and enhancer of split1 
(Hes1) in thymocytes was increased in these FTOCs in presence of dimeric Dlk1, while FTOCs 
from mice deficient for Hes1 were hypocellular and unresponsive to the Dlk1 dimer (Kaneta et 
al., 2000). Hes1 was also found to be expressed in the 3rdpp (Annex 2). Hence, these findings 
reveal that Hes1 is not only expressed by thymocytes and may therefore predict that Dlk1 also 
regulates Hes1 expression in TECs. Although Hes1 is a target of notch signalling, which has been 
demonstrated to be essential in T cell lineage commitment. Several delta-like ligands (i.e. Dll1, 3 
and 4), which are members of the notch signalling pathway were not detected in the 3rdpp at 
E10.5 (Annex 2) (Kim and Siu, 1998; Radtke et al., 2004; Radtke et al., 1999; Wilson et al., 
2001). Nevertheless, Dll1 and Dll4 are expressed in thymic epithelial cells at E12.5 and were 
shown to be a downstream target of FoxN1 (Tsukamoto et al., 2005). Taken together, these 
findings suggest that notch signalling is not operating at E10.5 in the ventral aspect of the 3rdpp 
and that Dlk1 as well as Hes1 thymic epithelial expression are most likely not dependent on 
Notch signalling. In that regard, Dlk1 expression is upregulated in some tissues by FoxA2, which 
appears to be positioned upstream of Tbx1 and of Shh signalling (Wolfrum et al., 2003; 
Yamagishi et al., 2003). However, Tbx1 and FoxA2 were both preferentially expressed in the 
dorsal epithelium within the 3rdpp (Table 3.8 & Fig.3.46). 
 
4.11 Increased expression of Neurexin 1 in the ventral aspect of the 3rdpp, a 
gene involved in cell-cell interaction 
 
Neurexin 1 (Nrxn1) consists of two related proteins generated by alternative use of promoters. 
The protein of Nrxn1 consists of a single transmembrane region and extracellular domain with 
repeated sequences similar to that of laminin A. The gene for Nrxn1 has two independent 
promoters so that a longer mRNA encoding for α-Nrxn1 and a shorter mRNA encoding for β-
Nrxn1 are generated (Rowen et al., 2002). The genomic organisation consists of a total of 24 
exons whereby 23 are used in the α-Nrxn1 transcript and 7 in the Nrxn1 β-transcript (Rowen et 
al., 2002). As Nrxn1 transcripts are also extensively spliced at five sites with the sites 1, 2, and 3 
unique for the α-Nrxn1 transcripts and the sites 4 and 5 common to both, α-Nrxn1 and β-Nrxn1, 
transcripts (Rowen et al., 2002). As many as 288 different variants can be generated for α-Nrxn1 
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and 4 for β-Nrxn1 (Rowen et al., 2002). α-Nrnx1 is a receptor for alpha-latrotoxin and 
neurexophilins, whereas β-Nrxn1 is a receptor for neuroligins (Ichtchenko et al., 1995; Missler et 
al., 1998; Ushkaryov et al., 1992). Mice deficient for α-Nrxn1 are viable and display no obvious 
structural phenotype but have defective release of calcium-triggered neurotransmitters (Geppert 
et al., 1998; Kattenstroth et al., 2004; Missler et al., 2003). Nrxn1 is also expressed outside of the 
neuronic system (Fig.3.36 and Fig.3.37). Its role may thus also relate to the formation and 
function of other organs. β-Nrxn1 but not α-Nrxn1 transcripts were detected in the ventral aspect 
of the 3rdpp (Fig.3.32). β-Nrxn1 binds CASK (Calcium/Calmodulin-depend serine protein 
kinase), which effects the signal transduction (Zhang et al., 2001). Transcripts for Nrxn1 are 
ubiquitously expressed in epithelial cells lining the 2nd, 3rd and 4thpp (Annex 2). Nrxn1 (α + β) 
expression is maintained throughout thymic development in both thymic epithelia and thymocyte 
with the notable exception of single positive mature thymocytes (Fig.3.33 & Fig.3.34). There is 
circumstantial evidence that would suggests that β-Nrxn1 is a target of Bmp4, as overexpressing 
Bmp4 in vitro can initiate Nrxn1 expression ectopically in the brain and it is therefore 
conceivable but by no means proven that this molecule plays a role in early thymus 
organogenesis. Support for this contention is furthermore provided by the concomitted expression 
of CASK in the ventral aspect of the 3rdpp and by the fact that mice deficient for Tbx1 have 
downregulated the expression of Nrxn1 as early as E9.5 (Ivins et al., 2005). 
 
4.12 Genes upregulated in the ventral aspect of the 3rdpp involved in 
extracellular matrix interactions 
 
In vitro studies have demonstrated the roles of Heparan sulfate proteoglycans (HSPGs) in many 
cellular events. Recently, in vivo studies have begun to clarify their essential functions in 
organogenesis (Lin, 2004). In particular, HSPGs play crucial roles in regulating key 
developmental signalling pathways such as the Wnt, Hedgehog, transforming growth factor-beta 
and fibroblast growth factor pathways (Lin, 2004). HSPGs are part of macromolecules complexes 
of the cell-surface and extracellular matrix (ECM) and are composed of a core protein decorated 
with covalently linked glycosaminoglycan (GAG) chains (Lin, 2004). Col1a1 (Procollagen, type1 
alpha 1), Spock2 (Sparc/osteonectin and kazal-like domains proteoglycan 2), Galnt3 (N-
acetylgalatosaminyl transferase 3) and Hs2st1 (Heparan sulfate 2-O-sulfotransferase 1) form part 
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of the ECM or contribute to its assembling and have an increase of their mRNA transcripts in the 
ventral aspect of the 3rdpp by at least 3 fold if not exclusively expressed when compared to the 
dorsal side (Fig.3.21). Spock2 (a.k.a. testican-2), which encodes a member of a novel Ca(2+)-
binding proteoglycan family was suggested to play a role in the development of the central 
nervous system while Galnt3 encodes a glycosyltransferase responsible for initiating mucin-type 
O-glycosylation on glycoproteins (Schnepp et al., 2005; Topaz et al., 2004; Vannahme et al., 
1999). Colla1 transcripts were restricted to the ventral part of the 3rdpp (Fig.3.21). Although the 
expression of Colla1 has been shown to be regulated by Tgfβ1 in fetal fibroblasts nothing is 
known regarding the transcriptional control in thymic epithelial cells (Gallivan et al., 1997). 
Nevertheless, transcripts for Tgfβ2 (Fig.3.29) but not of Tgfβ1 (Annex 2) are also present in the 
ventral circumference of the 3rdpp and even more there when compared to the dorsal part. Colla1 
may hence be eventually upregulated by Tgfβ2 and/or an other member of the Tgfβ signalling 
family. Hs2st1 encodes for a heparan sulphate 2-O-sulphotransferase, which acts at an 
intermediate stage in the biosynthesis of heparan sulphate (HS). A cortical prerequisite for HS to 
bind to different ligands including Fst (Follistatin)/activin-binding protein, which was identified 
as being differentially expressed within the 3rdpp (Fig.3.21) (Nakamura et al., 1991). It is 
presently thought that different sulfation patterns created by distinct sulfotransferases such as 
Hs2st1 of HSPGs result in differences in the capacity to bind cell growth factors and thus in 
diverse signalling outcomes (Nogami et al., 2004). Mice deficient for Hst2st1 die in the neonatal 
period and exhibit bilateral renal agenesis and defects of the eye and the skeleton, a phenotype 
that has been suggested to be a consequence of compromised interactions between growth factors 
and their signal-transducing receptors (Bullock et al., 1998; Wilson et al., 2002). Data of these 
mutant mice have provided evidence that the regulated synthesis of differentially glycosylated 
proteoglycans can affect morphogenesis during murine development (Bullock et al., 1998). 
Taken together, these results may predict that Hs2st1 generates different sulfation patterns of 
HSPGs between the dorsal and ventral aspect of the 3rdpp to provide an appropriate and spatio-
temporal extracellular environment for morphogenetic signal transduction such as the Bmp 
and/or Tgfβ signalling. Hs2st2 may also play a role in the modulation of these signals so that the 
ventral aspect of the 3rdpp can adopt a thymic epithelial cell fate since Fst, an antagonist of the 
Tgfβ signalling, is known to bind to HSPGs. However, mice deficient for Hs2st1 have not been 
reported to have thymic anomalies. 
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4.13 Expressed sequence target genes upregulated in the 3rdpp 
 
Among the genes specifically present in the ventral aspect of the 3rdpp when compared to the 
dorsal part, two expressed sequence target genes (EST1 and EST2) were identified (Fig.3.21). The 
expression of EST1 in adult mice is detected in lymph tissues (i.e. thymus, bone marrow, spleen, 
lymph nodes) (Fig.3.37). EST1 was also detected in MTS24+ and MTS24- adult primary TECs as 
well as in several TEC cell lines (i.e. cTEC1.2, mTEC C6 and mTEC 3.10) but not in thymocytes 
(data not shown). As stated earlier, EST1 was found to belong to the TAP1 gene cluster. Hence, 
the fact that EST1 expression is essentially restricted to lymph tissues (Fig.3.37) in contrast to 
TAP1, which is almost expressed in all cell types, predicts that EST1 and TAP1 may have a 
different function. This is consistent with the observation that the polyA tail of EST1 is located at 
5’ upstream of TAP1 and that EST1 does not encode for exon11 of TAP1. Nevertheless, both 
transcripts, EST1 and TAP1, encode for the ATP-binding cassette. Taken together, these data 
suggest that EST1 is an alternative splice variant of TAP1 that may have a particular function for 
the immune system. 
 
In contrast to EST1, EST2 expression was not detected in any lymphoid tissues (including the 
thymus) examined by conventional RT-PCR but in the brain and testis (Fig.3.37). In regard to 
EST2 thymic expression, EST2 has been detected in the cTEC1.2 cell line but otherwise its 
expression could not be detected in adult primary TECs, in adult thymocytes or other TEC cell 
lines (cTEC 1.4, cTEC C9, mTEC 2.3, mTEC 3.10, and mTEC C6) examined (data not shown). 
EST2 transcripts were also found to be expressed in an entire E6.5 mouse cDNA library. This 
early expression in development as well as its expression in the ventral aspect of the 3rdpp and 
other tissues (e.g. Brain, testis) predicts a potential role in organogenesis. However, neither for 
EST1 nor for EST2 sufficient and substantial data are known so far to predict a function of these 
genes in the thymus. 
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5. Conclusions 
 
The work described in this thesis leads to the following facts: 
 
• The establishment of a protocol for the microdissection and recovery of tissue for RNA 
extraction. This method combined with gene expression profiling by microarrays allows the 
identification of genes differentially expressed between two tiny anatomical sites, i.e. the 
ventral and the dorsal aspects of the 3rdpp in mouse embryos at E10.5. 
 
• The identification of genes differentially expressed in the 3rdpp and thus potentially associated 
with early thymus development. Based on the limited number of experiments carried out, 
neither CD44, Phlda2 or Sp8 when not expressed in mice result in a disturbed commitment of 
endodermal cells to the thymic epithelial cell fate. 
 
• Most of the genes identified by this method were expressed in the thymus during 
development and post-natal life. Some of the gene products, could be detected both in thymic 
epithelial cells and thymocytes (e.g. Bmp4, Fst, c-Myc, Sp8, Phlda2 and Nrxn1), whereas 
others, e.g. WIF1 and Flrt3, were restricted in their expression to thymic epithelial cells. 
 
• Several of the genes identified to be differentially expressed in the 3rdpp are involved in the 
Tgfβ signalling (e.g. Bmp4, Fst, Tgfβ2 and Bambi) or the Wnt signalling (e.g. WIF1, Nkd1 
and Sfrp2) while others are targets of either or of both of these signalling pathways (e.g. c-
Myc and Nrxn1). 
 
• Fst, Phlda2 and Nrxn1 transcripts, which were identified to be upregulated in the ventral 
aspect of the 3rdpp at E10.5, were noticed to be downregulated in the pharyngeal region of 
mouse embryos deficient for Tbx1 at E9.5 and are thus revealing that these genes might be 
targeted by Tbx1 (Ivins et al., 2005). 
186 
6. Perspectives and Outlook 
 
Several candidate genes shown to be differentially upregulated or even exclusively expressed 
within the 3rdpp are involved in transcriptional regulation. For example, Fst and Nrxn1 genes 
were both found to be downregulated in the pharyngeal region of Tbx1 deficient embryos at E9.5 
(Ivins et al., 2005). Since the Tbx1 gene is essential for the normal development of the thymus, I 
would first start to analyse the thymic expression of K5 and K8 TEC markers between 13.5 and 
15.5 days of mouse gestation by immunohistochemistry in embryos deficient for Fst and Nrxn1 
genes, respectively. This in order to reveal whether or not the early development of the thymus 
proceeds normally in mice mutant for these candidate genes. In case, an abnormal thymus 
phenotype is revealed in the deficient mice, I would accordingly analyse the mutant thymus at 
earlier stages and at later stages than examined, always in comparison to wild type littermates to 
determine precisely at which stage of development, the candidate gene appears to be required. 
 
In case, embryos deficient for a given candidate gene is not available or die before they reach the 
E12.5 stage of development, I would try to generate a conditional knock-out mice for the given 
candidate gene. In more detail, these mutants would be generated as such as that the expression 
of the candidate gene is abolished in thymic epithelial cells (using a Cre/loxP system) as early as 
at E10.5. For example, by generating a knock-in mice, in which loxP sites have been inserted into 
the locus of the gene of interest as such as these mutants have only an expression deficiency 
when crossed to mice transgenic for the Cre gene under the control of a promoter from a gene 
whose expression is well expressed at E10.5 in the ventral aspect of the 3rdpp and whose 
expression is relatively restricted to the pharyngeal area (e.g. Hoxa3). To further reveal a role of 
the candidate genes, I would also analyse in fetal thymic organ cultures (FTOCs) the effect of 
overexpressing the candidate gene or of neutralizing antibodies for the examined candidate gene 
on the development of thymocytes as well as their effects on the growth of thymic epithelial cells 
(using a BrdU staining protocol). In that regard, I would start to examine the effect of 
neutralizing antibodies for WIF1 in FTOCs on the development of thymocytes as well as its 
effect on the expansion of thymic epithelial cells since this has not been tested yet. In addition, a 
functional analysis could also be done by testing the effect of overexpressing the candidate gene 
in a TEC cell line (i.e. cTEC1.2) and determine whether its affects the expression of several 
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important genes for thymus development (e.g. FoxN1, Pax1, Pax9, Hoxa3, Six1, Eya1). In fact, 
this expression analysis of essential genes in thymus development could also be examined in the 
different FTOCs after their incubation in presence of either excessive amount or of neutralizing 
antibodies for that candidate gene to reveal whether the thymic expression of  these genes are 
affected. 
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7. Appendix 
 
7.1 Annexes 
 
Annex 1 
Genes differentially expressed within the 3rdpp as identified by microarray analysis. 
 
Probe ID1 Gene name Gene 
Symbol 
D1 D3 V1 V3 Microarray 
ratio (3) 
92943_at glutamate receptor, ionotropic, AMPA1 (alpha 1) Gria1 A2 A P2 M2 13,78 
92346_at neurofilament 3, medium Nef3 A A P P 13,07 
98817_at follistatin Fst A A P P 10,40 
94305_at procollagen, type I, alpha 1 Col1a1 A A M A 9,96 
92203_s_at CD6 antigen CD6 A A A A 8,93 
102204_at v-maf musculoaponeurotic fibrosarcoma oncogene family, protein B  Mafb A A P A 8,76 
160172_at GTL2, imprinted maternally expressed untranslated mRNA Gtl2 A A A A 8,37 
161346_f_at protease, serine, 19 (neuropsin) Prss19 A A P A 8,03 
99916_at protein kinase C, eta Prkch A A P A 7,96 
93455_s_at bone morphogenetic protein 4 Bmp4 P P P P 7,82 
100548_at phosphoprotein enriched in astrocytes 15 Pea15 A A A A 7,49 
101538_i_at carboxylesterase 3 Ces3 A A P P 6,79 
103378_at prolactin-like protein A Prlpa A A A A 6,71 
92293_at RIKEN cDNA C130076O07 gene EST A A A A 6,27 
94379_at kinesin family member 1B Kif1b A A A P 5,97 
94515_at sulfide quinone reductase-like (yeast) Sqrdl A A A P 5,74 
100746_at EST EST A A A A 5,41 
162162_f_at EST EST A A A A 4,98 
162319_i_at EST EST A A A A 4,86 
95465_s_at Transmembrane protein 37 Tmem37 A A P P 4,74 
93642_at growth differentiation factor 1  Gdf1 A A P A 4,74 
97264_r_at casein kinase 1, delta Csnk1d A A A A 4,64 
96486_at Syntrophin, basic 1 Sntb1 A A P P 4,45 
104021_at homeo box A11 Hoxa11 A A A A 3,67 
92535_at early B-cell factor 1 Ebf1 A A A A 3,61 
95940_f_at EST EST A A A A 3,50 
103539_at cytoplasmic tyrosine kinase, Dscr28C related (Drosophila) Tec A A P P 3,48 
103794_i_at T-cell immunoglobulin and mucin domain containing 2 Timd2 A A A A 3,39 
96789_i_at galactose mutarotase Galm A A P A 3,30 
160860_at growth differentiation factor 10 Gdf10 A A A A 3,17 
99876_at src-like adaptor Sla A A A A 3,16 
96600_at EST EST A A P P 3,11 
104712_at myelocytomatosis oncogene Myc P P P P 3,01 
101154_at EST EST A A P P 2,92 
102956_at homeo box, msh-like 2 Msx2 A A P P 2,91 
103629_g_at lymphoid enhancer binding factor 1 Lef1 P A P P 2,90 
92990_at zinc finger protein 93 Zfp93 A A P P 2,78 
103569_at SH3-domain GRB2-like B1 (endophilin) Sh3glb1 P P P P 2,52 
104066_at EST EST A A P M 2,51 
102025_at chemokine (C-X-C motif) ligand 13 Cxcl13 A A A A 2,50 
100884_at aldo-keto reductase family 1, member B8 Akr1b8 A A P P 2,21 
103570_at C1q and tumor necrosis factor related protein 3 C1qtnf3 A A P P 2,15 
92681_at melanoma antigen, family L, 2 Magel2 A A P P 1,77 
101851_at Cd200 antigen CD200 A A P P 1,73 
99937_at mesenchyme homeobox 2 Meox2 P P P P 1,24 
114697_at CD44 antigen CD44 A A P P 23,63 
113088_at zinc finger, DHHC domain containing 21 Zdhhc21 A A P P 8,87 
114048_at DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked Ddx3y A A P P 8,22 
116782_at EST EST P A P P 7,28 
163730_i_at EST EST A A A A 6,32 
107112_at Transmembrane protein 16A Tmem16A A P P P 5,18 
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117331_at LIM and cysteine-rich domains 1 Lmcd1 A A A P 4,97 
117279_at EST EST A A P P 4,95 
115683_at EST EST A A P P 4,78 
163423_at Wnt inhibitory factor 1 Wif1 A A M A 3,65 
116747_at blood vessel epicardial substance Bves A A P P 3,42 
106971_at RIKEN cDNA A630031M04 gene Vps13d A A A A 3,34 
162531_at BMP and activin membrane-bound inhibitor, homolog (Xenopus 
laevis) 
Bambi P A P P 3,17 
114148_at EST EST A A P P 3,16 
162739_at inositol polyphosphate-5-phosphatase F Inpp5f A A P M 3,10 
107952_i_at whn-dependent transcript 2 Wdt2 A A M P 3,04 
163934_at sema domain, transmembrane domain (TM), and cytoplasmic domain, 
(semaphorin) 6D 
Sema6d A P P P 2,77 
108760_at EST EST A A P P 2,42 
114766_at neurexin I Nrxn1 A A P P 2,37 
163829_r_at chemokine (C-C motif) receptor 9 Ccr9 A A P P 2,33 
164237_at KH domain containing, RNA binding, signal transduction associated 3 Khdrbs3 A A M M 2,21 
114338_at v-maf musculoaponeurotic fibrosarcoma oncogene family, protein B  Mafb A A P P 2,16 
163582_at serine/arginine-rich protein specific kinase 2 Srpk2 A A P P 2,11 
108001_at EST EST A A P P 2,08 
106290_at EST EST A A P P 2,01 
167347_i_at EST EST A A A A 10,90 
134352_at EST EST A A P P 10,76 
137059_at EST EST A A A A 8,44 
166199_at gene model 1752, (NCBI) Gm1752 A A P P 6,12 
141032_at EST EST A A M A 5,42 
166264_at FYN binding protein Fyb A A A A 5,11 
137321_at EST EST A A A A 4,61 
135615_at EST EST A A P P 4,60 
133727_at leucyl/cystinyl aminopeptidase Lnpep A A P P 4,31 
134357_at EST EST A A P A 4,31 
165813_at EST EST A A A A 4,17 
166569_f_at SH3-domain binding protein 1 Sh3bp1 A A P A 4,12 
136661_at EST EST A A A P 3,92 
167905_f_at fibronectin leucine rich transmembrane protein 3 Flrt3 P P P P 3,81 
169259_f_at EST EST P P P P 3,75 
139234_at CAP, adenylate cyclase-associated protein, 2 (yeast) Cap2 A A M A 3,66 
138501_r_at EST EST A A P A 3,48 
128821_at EST EST A A M M 3,32 
135184_at EST EST A A P P 3,11 
135317_at EST EST A A P P 3,07 
169068_i_at EST EST A A P A 3,03 
137713_at EST EST A A M P 2,88 
166600_at KH domain containing, RNA binding, signal transduction associated 3 Khdrbs3 P P P P 2,81 
134774_at EST EST A A P A 2,77 
166521_f_at Gene model 106 (NCBI) Gm106 A A A P 2,62 
169997_i_at p21 (CDKN1A)-activated kinase 3 Pak3 A A P A 2,62 
133203_at EST EST A A P A 2,58 
129286_at EST EST A A P A 2,50 
130608_at EST EST A A P A 2,42 
130957_f_at EST EST P P P P 2,37 
168351_at EST EST A A P P 2,34 
137595_at EST EST A A P P 2,27 
135649_at EST EST A A P P 2,23 
166675_at EST EST A A P A 2,16 
94101_at zinc finger protein 98 Zfp98 A A A A 5,78 
98818_at nuclear receptor subfamily 3, group C, member 1 Nr3c1 A A A A 4,72 
102653_at ryanodine receptor 2, cardiac Ryr2 A A A A 4,22 
102280_at protocadherin 7 Pcdh7 A A P P 3,97 
162439_at POU domain, class 2, associating factor 1 Pou2af1 A A A A 3,81 
102299_at protein kinase C, alpha Prkca A A P A 3,49 
93711_at EST EST A A A P 3,44 
104375_at sparc/osteonectin, cwcv and kazal-like domains proteoglycan 2 Spock2 A A P P 3,19 
101178_at sema domain, immunoglobulin domain (Ig), short basic domain, 
secreted, (semaphorin) 3C 
Sema3c A A P P 2,97 
95625_at solute carrier family 6 (neurotransmitter transporter, creatine), member Slc6a8 A A P P 2,83 
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94419_at solute carrier family 19 (sodium/hydrogen exchanger), member 1 Slc19a1 A A P P 2,70 
100943_at solute carrier family 1 (glutamate/neutral amino acid transporter), 
member 4 
Slc1a4 A A P P 2,66 
161882_f_at retinol dehydrogenase 13 (all-trans and 9-cis) Rdh13 A A A M 2,54 
101879_s_at complement receptor related protein Crry A A P P 2,32 
103090_at EST EST A A P P 2,26 
161026_s_at synaptotagmin-like 4 Sytl4 A A P P 2,22 
104548_at pleckstrin homology-like domain, family A, member 2 Phlda2 A A P A 2,09 
110311_at naked cuticle 1 homolog (Drosophila) Nkd1 A A A A 5,81 
106100_at histamine receptor H 1 Hrh1 A A A A 3,80 
106861_at adaptor-related protein complex 3, sigma 2 subunit Ap3s2 A A A M 3,40 
114507_at GTP binding protein 2 Gtpbp2 A A A A 3,35 
107779_at NIMA (never in mitosis gene a)-related expressed kinase 4 Nek4 A A A A 3,05 
164972_r_at nerve growth factor receptor (TNFRSF16) associated protein 1 Ngfrap1 A A P A 2,96 
106017_at adaptor-related protein complex 1, sigma 2 subunit Ap1s2 A A A P 2,39 
109301_i_at calpastatin Cast A A A P 2,25 
169398_i_at EST EST A A A A 7,45 
166402_i_at solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) 
transporter), member 3 
Slc35a3 A A P A 4,77 
170678_i_at EST EST A A A A 3,51 
169016_at EST EST A A A A 3,38 
167747_f_at EST EST A A M A 2,06 
99011_at UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-
acetylgalactosaminyltransferase 3 
Galnt3 P P P P 4,57 
92722_f_at Sine oculis-related homeobox 1 homolog (Drosophila) Six1 P P P P 3,12 
100924_at GATA binding protein 3 Gata3 P P P P 3,04 
97942_g_at calpain 6 Capn6 P P P P 2,65 
102306_at heparan sulfate 2-O-sulfotransferase 1 Hs2st1 P P P P 2,60 
93568_i_at EST EST P P P P 2,57 
160899_at Purkinje cell protein 4 Pcp4 P P P P 2,15 
160670_at tumor necrosis factor receptor superfamily, member 19 Tnfrsf19 A P P P 1,95 
103538_at T-box 3 Tbx3 M A P P 1,73 
99178_at glycoprotein m6b Gpm6b P P P P 1,58 
110654_at N-acylsphingosine amidohydrolase 2 Asah2 P P P P 3,57 
164044_r_at EST EST P P P P 3,15 
111896_at EST EST P P P P 2,30 
 
Explanations: (1) Probe ID refers to the affymetrix reference number for a probe set specific for a given gene. (2) A; 
M and P denote absent, marginal and present calls, respectively. The ratio is defined as the average fold difference in 
signal intensity between two samples independently generated taken from the dorsal and the ventral epithelium of the 
3rdpp, as measured by microarray analysis (3). Samples 1 and 2 of the dorsal and ventral aspects of the 3rdpp are 
annoted as D_1, D_2, V_1 and V_2, respectively. 
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Annex 2 
Microarray data for genes potentially involved if not known to be important for thymus development. 
 
Probe ID Gene 
Symbol 
 
D_1 
 
D_2 
 
V_1 
 
V_2 
 
 
3_1 
 
3_2 
 
2_1 
 
2_2 
 
4_1 
 
4_2 
 
4_3 
Microarray 
V/D 
ratio 
Microarray  
3/2 
ratio 
92674_at FoxN1 A A A A A A A A A A A 3,35 4,19 
115295_at FoxN1 A A A M A A A A A A A 2,80 6,02 
161049_at FoxG1 A P P P P A A A A A A 2,21 0,68 
94709_at Gcm2 P P P P P A P P P P P 0,36 3,89 
96595_at Pax1 P P P P P A P P A M M 1,32 14,38 
100697_at Pax3 A A A A A A A A A A A 0,39 0,97 
98838_at Pax9 P P P P P A P P A P A 0,68 2,00 
163890_at Hoxa3 P P P P P A P P P P P 1,13 3,88 
169259_f_at Six1 P P P P P A P P A A M 3,75 11,37 
94706_s_at Eya1 P P P P P P P P P P P 1,52 1,29 
98419_at Meox1 P P P P A P P P P P P 0,66 3,99 
109325_at Bmp7 P P P P P P P P P M P 0,88 0,51 
101526_at Msx1 A P P P P P A P A A A 1,98 1,34 
102984_g_at Smad1 P P P P A P P P P P P 1,08 0,86 
97509_f_at Fgfr1 P P P P P A P A A A A 2,10 0,75 
162171_f_at Fgfr2 P P P P P A P P P M P 0,90 0,47 
100277_at Inhba A A P P P A P A M A A 1,63 0,13 
101918_at Tgfb1 A A A A A A A A A A A 0,36 1,12 
108468_at Bmpr1a P P P P P P P P P P P 1,54 1,27 
98841_at Acvr2 P P P P P P P P P P P 0,97 0,89 
97727_at Nog A P A A M A P A A A A 0,58 1,29 
141073_at VEGF A A A A A A A A A A A 0,42 0,61 
160887_at Hes1 P P P P P P A P M M A 0,69 1,41 
98623_g_at Igf2 P P P P P P P P P P P 1,50 1,36 
160453_at Ryk P M P P P M P P A A P 1,19 2,18 
94134_at Wnt1 A A A A A A A A P A A 0,78 0,97 
101975_at Dlk1 P P P P P P P P P P P 3,39 2,35 
92931_at Dll1 A A A A A A A A A A A 0,97 1,17 
102746_at Dll3 A A A A A A A A A A A 1,01 1,15 
163429_at Dll4 A A A A A A A A A A A 2,47 0,84 
102248_f_at CASK P P P P P P P P P P P 1,20 0,99 
104189_at Traf6 P P P P P A P P P P P 1,31 3,21 
 
Explanations. A, M, P denote an absent, a marginal and a present call, respectively. The ratio is defined as the 
average fold difference in signal intensity between two samples (generated independently) of the dorsal and the 
ventral epithelium of the 3rdpp (V/D) and the 2nd and 3rdpp (3/2), respectively, as measured by microarray analysis. 
Duplicate samples of the dorsal and the ventral 3rdpp epithelium of the 3rdpp and 2ndpp and 3rdpp are respectively 
annoted as D_1, D_2 and V_1, V_2, and 2_1, 2_2 and 3_1, 3_2. 
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